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The medical profession has increased its acceptance of the benefits of exercise training for 
patients with uncomplicated coronary artery disease. Access to more modem technology and 
better management of this condition has led to an increase in the number of patients surviving 
acute coronary episodes. Some of these patients may have developed chronic asymptomatic 
left ventricular dysfunction and/or residual myocardial ischaemia, and could become potential 
candidates for cardiac rehabilitation if exercise training could induce physiological benefits 
without further deteriorating their condition. 
Over the last 10 years, several patients at moderate to high risk of future cardiovascular events 
because of the presence of left ventricular dysfunction and/or myocardial ischaemia have been 
accepted for cardiac rehabilitation at the Johannesburg Cardiac Rehabilitation Center. 
The purpose of the study was to evaluate the effects of exercise training on left ventricular 
function and exercise capacity in patients with coronary artery disease and varying degrees of 
left ventricular dysfunction and/or myocardial ischaemia attending the Johannesburg Cardiac 
Rehabilitation Center. 
The degree of left ventricular impairment on admission to the cardiac rehabilitation 
programme was evaluated in 118 patients with documented coronary artery disease, by 
comparing the left ventricular function of these patients to that of 31 volunteers without 
known cardiac disease using resting and exercise radionuclide ventriculography (Chapter 3). 
Significant alterations in systolic and diastolic left ventricular function were seen both at rest 
and during exercise in patients compared to controls. Ejection fraction and peak filling rate 
were significantly reduced at rest (51.2% ± 1.2 vs 61.1 % ± 2.4, p=0.0004 and 2.04 ± 0.07 vs 
2.39 ± 0.1_3, p=0.023, respectively), while peak ejection rate, average ejection rate and peak 
filling rate had an attenuated increase in response to exercise (p=0.009, p=0.007 and p=0.003 
respectively). Sixty two percent of patients had a normal ejection fraction while it was 
moderately impaired in 23% and severely impaired in 15~. Patients with depressed ejection 
fraction also had chronic ventricular dilatation at rest whereas they maintained cardiac output 
during exercise as a result of a greater increase in heart rate rather than an increase in end-
XXIX 
diastolic volume. Even some patients with normal ejection fractions demonstrated alterations 
in diastolic function suggesting some degree of subclinical myocardial ischemia. 
We next evaluated the predictors of exercise capacity in another group of 171 patients with 
coronary artery disease and various degrees of left ventricular dysfunction (Group 0), with 
special emphasis on the role of the left ventricular systolic and diastolic dysfunction measured 
on admission to the programme (Chapter 4). One hundred and six patients had an EF:::50% 
(Group 1), 38 had and EF:::35% and <50% (Group 2) and 27 had and EF<35% (Group 3). 
Resting parameters of systolic and diastolic left ventricular function did not predict the 
exercise capacity of patients with coronary artery disease at any level of left ventricular 
impairment. Non cardiac factors including age, gender, Broca index, and forced vital capacity 
explained 50% of the variation in peak oxygen uptake in Group O (r2=0.54, p=0.0001). After 
exercise training all groups showed a significant increase in peak oxygen uptake ( G 1: 25 .2 ± 
6.1 to 28.7 ± 7.1 ml/kg/min, p<0.001; G2: 25.1 ± 6.5 to 30.5 ± 6.3 ml/kg/min, p<0.001 ; G3: 
20.6 ± 5.4 to 24.1 ± 6.9 ml/kg/min, p<0.001) , ventilatory threshold (Gl: 17.0 ± 3.7 to 18.9 ± 
4.4 ml/kg/min, p<0.001; G2: 16.6 ± 2.9 to 18.8 ± 3.4 ml/kg/min, p<0.01; G3: 14.3 ± 3.0 to 
16.4 ± 3.8 ml/kg/min, p<0.001) and treadmill time to exhaustion (Gl: 11.3 ± 3.4 to 13.6 ± 3.9 
minutes, p<0.001; G2: 11.4 ± 3.5 to 14.7 ± 3.4 minutes, p<0.001; G3: 9.2 ± 3.4 to 11.5 ± 4.0 
minutes, p<0.001). The magnitude of the improvement in these variables was the same for all 
groups. 
We analysed more carefully the effects of a 6 month exercise training programme on the 
physiological status and left ventricular function of twenty eight patients recovering from an 
acute myocardial infarction and with a left ventricular ejection fraction of 30% or less 
(Chapter 5). Twenty two patients who completed the exercise training programme showed a · 
significant improvement in maximal exercise capacity and a significant reduction in their 
cardiovascular demands during submaximal exercise. Peak oxygen consumption was 
increased by 12% after training (19.4 ± 3 vs 21.8 ± 4.8 ml/kg.min, p<0.05) and exercise time 
to exhaustion by 33% (527 ± 171 vs 700 ± 186 seconds, p<0.001). The double product at the 
same subinaximal work load was significantly reduced (214 ± 52 vs 194 ± 44 bpm.mmHg x 
100, p<0.05). These benefits were achieved without any adverse effects on resting (25.4 ± 5 
XXX 
vs 28.5 ± 7.9%, p<0.05) or exercise (27.3 ± 7.7 vs 29.9 ± 9.5%, p<NS) left ventricular 
ejection fraction. 
We next assessed the effect of myocardial ischaemia developing during exercise on the left 
ventricular function and adaptability to training of patients with coronary artery disease 
enrolled into a 6 month exercise training programme (Chapter 6). Twenty two patients with 
exercise-induced myocardial ischaemia, 10 with symptomatic ischaemia and 12 with silent 
ischaemia, defined by ST segment depression during maximal exercise testing and by 
transient perfusion defects during radionuclide perfusion imaging using Tc-MIBI, constituted 
our experimental group (EG). Fifty patients without evidence of exercise-induced myocardial 
ischaemia were assigned to the control group for exercise training (CG-ET) and 31 subjects 
without signs or symptoms of cardiac disease constituted the control group for the measures of 
left ventricular function (CG-LV). EG had significant abnormalities in systolic and diastolic 
left ventricular function at rest compared to CG-LV and maintained their cardiac output 
during exercise through increases in both heart rate and end-diastolic counts. EG showed 
significant increases in ventilatory threshold (16.8 + 3.0 to 18.7 + 2.6 ml/kg/min, p<0.003) 
and peak oxygen uptake (25.2 + 5.1 to 26.9 + 5.4 ml/kg/min, p<0.02) which were of a similar 
magnitude to the changes in CG-ET, but the latter also showed significant reductions in heart 
rate (110.7 + 2.5 to 104.5 + 2.0 bpm, p<0.091), systolic blood pressure (168.8 + 4.2 to 154.3 + 
3.5 mmHg, p<0.002) and rate-pressure product (18.9 + 0.7 to 16.3 + 0.5 bpm x mmHg x 10
3
, 
p<0.001) at submaximal levels. No significant changes in these measures 'Yere found in the 
subgroups with silent or symptomatic exercise-induced myocardial ischaemia after 6 months. 
No increase in heart rate or treadmill time at onset of myocardial ischaemia was seen in the 
EG or in the subgroups with silent or symptomatic ischaemia as a result of training. 
We next assessed the ventilatory responses to exercise in a subgroup of 102 patients from the 
- cohort studied in Chapter 4, before-and after 6 months of exercise training (Chapter 7). Group 
1 (Gl) included 63 patients with EF:=:50%, Group 2 (G2) included 21 patients with EF:=:35 and 
<50% and Group 3 (G3) included 18 patients with EF<35%. As above all groups showed a 
significant increase in peak oxygen uptake and treadmill _time after training in spite of G3 
patients being significantly more deconditioned than G2 and G 1 patients on admission to the 
program (Gl: p=0.0001 arid p=0.0001; G2: p=0.0001 and p=0.001; G3: p=0.01 and p=0.01; 
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respectively). Patients in G3 had a significantly higher minute ventilation/carbon dioxide 
excretion ratio (VE/VC02) than patients in G2 and G 1 at 9 minutes, at peak exercise, before 
(9 minutes: p=0.046 and p=0.025, peak: p=0.024 and p=0.002, respectively) and after 
training (9 minutes: p=0.011 and p=0.005, peak: p=0.001 and p=0.0001, respectively) and 
also at the point of maximum ventilatory efficiency. The slope of the relation VE to VC02 
was significantly higher in G3 patients than in those in G2 and G 1 (p=0.0001 respectively) 
and was not reduced by exercise training in any group. 
Lastly, we evaluated the effects of 6 and 18 months of exercise training on the left ventricular 
function of patients with coronary artery disease evaluated in Chapter 3. One hundred and 
eighteen patients who entered and finished the 6 month t~_aining programme ( cohort ET6) 
were divided into 4 categories according to their compliance in terms of attendance to 
prescribed exercise sessions: <40% attendance - n=16 (Cl), ::40 - <60% - n=23 (C2), ::60 -
<80% - n=33 (C3) and ::80% - n=46 patients (C4). Forty patients finished the 18 month 
programme (cohort ET18) and were divided into 3 categories: <60% - n=l 1 (Cl), >60 - <80% 
- n=14 (C2) and ::80% - n=15 (C3). We found that the most significantly beneficial effects 
were obtained by those patients who attended more than 80 % of the possible sessions for a 
period of 6 months. Adaptations at maximal (peak V02: 26.1 .±: 0.9 to 29.7 .±: 1.1 ml/kg/min, 
p<0.01) and submaximal effort (heart rate: 113.5 .±: 3.4 to 108.3 .±: 3.1, p<0.01; blood pressure: 
156.8 .±: 4.4 to 147.8 .±: 3.7 mm.Hg, p<0.05; rate-pressure product: 18.0 .±: 0.9 to 16.0 .±: 0.6 
bpm.mm.Hgx103, p<0.01) were observed as well as a resting bradycardia (75.0 .±: 2.4 to 70.8 .±: 
2.2 bpm, p<0.01) and an improvement in diastolic function as demonstrated by a significantly 
greater increase in PFR (p=0.037) and AV-RFR (p=0.046) during exercise than in the other 
groups. 
Conclusions 
Patients presently accepted for cardiac rehabilitation showed a high incidence of left 
ventricular function abnormalities emphasizing the need for risk stratification procedures in 
order to guide the monitoring and supervision of their exercise training sessions. 
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Non cardiac factors were better predictors of the · effort tolerance in these patients than 
parameters of left ventricular function at entry to an exercise programme or after 6 months of 
training. A similar degree of adaptation to training was seen in all patients regardless of their 
degree of left ventricular systolic or diastolic dysfunction on admission to the programme. 
After 6 months of exercise training, patients with severe left ventricular dysfunction were able 
to derive physiological benefits at maximal and submaximal levels of effort without any 
deleterious effect on their left ventricular function, suggesting that physical training should 
form part of the comprehensive management of these patients. 
In patients with myocardial ischaemia, exercise training produced improvements in maximal 
exercise capacity but failed to elicit physiologic adaptations at a submaximal workload or to 
increase the threshold for ischaemia. It is possible that exercise training could have improved . 
cardiovascular efficiency if patients would have been on an aggressive coronary risk factor 
programme, with particular emphasis to lipid lowering. 
Asymptomatic patients in NYHA classes I and II and with an EF below 35% had a greater 
ventilatory response to effort and lower ventilatory efficiency than patients with moderately 
impaired or normal left ventricular function. Despite increasing their tolerance to effort, 
exercise training failed to reduce their ventilatory response to exercise suggesting that 
mechanisms other than a reduced blood flow or early non-independent metabolism might be 
implicated in the pathophysiology of this important symptom. 
Both groups of patients with left ventricular dysfunction and with myocardial ischaemia 
maintained their cardiac output by using the Frank Starling mechanism. While patients with 
left ventricular dysfunction developed a chronic increase in end-diastolic volume at rest, 
patients with myocardial ischaemia developed an .acute increase during exercise. 
Improvements in left ventricular diastolic function were observed in patients who attended 
80% or more of the possible sessions during the first 6 months. These patients also obtained 
the greatest benefits from the exercise training programme improving their maximal exercise 
capacity, reducing their blood pressure and heart rate at submaximal effort and developing a 
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resting bradycardia. Attendance for a further 12 months produced no additional benefits other 
than contributing to maintain the maximal exercise capacity reached the year before. 
However, it is possible that longer participation in a structured cardiac rehabilitation 
programme could have some effects in promoting better adherence to exercise training and an 
overall healthier lifestyle. 
In summary: 
Patients enrolling in contemporary cardiac rehabilitation programmes may have alterations in 
systolic and/or diastolic left ventricular function as well as residual myocardial ischaemia. 
Regardless of their degree of left ventricular dysfunction these patients can derive similar 
beneficial physiological adaptations to those of patients with normal left ventricular function 
because the effects of exercise training are more manifested in the periphery than in the 
central circulation. Even patients with ejection fractions of 30% or lower can fully benefit 
from exercise training during both submaximal and maximal exercise without the risk of 
further jeopardizing their already severely compromised left ventricular function. On the other 
hand, exercise training might be marginally important in patients with myocardial ischaemia 
who only increased their maximal exercise capacity in response to exercise training. 
Aggressive cholesterol lowering in these patients could be a strategy more relevant than 
exercise training to reverse the disease process and improve their quality of life. Adherence to 
80% or more of the possible exercise sessions is required in order to elicit full training 
benefits, at rest, during submaximal and during maximal exercise as well as a possible 
improvement in left ventricular function, in patients participating in moderate intensity 






Cardiac rehabilitation is an accepted mode of treatment for patients with coronary artery 
disease (CAD). Medically supervised exercise conditioning is the focal point of cardiac 
rehabilitation programmes and it is this, which primarily differentiates such programmes 
from simple counselling services (1). 
Traditionally designed for patients recovenng from an acute myocardial infarction, 
cardiac rehabilitation has been expanded to include patients after revascularization 
procedures, patients with coronary risk factors, older patients and higher risk patients, that 
is, subjects with residual myocardial ischaemia and with left ventricular dysfunction. 
An improvement in the patient's submaximal and maximal exercise capacity is one of the 
major end-points of cardiac rehabilitation programmes. This is particularly important in 
ambulatory patients with chronic heart failure in whom exertional dyspnoea and fatigue 
are important causes of morbidity and inability to return to work (1). 
In patients with CAD, normal or near-normal exercise capacity has generally been thought 
to reflect normal left ventricular (L V) function. The assumption that exercise capacity 
relates to the severity of heart disease has formed the basis of the New York Heart 
Association classification of patients with heart disease, which has become the most 
commonly used clinical classification for this type of patient (2). 
For many years, patients with heart failure were advised to refrain from physical activity 
and to maintain a sedentary existence, for fear that physical training would result in further 
deterioration of L V functum. It is only -in the last decade that some cardiac rehabilitation 
centres have started accepting this type of patient on their programmes. The Johannesburg 
Cardiac Rehabilitation Centre, in Johannesburg, South Africa, is one of these centres. 
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1.2 Cardiac rehabilitation 
1.2.1 Introduction 
Structured cardiac rehabilitation programmes were developed in the 1960s and their benefits, 
additional to standard medical care, have been demonstrated. The acknowledgement of these 
benefits led the World Health Organization Expert Committee on Rehabilitation of Patients 
with Cardiovascular Diseases (1993) to recommend that cardiac rehabilitation programmes 
become an essential part of the care that should be available to all cardiac patients worldwide 
(3). This can only be achieved if such programmes match the needs and resources of each 
community, and in this way become a component of comprehensive cardiac care integrated 
into existing health-care delivery systems. Thus it was recommended that basic, intermediate 
or advanced facilities should be developed according to the needs of different communities 
(See Annexure 1.1 ). 
1.2.2 Proven benefits of cardiac rehabilitation 
Several recent publications confirm that cardiac rehabilitation services are indeed 
beneficial and cost-effective ( 4-7). 
The "Clinical Practice Guideline: Cardiac Rehabilitation" (4) developed under a contract 
from the Agency for Health Care Policy and Research with the support of the National 
Heart, Lung, and Blood Institute, is perhaps the most comprehensive currently available 
document to address the subject. The contract was awarded in 1992 to the American 
Association of Cardiovascular ana. Pulmonary Rehabilitation, which convened a private-
sector multidisciplinary pan~l of experts representing a diversity of health care specialities: 
cardiology, internal medicine, family medicine, nursing, beh_avioural science, dietetics, 
physical therapy and exercise physiology as well as consumer representatives. The panel 
based its conclusions and recommendations principally on scientific evidence from the 
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critical review of over 400 original reports published in peer-reviewed medical and health 
sciences journals. When the scientific literature was incomplete or inconsistent in a 
particular area, the recommendations reflect the professional judgement of panel members 
and consultants. The greatest weight of evidence (A) was given to well-designed and well-
executed randomized controlled trials, and the least weight was accorded to observational 
studies (C) (Annexure 1.2). 
The most substantial benefits included: improvement in exercise tolerance, improvement 
in symptoms, improvement in blood lipid concentrations, reduction in cigarette smoking, 
improvement in psychosocial wellbeing and reduction of stress and reduction in mortality. 
Of the 24 randomized and non-randomized controlled trials that reported mortality 
outcomes only 6 managed to show a reduction in mortality in rehabilitation versus control 
patients. Two recent meta-analyses of randomized controlled trials (8,9) which included 
more than 4000 patients with coronary artery disease, confirmed that the lack of consistent 
results was due to the inability of single studies to enroll adequate numbers of patients in 
order to be able to measure significant mortality reductions. The meta-analyses were able 
to show a 25% reduction in mortality at the 3-year follow-up in rehabilitation versus 
control patients, which is similar to that reported for the use of beta-blocking agents 
following myocardial infarction or the use of angiotensin converting enzyme inhibitors in 
patients with left ventricular systolic dysfunction. This beneficial outcome was greater in 
the trials using the multifactorial components of cardiac rehabilitation than in the trials that 
used exercise training as the sole intervention. 
Information obtained from two large surveys (10,11) showed that exercise cardiac 
rehabilitation is a safe modality of treatment for cardiac -patients as evidenced by a very 
low rate of myocardial infarctions and cardiovascular complications during exercise 
training (Annexure 1.3). 
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Improvemem in pathophysiologic measures was also reviewed in the guidelines. Two 
randomized controlled trials of multifactorial rehabilitation (12,13) including exercise 
training and intensive dietary intervention, showed less progression and greater regression 
of the disease in rehabilitation versus control patients, when measured with digitally 
processed coronary angiography. The Stanford Coronary Risk Intervention Project (14) 
showed significant improvement in slowing the rate of progression of coronary 
atherosclerotic lesions over 4 years in individuals with angiographically-defined CAD 
assigned to a multifactor cardiovascular risk reduction programme versus individuals 
assigned to usual cardiological care. 
The Secondary Prevention Panel of the American Heart Association published their 
Consensus Statement: "Preventing Heart Attack and Death in Patients with Coronary 
Disease", with the endorsement of the Board of Trustees of the American College of 
Cardiology (5). They stated that there is strong scientific evidence that in patients with 
coronary artery disease, "comprehensive risk factor interventions can extend survival, 
improve quality of life, decrease the need for interventional procedures such as angioplasty 
and bypass grafting and reduce the incidence of subsequent myocardial infarction". 
The above recommendations were agam reinforced in September 1995 at the 27th 
Bethesda Conference of the American College of Cardiology, the theme being "Matching 
the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events" 
(6). It was agreed that risk factor management is the cornerstone of the optimal care of 
patients with cardiovascular disease. It was also recognised that, in spite of the available 
scientific evidence in support of risk factor management, the proportion of high risk 
patients receiving appropriate care is alarmingly low. 
Similar recommendations were made a year earlier by the Task Force of the European 
Society of Cardiology, European Atherosclerosis Society and ~uropean Society of 
Hypertension which were published simultaneously in Atherosclerosis and the European 
Heart Journal in 1994 (7). 
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The multidisciplinary team approach was selected as the optimal technique to achieve the 
risk factor modifications recommended above, reinforcing the role of cardiac rehabilitation 
in risk factor management. 
1.3 Cardiac Rehabilitation in South Africa 
1.3.1 Introduction 
Despite declining mortality rates from cardiovascular diseases in industrialised countries, 
such as the United States of America and also Western Europe, Australia, New Zealand 
and Japan, cardiovascular diseases represent an increasing problem in the developing 
countries of Latin America, Africa and Asia. Modernisation, control of communicable 
disease and a resulting increase in life expectancy of people in these countries account for 
the increased prevalence of these diseases (3). 
South Africa is no exception. Increasing urbanisation associated with marginal increases in 
income result in greater exposure to new consumer opportunities, while poor education 
results in more vulnerability to mass advertising with a negative impact on recognised risk 
factors such as smoking and the adoption of high fat diets. 
1.3.2 The need 
South Africa has one of the highest rates of coronary artery disease in the world, with the 
Asian population ranking first in terms of mortality and the White pop_ulation ranking 3rd 
after Northern Ireland and Scotland (Table 1.1) (15). It was estimated that in 1980 
approximately 50 000 South Africans suffer heart attacks every year, 25% of which are 
probably fatal. This leaves many of the possible 37 000 survivors as well as most people 
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undergoing revascularization procedures, as future candidates for cardiac rehabilitation 
(16). 
Although there appears to be a downward trend in mortality figures (Table 1.2), there is 
still a "coronary epidemic" which will remain a problem for many years to come (15). 
Chronic diseases which share similar risk factors as a result of an unhealthy lifestyle, such 
as cerebrovascular accident, myocardial infarction, tobacco and nutrition-induced cancer, 
chronic obstructive airway disease, diabetes, some liver and renal disease and 
osteoporosis, accounted for 25% of deaths of all South Africans and 29% of economically 
active 35 - 64-year-olds whose deaths were reported in 1988. Cerebrovascular disease and 
coronary artery disease were the two major contributors to these deaths, accounting for 8 
% respectively of the overall mortality (17). 
Using the South African population aged 15-64 years as determined in the census of 1985 
(total population: 18 485 644), it was estimated that 4.9 million Sout Africans were current 
smokers, that 5.5 million had blood pressure readings above 140/90 mrnHg and that 4.8 
million had hypercholesterolaemia. Accordingly, approximately 50% of this population 
was at risk of developing heart disease and thus required lifestyle modification and 17% 
was at sufficiently high risk to require medication (17J. 
From the data above it becomes evident that there is a continual loss to commerce and 
industry as well as a loss to society in the disruption of family life. There is, therefore, an 
obvious need for the development of primary prevention strategies and for the 
establishment and acceptance of cardiac rehabilitation programmes in order to conserve 
much needed manpower. 
Table 1.1 Age-standardised mortality rates from Ischaemic Heart Disease in South 
African populations in 1985 and 1989 compared with rates in other countries 
in 1985; rates per 100 000 population aged 30-49 years (15). 
COUNTRY MALE FEMALE 
1985 1989 1985 1989 
SOUTH AFRJCA 
Blacks 18 17 11 10 
Asians 499 417 234 182 
Coloureds 245 198 134 113 
Whites 391 257 117 83 
NORTHERN IRELAND 406 130 
FINLAND 390 79 
SCOTLAND 398 142 
ENGLAND 318 94 
USA 235 80 
DENMARK 251 69-
AUSTRALIA 247 76 
CANADA 230 66 
ISRAEL 183 73 
SWITZERLAND 40 30 -
-
FRANCE 94 20 
JAPAN 38 13 
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Table 1.2 Age-standardised mortality rates per 100 000 ( world population, all ages) for 
total deaths and for Ischaemic Heart Disease deaths in South African 
populations in 1978 and 1989, with percentage falls in mortality (15). 
BLACKS ASIANS COLOUREDS WHITES 
M F M F M F M F 
1978 
Total mortality rate 1072 661 1306 980 1691 1108 1002 615 
IHD mortality rate 16 9 355 196 171 94 314 133 
1989 
Total mortality rate 1068 832 1130 755 1392 911 631 366 
IHD mortality rate 11 8 226 113 110 71 139 55 
% fall in total - - 14 23 18 18 37 41 
mortality rate 
% fall in IHD - - 36 43 36 25 56 59 
mortality rate 
1.3.3 The South African Association of Cardiovascular Rehabilitation 
The prevalence of cardiovascular diseases in South Africa, the underutilisation of existing 
cardiac rehabilitation services, the lack of standards and/or guidelines for cardiac 
rehabilitation, and the lack of an adequate remuneration system for health professionals 
working in the field created the need for the formation of a body which could co-ordinate 
and promote cardiac rehabilitation services in South Africa. 
The South African Association of Cardiovascular Rehabilitation was created in July 1994. 
It is controlled by a Board of Directors whose members are all actively involved in cardiac 
rehabilitation. Multidisciplinary participation as well as geographical representation were 
assured. 
The aim of the Association is to promote and develop the practice of cardiac rehabilitation 
in South Africa. Specific objectives are: 
1- To promote the practice of primary and secondary prevention/rehabilitation through 
supervised exercise training and lifestyle modification. 
2- To promote throughout the public sector an increased awareness and understanding of 
cardiac rehabilitation services. 
3- To provide professional education and to encourage research within cardiovascular 
rehabilitation through the creation of guidelines, the promotion of educational 
conferences, scientific meetings and publications. 
4- To promote a multidisciplinary approach towards cardiac rehabilitation providing ways 
and means to enhance career developments for Association members. 
1.3.4 Cardiac rehabilitation programmes in South Africa 
A preliminary questionnnaire-based survey, performed by the South African Association 
of Cardiovascular and Pulmonary Rehabilitation in 1994 identified 13 centres where 
9 
cardiac rehabilitation played an important part of the services provided. They were all 
located in the major cities: five in Johannesburg, two in Cape Town, two in Pretoria, one 
in Bloemfontein, one in Durban, one in Port Elizabeth and one in East London. Although 
this was probably an underestimation since small programmes unknown to the Board of 
Directors of the Association were not considered, it shows how underdeveloped cardiac 
rehabilitation is in South Africa. 
According to the World Health Organisation classification of the level of service provided 
(3), of the 13 programmes identified, one was considered basic, ten intermediate and two 
advanced. Five programmes were hospital-based and eight community-based. Four 
programmes offered Phase 1 cardiac rehabilitation, 9 Phase 2, 10 Phase 3 and 8 Phase 4. 
All programmes required exercise testing before admission onto the programme and in 7 
the exercise tests were done at the centre itself. Eleven required also a lipid evaluation at 
entry. All programmes had an aerobic exercise conditioning component which was 
complemented by resistance training activities in eight. All programmes required their 
patients to fill in a log card and only 2 programmes provided telemetric monitoring. 
Educational sessions were available in 12 out of the 13, psychological counselling in 11, 
nutritional counselling in 10 and smoking cessation programmes in only 2. 
1.3.5 The Johannesburg Cardiac Rehabilitation Programme 
The South African Health Act of 1977 decreed that the responsibility for rehabilitation 
should be taken by the local authorities. As a result, in September 1982, the Health 
Department of the Johannesburg City Council established a Cardiac Rehabilitation facility 
at the Civic Centre in Johannesburg. Cardiac rehabilitation was undertaken by the 
Johannesburg local authority since cardiovascular disease was deemed a priority, certainly 
for the White, Asian and Coloured groups of the population. Since its inception, the 
cardiac rehabilitation centre has been entirely non-racial, both in staffing as well as 
patients. The service is provided free of charge to all appropriate patients referred by 
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medical practitioners, as the Health Act does not make any provision for charging for 
health services provided by the local authority. In 1990 the Centre expanded its services by 
opening a satellite centre in Lenasia, an Asian community. 
The Johannesburg Cardiac Rehabilitation Centre has rapidly grown to become the largest 
rehabilitation centre of its kind in Southern Africa. The facility provides early post-
discharge (Phase 2) (Johannesburg Centre only), community-based (Phase 3) 
(Johannesburg and Lenasia Centres) and maintenance (Phase 4) (Johannesburg and 
Lenasia Centres) programmes for cardiac sufferers and combines supervised exercise 
sessions with a lifestyle modification programme aimed a risk factor modification. Two 
hundred and fifty patients attend the Johannesburg Centre on Mondays, Wednesdays and 
Fridays between 7.00 am and 7.00 pm and 70 patients attend the Lenasia Centre the same 
days between 4.00 and 7.00 pm. 
The type of patient admitted to the Centre varies from subjects with only coronary risk 
factors who come for prevention, and low risk patients recovering from an uncomplicated 
heart attack, to very high risk patients with chronic heart failure. 
The Centre's activities are run by a multidisciplinary team which includes doctors with a 
sports medicine and/or cardiological background, nursing sisters, physiotherapists, 
biokineticists, dieticians and psychologists. 
The exercise sessions consist of a warm-up, walking, walking-jogging, jogging or cycling 
and a cool-down. Rowing machines and air-dynes are also available. In 1991, resistance 
training using circuit weight stations was introduced to complement aerobic activities of 
medically stable patients after 3 months on the programme. All exercise sessions are 
medically supervised and patients are asked to fill a log card for tracking of their 
compliance. Patients are individually counselled and group educational sessions on 
different topics are given on a weekly basis. Various topics are discussed, namely risk 
factor modification, medication, diet, stress and stress management, symptoms, benefits of 
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exercise and exercise prescription, as well as basic cardiac life support. Partners are 
encouraged to come to these discussion sessions. Individual and group psychotherapy 
sessions including relaxation techniques are also provided. After 18 months on the 
programme patients can be discharged from the centre or placed on a home programme. 
Soon after the Centre was established a group of patients expressed the desire to assist in 
raising funds. For this purpose they formed the "Superheart" Committee under the 
auspices of the Southern Transvaal branch of the Heart Foundation. This committee has 
been very active in the purchasing of equipment, and has contributed a great deal to the 
success of the unit. 
Research and teaching form an integral part of the Centre's activities. The programme and 
its effects on cardiac patients, with special emphasis on compliance, exercise tolerance, 
lipid profile, the elderly and patients with chronic heart failure have been described in 
several papers and presented at local and international conferences. Physiotherapy, 
biokineticists and comniunity health students spend time at the Centre as part of their 
training and MSc students from the University of the Witwatersrand attend lectures 
regularly. 
The Centre has organized two consecutive Cardiac Rehabilitation Symposiums in 1993 
and 1994 with local and international speakers, and has also been instrumental in the 
creation of the South African Association of Cardiovascular Rehabilitation where three 
staff members are on the Board of Directors. In addition to its local role, the Centre has 
been acknowledged internationally: The Head of the Centre was invited to the USA in 
October 1994 to deliver a lecture on "Car:_diac rehabilitation in South Africa" _at the 9th 
Annual Meeting of the American Association of Cardiovascular and Pulmonary 
Rehabilitation, the world's largest organisation in this field. 
In summary, the Johannesburg Cardiac Rehabilitation Centre is at the forefront of the 
prevention of cardiac diseases, the rehabilitation of cardiac sufferers, cardiac rehabilitation 
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research and the education of patients, students and professionals. Based on the World 
Health Organisation recommendations, the Centre should be considered an advanced 
facility. 
1.4 Medical assessment of patients admitted for cardiac rehabilitation 
1.4.1 Introduction 
Patients need to be medically evaluated before enrolling in a cardiac rehabilitation 
programme. Whether patients will be assessed on site or by their referring doctors will 
depend on the facilities and staff structure of the rehabilitation centre. Ideally, the medical 
assessment would consist of a complete medical history of the patient, a comprehensive 
examination, a fasting lipogram and blood glucose determination, a resting 
electrocardiogram (ECG), lung function testing, anthropometric measurements, a 
cardiopulmonary exercise test and measurement of L V function. The functional capacity 
of the patient as well as any abnormal responses to exercise testing including myocardial 
ischaemia, are determined. In selected cases the diagnosis of ischaemia requires 
radionuclide perfusion imaging procedures. Through echocardiography or radionuclide 
ventriculography the left ventricular function of patients is evaluated. An appraisal of the 
coronary risk profile of patients is performed with a view to lifestyle modification 
strategies. Patients are subsequently categorized into low, moderate and high risk of 
exercise-related cardiac events, and the patient's level of risk will determine the extent of 
the supervision and monitoring of the patient during exercise sessions. 
13 
1.4.2 Assessment of exercise capacity_ 
1.4.2.1 Introduction 
Most human physiological systems or organs have a large reserve capacity. Disease 
reduces that reserve capacity, but clinical manifestations may occur only when this 
capacity is greatly reduced. The general objective of exercise testing is to determine 
performance characteristics which usually cannot be adequately obtained from either the 
clinical history or the physical examination of the patient at rest (18). Clinical applications 
may include diagnostic, functional, and therapeutic objectives (19). Diagnostic and 
prognostic evaluation of suspected or established cardiovascular disease is the most 
common clinical application of exercise testing. Functional exerci$e testing is used in the 
determination of exercise capacity and cardiopulmonary responses in patients who require 
exercise prescriptions or occupational activity guidelines. Exercise testing may also be 
used to optimize medical therapy with certain classes of drugs. Furthermore, since 
cardiovascular fitness as defined both by submaximal and maximal responses to exercise 
testing has been inversely associated with cardiovascular disease (20), and all-cause 
mortality in men (20,21) and women (21), the use of exercise testing to establish 
cardiovascular fitness becomes an important tool for investigating the role of physical 
activity in cardiovascular disease. 
Of the 3 types of skeletal muscle contractions that stress the cardiovascular system, 
dynamic stress is preferred for testing over isometric (ie. handgrip) and combination of 
isometric and dynamic (ie. carrying a heavy object while walking) stresses because it 
imposes a volume load to the left ventricle producing a cardiovascular resp_onse 
proportional to the severity of the exercise (18). 
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1.4.2.2 Maximum oxygen uptake 
Oxygen uptake by the lungs immediately increases when dynamic exercise is begun. At 
any intensity of exercise, oxygen uptake will initially increase and then remain relatively 
stable by the 2nd minute of exercise at the same level, achieving what is called as steady 
state. At steady state, heart rate, blood pressure, cardiac output and pulmonary ventilation 
are maintained at reasonably constant levels (18). 
Maximal oxygen uptake (V02) is the highest level of oxygen uptake that an ambulatory 
person can achieve by dynamically exercising a large fraction of his or her muscle mass 
(22,23). By rearrangement of the Fick equation, V02 max defines the limits of the 
circulatory transport of oxygen by the product of the maximal cardiac output (limits of the 
circulatory pump) and the maximal arteriovenous oxygen difference (limits of extraction 
from the peripheral circulation by the metabolically active tissues) (22). V02 max has a 
strong genetic component, declines progressively with age, is higher in men than women, 
varies with physical activity status, averaging 20-30% greater in the well-trained athlete 
and 20-30% less in the sedentary subject, and is affected by cardiovascular disease (18). 
Because larger persons have generally more muscle mass and the capability of burning 
more oxygen per unit of time, aerobic capacity is often expressed relative to body weight 
as milliliters of oxygen per kilogram of body weight per minute (ml/kg/min) (24). It is 
convenient also to express oxygen uptake in multiples of metabolic units above resting. 
The metabolic equivalent (MET) is a unit of sitting resting oxygen uptake: 1 MET=3.5 
ml/kg/min. 
Because it is easily measured and highly correlated with cardiac output and endurance 
performance, V02 max is being used as the gold standard for assessment of aerobic 
capacity (24). 
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1.4.2.3 Equipment and Protocols 
Of the numerous devices used to provide dynamic exercise for testing, the cycle ergometer 
and the treadmill are the most commonly used today (18). 
In the USA, exercise testing is mainly performed on a motor driven treadmill while, in 
European countries, the bicycle ergometer is much more popular, probably because 
Europeans are more familiar with bicycle riding than are Americans. Cycle ergometer tests 
provide for stable electrocardiographic and blood pressure recording. Patients not 
accustomed to cycling will often be unable to reach a maximal heart rate because of 
premature leg fatigue . Furthermore, the patient controls the rate of cycling and not the 
ergometer providing less precise control of work than during exercise on the. treadmill. 
Walking on a treadmill seems easier for the vast majority of the population since walking 
and even running are more natural activities. Exact recordings of the blood pressure and 
electrocardiogram at near maximal workloads may be difficult to obtain during treadmill 
exercise. Hand support is common practice among cardiologists leading to an increase in 
the estimated exercise capacity of the patient (18). The major disadvantage of treadmill 
exercise is that the workload is difficult to standardise. Factors other than treadmill speed 
and gradient such as the subject holding on to the rail or walking with long or short strides 
can affect the final workload achieved. 
A maximal exercise test that takes the subject to a level of intensity where fatigue, muscle 
weakness or other symptoms will prohibit further exercise, is the preferred testing 
modality. 
There are many exercise protocols available. A vigorous exercise protocol may be suitable 
for the screening of relatively healthy individuals while a less strenuous one may be more 
adequate for the evaluation of the functional capacity of patients with coronary artery 
disease. 
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The Balke treadmill test (25) increases the gradient 1 % per minute while holding speed 
constant at 3.3 mph. This test is too fast for many persons and takes 10 to 18 minutes for 
many healthy subjects. Measurements of oxygen uptake at any given load are 
underestimated because oxygen uptake continues to rise for one and a half to two and a 
half minutes at the same loads even in normals. Another test, developed by Taylor, 
requires repeated testing over days to define a plateau of the maximal oxygen uptake as the 
work loads of successive tests are progressively increased (23) . 
Continuous multistage protocols where time is allowed in order to achieve a steady state 
are more physiological and adequate for cardiac patients. One of the most commonly used 
protocols is the Bruce protocol (26) in which both speed and gradient are increased every 3 
minutes until exhaustion and/or disabling symptoms are attained. This multistage test 
provides assessment of both submaximal performance and maximal aerobic power. The 
metabolic cost of the testing procedure varies directly with body weight and physical 
intensity and duration of the exertion and indirectly with mechanical efficiency. Because 
walking and running represent work against gravity, oxygen uptake should have a weight 
correction. The protocol assumes that all the body weight is supported by the legs, not 
allowing support from the handrail. Mechanical efficiency is nearly constant for most 
ambulatory persons and slightly greater in well-coordinated and highly trained runners. In 
both normals and cardiac patients, mean submaximal V02 tends to plateau during the last 
minutes of stages I and II and thereafter both groups exhibit a nearly linear increase in 
oxygen uptake with the duration of the exercise. Variance is high during the first minutes 
because of apprehension in some individuals and diminishes progressively. The Bruce 
protocol provides an expeditious, safe and reliable method to measure V02 max 
physiologically and to estimate it clinically. Values obtained within minutes are 
comparable to those obtained by discontinuous _!Pethods requiring two m: more days-
(23,26). It has the advantage for normal subjects of being relatively short in duration but 
the disadvantage for most cardiac patients or elderly individuals of having vigorous 
exercise workloads with a gradient of 10% from the beginning of the test. In general when 
any exercise protocol requires speeds beyond 3.4 mph, individuals with shorter stature will 
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have to jog in order to keep pace. This may result in an awkward physical posture, 
excessive mental stress for the patient and frequent production of artefacts due to 
deterioration of the ECG signal. 
The Chung protocol (27) overcomes these problems and is closer to the ideal for cardiac 
patients. The protocol includes seven three minutes stages with approximately increasing 
intensities for stage of 2 METs or less. The initial speed is 1. 7 mph with 0% gradient for 3 
minutes during the warming up period. The gradient is increased 4% at each stage and the 
speed remains constant at 3mph. Most patients with coronary artery disease do not require 
workloads beyond 8 METs (Stage IV), whereas sedentary healthy subjects can seldom 
exercise at workloads above 10-11 METs (Stages 6 or 7). 
Another type of approach are ramp protocols where work load is continuously increased, 
gradually causing heart rate to increase in a "ramp" upward. The advantages of such 
protocols are a constant work rate, decreased exercise time, and accurate determination 
and possibly estimation of aerobic parameters (28). Computer software has been 
developed to generate such protocols for a bicycle ergometer or a treadmill (29) . The ratio 
of oxygen uptake to work rate, expressed as a slope has been found higher for the ramp 
tests than for standard exercise protocols like the Bruce protocol. (30). Ramp protocols 
have gained more attention recently for their use in defining the intensity for work phases 
during interval training in patients with chronic heart failure (31 ). 
Taylor and co-workers (23) suggested that if a 2.5 percent increase in treadmill gradient 
was not accompanied by more than 150 ml 0/min increase in oxygen uptake this was 
suggestive of the individual reaching his cardiopulmonary limit. This became the plateau 
concept and has been widely applied for decades. However-disagreement exists today 
regarding the recognition of maximal cardio-respiratory limits (32). In any case, cardiac 
patients cannot often achieve those "maximal" levels because of leg fatigue, angina, lack 
of motivation and discomfort. It is therefore customary to refer to V02 max as the peak 
V02 during maximum exercise. 
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V02 max is not routinely measured in clinical practice because it requires relatively 
expensive equipment, highly trained technicians and time and cooperation from the 
subject. Since the interindividual variation in mechanical and metabolic efficiency is quite 
low among adults during activities that do not require much skill such as walking or 
running on a motor-driven treadmill or cycling on a stationery ergometer, oxygen uptake 
could be estimated from the rate of work (26,33). However treadmill experience, large 
standard errors of prediction equations and protocol design suggest that in research in 
which V02 is an important parameter to assess, its direct measurement from expired a
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will obviously provide the most accurate results (34). 
The collection and analysis of an expired gas sample that is taken during the last minute of 
an exercise test is used to determine V02 max directly (35) . The ventilatory threshold has 
been most commonly defined as the first deviation in linearity of the ventilation plotted 
against the oxygen consumption. This point of hyperventilation was classically labelled 
the "anaerobic threshold" by Wasserman and colleagues (36,37), who theorized that 
ventilation was increased due to the increase in carbon dioxide production secondary to the 
buffering of lactic acid (H2C03 <=> H2 + CO2). The association between the point of 
hyperventilation and a turning point in lactic acid is today still controversial (38). 
The ventilatory threshold could_also be defined as the oxygen uptake before the systematic 
increase in the ventilatory equivalent for 0 2 without a concomitant increase in the 
ventilatory equivalent for CO2 (36) or by using the V-slope method introduced in 1986, 
Beaver and colleagues (39) from the same laboratory as Wasserman. The V-slope method 
consisted of a computerized regression analysis of the slopes of the CO2 uptake (VC02) vs. 
V02 uptake plot, which detects the beginning of the excess CO2 output. The
 authors 
claimed that this method may h~e some advantages over _others that depend on regular 
breathing pattern and respiratory chemosensitivity. This method was subsequently 
simplified by others ( 40). All three methods discussed above continued to be widely 
utilized. 
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1.4.2.4 Exercise testing in patients with chronic heart failure 
Since most symptoms in chronic heart failure are manifested on exertion, the assessment 
of exercise capacity during exercise testing is an important tool for assessing the severity 
of the disease (41). The evaluation of different drug treatments, the effect of exercise 
rehabilitation programmes or cardiac transplantation of these patients have made necessary 
the use of a more objective tool than the clinical examination and the responses to the New 
York Heart Association questionnaire. 
The safety of a graded maximal exercise test has been established in a group of 607 stable 
patients participating in the Veterans Administration Cooperative Heart Failure Trial ( 42). 
Exercise protocols must allow patients to exercise long enough in order to acquire 
sufficient data to discriminate for different grades of exercise limitation. Furthermore, 
stages must be long enough to allow patients with chronic heart failure (CHF) to reach 
steady state; very often haemodynamic and metabolic responses to exercise are delayed 
when cardiac output is reduced (41). The Chung protocol has all the necessary 
requirements for the accurate and reproducible testing of this type of patient. 
Recent studies have suggested that adding respiratory gas analysis to the exercise test 
provides a more objective assessment (41) . Although exercise duration correlates 
significantly with oxygen uptake, the relationship between the two variables is not 
sufficiently strong. Furthermore, repeated tests may improve exercise duration by 
improving the efficiency (the individual walks better), without a corresponding increase in 
V02 (41). Although patients with CHF may never achieve a true V02 max, the 
measurement of oxygen consumption at peak exercise, peak V02, is reproducible and 
permits classification of- patients intci subgroups -according to the level of functional 
impairment. The ideal index of exercise capacity would be one that is independent of the 
patient's motivation, that is one that is totally objective. Since the onset of acidosis is 
independent of the patient's motivation, the anaerobic threshold could provide an objective 
means of assessing the exercise capacity of these patients. In spite of the anaerobic 
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threshold concept having being challenged, measurement of the ventilatory threshold 
could provide information regarding the general motivation of patients. For example 
changes in maximum oxygen consumption in the absence of a change in ventilatory 
threshold, could suggest an alteration in the patient's motivation rather than a change in 
functional capacity (41). Submaximal tests such as the 6 minute walking test (43) could be 
used to assess the exercise capacity of patients with CHF in centres that do not have access 
to gas analysis equipment. These tests are better tolerated and closer to the daily activities 
of patients. 
1.4.3 Assessment of left ventricular function 
1.4.3.1 Background 
The evaluation of L V function by noninvasive methods is an important part of the study of 
cardiac patients attending cardiac rehabilitation programmes. 
The ability of the myocardium to contract, a direct consequence of the balance between 
myocardial oxygen supply and demand provides a useful functional measure of the 
importance of coronary lesions. Since narrowed coronary arteries may carry sufficient 
oxygenated blood to supply myocardium oxygen demands at rest, complete assessment of 
the physiologic importance of the coronary artery lesion will require some type of 
intervention like physical exertion that will test the functional reserve capacity of the 
coronary arteries. Hence abnormalities of left ventricular function during exercise may 
reflect myocardial ischaemia ( 44). 
The identification and quantification of L V dysfunction can be done either by 
echocardiography ( 45) or radionuclide studies ( 46). 
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1.4.3.2 Echocardiography 
Echocardiography involves the method of transmitting ultrasound waves and of receiving 
and recording those waves that have been reflected by cardiac structures. It also includes the 
art of analysing and interpreting the patterns recorded. The echocardiographic examination 
has become part of the routine examination of cardiac patients by cardiologists. The quality 
of the examination is highly dependent on the expertise of the technician involved. The 
primary usefulness of routine L V recordings lies in the detection of wall motion 
abnormalities, the measurement of chamber size and the determination of circumferential 
muscle fibre shortening velocity. It also has the ability of providing serial measurements of 
certain parameters of left ventricular function ( 45). 
M-mode and two-dimensional echocardiographic techniques are frequently employed to 
assess cardiac structure and performance. They both demonstrate cardiac anatomy by 
detecting echoes reflected from large interfaces, such as those that occur between 
myocardium and blood. M-mode echocardiography offers an extremely high sampling rate 
and is thus most helpful for recording rapidly moving structures such as valve leaflets. Two-
dimension echocardiography provides more complete spatial sampling and correct anatomic 
orientation and thus provides a more comprehensive overview of cardiac anatomy. New 
developments in technique have permitted the evaluation of blood flow through Doppler 
echocardiography including color flow Doppler and the obtainment of higher quality 
imaging through trans-oesophageal echocardiography ( 45). 
The following applications in patients with coronary artery disease have been identified (39): 
1- Detection of ischaemic muscle: When a muscle becomes ischaemic, its motion is altered 
almost immediately. Two-dimension echocardiography is now the principal ultrasonic 
technique for detecting regional wall motion abnormalities in patients with coronary artery 
disease. 
2- Assessment of overall performance: The global ejection fraction (EF) as well as regional 
L V function can be predicted fairly well using 2-dimension echocardiography. 
3- Detection of reversible ischaemia 
Any form of stress such as pharmacological, using a vasodilator like dipyridamol or an 
adrenergic stimulating drug like dobutamine, or physical exercise, can be monitored by 
echocardiography. With bicycle exercise it is possible to perform the echocardiographic 
examination during effort whereas with treadmill testing one must rely on an immediate 
post-exercise examination. It is the introduction of digital echocardiographic recording that 
has made stress echocardiography a practical examination. The digital technique permits 
elimination of the respiratory artifact that occurs with the hyperventilation that accompanies 
exercise, allowing recording only of the cardiac cycles that are not obscured by inspiration. 
Furthermore, the digital technique allows one to display the resting and exercise images side 
by side for a better comparison. The sensitivity and specificity of stress echocardiography 
appears to be comparable to that of stress nuclear testing. 
One of the principal reasons for the popularity of and interest in echocardiography is that the 
examination is presumed to pose no hazard to the patient. Furthermore, no ionizing radiation 
is involved. 
1.4.3.3 Radionuclide methods 
1.4.3.3.1 Contrast left ventriculography vs radionuclide ventriculography 
Contrast left ventriculography was routinely used to assess regional and global left 
ventricular function (47) but offered several disadvantages over radionuclide studies (44): 
its invasive nature and the exposure to radiation made the procedure impractical for 
repeated studies as would be desirable in order to assess the effects of cardiac 
rehabilitation programmes. 
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the contrast medium could affect ventricular function directly and by production of 
ventricular premature contractions. On the other hand, exposure to radiation by 
radionuclide ventriculography is minimal, 160 mrad for 10-mCi dose of 
99mTechnetium, and the technique itself does not influence left ventricular function. 
1.4.3.3.2 Equilibrium vs first-pass radionuclide ventriculography 
Radionuclide techniques to assess left ventricular function use two types of methods, 
equilibrium or first pass. 
Equilibrium radionuclide angiocardiography was initially proposed in 1971 (48) and has 
been widely applied since then. It is based on an imaging agent remaining in the 
intravascular space. 9901Technetium (Tc)-labelled red blood cells are currently the agent of 
choice for blood pool imaging. While Technetium as pertechnetate moves freely in and out 
of the red blood cell and does not bind firmly to the cells in this chemical form, reduced 
Technetium species do not generally cross the cell membrane ( 49). Stannous compounds 
were found to be excellent reducing agents allowing the administered pertechnetate, after 
finding entry into the cells, to be reduced and become firmly bound to cell components (50). 
High labelling efficiency is achieved by consecutive treatment of the red cells with stannous 
ion and 99mTc pertechnetate. The technetium is bound to the beta chain of the haemoglobin 
molecule without altering the physical or biochemical property of the red cell, either in vivo 
or in vitro (51). The optimal stannous (Sn) ion concentration for maximal erythrocyte 
tagging was found to be between 10 and 30 µg Sn+2/kg body weight (50). Labelling may be 
done in vitro, ip. vivo or by a combined in vivo/in vitro technique. Despite the widespread 
use of in vivo labeling, especially for cardiac studies, variable labelling efficiency and 
urinary activity were reported. It seems that the Tc amount injected exceeds the binding 
capacity of the Sn-red blood cells, permitting the uptake of the excess by the thyroid and the 
gastric mucosa. This can obviously cause a deterioration in the quality of imaging. A slower 
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injection of pertechnetate and a higher amount of stannous, from 0.6 to 1.1 mgSn+
2 can 
improve the quality of the image (51). 
Scintigraphic images can be acquired with conventional scintillation cameras, either a single 
crystal standard Anger camera or with a multiple, small-crystal camera. The technique is 
based on the use of a physiological indicator such as the ECG to "gate", or physiologically 
synchronize, serial static imaging of the cardiac blood pool in relation to the cardiac cycle. 
The ECG is used to define the temporal relation between the acquired nuclear data and 
different phases of the cardiac cycle (ie. end-systole and end-diastole). Data acquisition 
depends upon an ECG signal being fed into a minicomputer, which uses the R-wave as a 
signal to begin acquiring scintigraphic events. Each cardiac cycle is sequenced into 30 to 50 
msec segments beginning with the R-wave of the ECG. All the count data occurring within a 
given segment are then summed for all cardiac cycles and a composite image frame formed 
for that segment. These images represent the activity acquired over 200 or more cardiac 
cycles at rest, so that there is sufficient count density to allow meaningful quantitative 
analysis ( 44,52,53). Current computer techniques are automated or semi-automated to allow 
rapid and routine data computation and analysis. A region of interest can be defined over 
either ventricle and time-activity curves can be generated from each region. 
The first transit technique ( 46,54) involves analysing the initial transit of an intr_avenously 
administered radionuclide bolus as it traverses the central circulation. It requires an imaging 
agent that is rapidly cleared from the intravascular space. Technetium-labeled sulfur colloid 
or technetium pertechnetate are those most commonly used. The multicrystal scintillation 
camera is preferred over the single crystal because of a higher count-rate acquisition 
capability. Duration of imaging is limited to the transit time of the bolus of activity through 
the heart and involves sampling for only the first 15 to 30 seconds after the injection. Frames 
acquired during activity transit through the cardiac chamber being studied are then summed 
to produce a cineventriculogram which usually consists of only 5 or 6 cardiac cycles. During 
first-pass transit the radioactive bolus is temporally and· anatomically separated in each 
ventricle, allowing for separate measurement of the performance of left and right ventricle by 
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selecting the appropriate region of interest. First pass studies are not widely used because the 
technique has specific instrumentation and radiopharmaceutical requirements. However, new 
technetium-99m-labeled perfusion tracers now make it possible to measure ventricular 
function by the first-pass technique when the radionuclide is injected primarily for 
myocardial perfusion imaging (55). 
Both first-pass and equilibrium evaluations can also be performed during exercise. Available 
exercise protocols such as the Bruce protocol which uses treadmill exercise are unsuitable 
for gamma camera studies, which require that the heart remain in a fixed position during 
acquisition of data, close to the camera's detector crystal. A cycle ergometer is usually 
employed, with the patient in a supine or erect seated position which allows for leg motion 
but no thoracic movement. With the equilibrium technique, this is most often done with 
supine bicycle ergometry (44) and with the first-pass, upright exercise can be performed 
(54,56). Borer and co-workers (44) first demonstrated the feasibility of radionuclide 
determination of EF during supine bicycle exercise using the equilibrium technique. 
Subsequent reports documented the possibility of multistage exercise tests with as little as 2-
minutes acquisition at each step (57). The first pass method is not amenable to multistage 
protocols as a new injection needs to be given for each determination and time is required for 
the background resulting from previous studies to stabilize and to be substracted (58). 
Measurements of regional and global systolic function expressed as EF as well as ventricular 
volumes and diastolic filling can be routinely derived. The EF is the number of stroke-
volume radionuclide counts divided by the number of end-diastolic counts times 100, with 
appropriate correction for background counts. The normal left ventricular EF is considered as 
50% or higher. In the _?-nalysis of diastolic function, the filling portion of the time-activity 
curve is assessed. Peak filling rate and the time required to attain the-peak filling rate are the -
most common parameters used for this purpose. The normal peak filling rate is 2.50 or more 
end-diastolic volumes per second. Since radioactivity is in equilibrium with the blood, count 
rates are directly proportional to the volume of blood in any given area of the blood pool 
sampled externally with the scintillation camera. Measuring ventricular volume on the basis 
of count rates of radioactivity presents a substantial advantage over conventional area-length 
geometric methods, because the count-based methods do not depend on geometric 
assumptions about the shape of the left ventricle (44). 
The equilibrium method has several advantages over the first pass method (59): 
1) The equilibrium method allows for multiple, sequential studies at rest, during and post 
exercise while the first transit method is restricted to a single measurement at rest and 
maximal exercise. 
2) It allows for better wall motion analysis because of the statistically superior images. 
3) The results or the quality of the image are minimally affected by the presence of 
arrhythmias, which could be excluded by the ECG gating mechanism or averaged as 
part of the longer imaging period. This is not the case in the first transit method where 
just a few cardiac cycles are acquired. 
4) It uses standard gamma cameras as found in most nuclear medicine departments which 
can also be portable. 
Disadvantages of the equilibrium method are: 
1) Relatively long acquisition times - 1 to 2 minutes. 
2) Use of only the left anterior oblique projection for quantitative analysis since it is the 
only one that effectively isolates the left ventricle from the right ventricle and right _ 
atrium. 
3) The spleen receives a relatively high radiation dose of 0.16 rad/mCi. 
1.4.3.3.3 Clinical applications in cardiac rehabilitation 
Radionuclide ventriculography allows for the simultaneous assessment of systolic and 
diastolic dysfunction. The latter is much more common than normally thought and about 
30% of patients admitted with congestive heart failure may have this abnormality (60). Its 
importance also increases with increasing age since diastolic filling declines with age (61). 
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Through serial studies, radionuclide determinations could be extremely valuable in assessing 
the haemodynamic response to exercise training in patients with coronary artery disease. 
Analysis of left ventricular volumes adds substantially to the evaluation of the effects of 
training in patients with L V dysfunction 
1.4.3.3.4 Accuracy 
1.4.3.3.4.1 At rest 
Radionuclide measured ejection fraction compares favourably in most studies with biplane 
cineangiographic volumes (57,62,63). The range of correlation coefficients has been between 
0.80 and 0.95, and the standard error of the estimate has been in the range of 2: 0.10 ejection 
fraction units for both methods. Most laboratories found that the first pass method has a 
slightly better correlation with the contrast angiogram than does the equilibrium study, but 
this difference was not statistically significant. 
1.4.3.3.4.2 During exercise 
A good correlation between ejection fraction generated from time-activity curves and 
ejection fraction determined by X-ray contrast left ventricular cineangiography indicates the 
validity of the count-volume proportionality assumptions upon which radionuclide 
angiography is based. It would therefore be logical to expect that if count data provide a 
g9od measure of EF, these data shou!d also provide an adequate measure of ventricular 
volumes and cardiac output. 
Sorensen and co-workers (64) validated the assumption that radionuclide count data closely 
reflect cardiac chamber volumes by showing parallel changes with the Fick cardiac output 
during exercise. Agreement between count and Fick methods persisted in the individuals 
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tested, without drugs, after reducing preload with nitroglycerine and after reducing heart rate 
with propranolol. Although their results applied only to normal subjects they support the 
feasibility of quantitatively evaluating changes in ventricular volumes during exercise to 
define mechanisms of ventricular dysfunction more accurately in patients with coronary 
artery disease. 
1.4.3.3.5 Reproducibility 
1.4.3.3.5.1 At rest 
Reproducibility is very important in_ a longitudinal study aimed at evaluating an intervention 
such as cardiac rehabilitation. Previous reports have suggested that for a single study done at 
rest, the intraobserver variability is in the range of 1 to 3 % for equilibrium studies and 2 to 7 
% for first transit, and the interobserver variability is 3 to 5 % and 2 to 9% for equilibrium 
and first transit respectively (65,66). For serial studies done either hours or days apart the 
variability has been in the 3 to 5 % range for both methods (67,68). 
1.4.3.3.5.2 During and post-effort 
Using the equilibrium method during exercise, Okada et al. (69) showed that both 
intraobserver and interobserver variability was in the range of 4 to 6 % with serial variability 
in the range of 5 to 7 %. Pfisterer et al (70) studied the reproducibility of ejection fraction 
determinations by equilibrium radionuclide angiography in response to supine bicycle 
exercise. All 16 patients with chronic stable CAD were studied on two separate occasions 
averaging 14.5 days apart. On each occasion the patients were studied first at rest, during a 
graded supine bicycle exercise with up to three levels of increasing work, and during the 
initial 10 minutes of the recovery period. Recordings were made at rest (5 min), and 
continuously throughout the entire exercise and recovery periods. The data were 
29 
subsequently divided into serial 2-min periods: exercise (2+3, 5+6, 8+9) and recovery 
(recl=2+3, 4+5, rec2=9+10). Each patient reached similar rate-pressure products in the 2 
studies. Mean EFs for the first and second studies were: at rest: 53.0 + 10.8% vs 52.5 + 
10.4%, r=0.95; submaximal exercise: 51.4 ± 12.0% vs 52.1 ± 12.8%, r=0.91; maximal 
exercise: 50.6 ± 12.6% vs 51.6 ± 12.9%, r=0.97; reel: 62.7 ± 11.6 vs 62.4 ± 12.2%, r=0.95; 
rec2: 55.5 ± 10.8% vs 57.2 ± 11.7%, r=0.91. They concluded that EF determined by 
equilibrium radionuclide ventriculography provided reproducible results in clinically 
stable individuals at rest, during peak supine bicycle exercise and during the early recovery 
period. The increase in EF to greater than the resting EF in the early recovery period 
(minutes 2 and 3) is called the overshoot phenomenon and shows the importance of using 
the ejection fraction during maximal exercise for diagnostic purposes rather than a post-
exercise value. The best correlation coefficient between the two tests was seen at peak 
exercise where the patients reached their maximal tolerable work limit, at rest and during 
the early recovery period at the time of the "overshoot" EF increase. Poorer correlations 
were found during the early, submaximal exercise level (minutes 2 and 3) and in the later 
recovery period (minutes 9 and 10 post-exercise). 
Little information is available on the variability of the first transit technique during exercise. 
Since cardiac output, stroke volume, heart rate and blood pressure responses to exercise are 
dependent upon body position, the relative merits of supine versus upright exercise positions 
need to be addressed when left ventricular function is evaluated. The sensitivity of the 
technique for the diagnosis of coronary artery disease has been reported as equal for the two 
exercise positions ( 44,54). 
1.4.4 Myocardial perfusion imaging 
Myocardial perfusion imaging is based upon obtaining images of radioactivity emanating 
from radioactive tracers whose uptake in myocardial cells is proportional to blood flow 
and myocyte integrity (71). When administered intravenously, their uptake by the 
myocardium approximates the fraction of the cardiac output perfusing the heart. Thallium 
(Tl)-201 became the most clinically used radiopharmaceutical for myocardial perfusion 
imaging with a conventional gamma scintillation camera since it offered superior physical 
properties for imaging with a scintillation camera than previous potassium analogs such as 
potassium-43 and rubidium-86 (71). In the 1980s, however, technetium-99m labelled 
myocardial perfusion agents with superior physical characteristics to Thallium were 
developed (72). These were the Tc-99m-labelled isonitrile compounds of which Tc-99m 
methoxyisobutylisonitrile (sestamibi) is the most applicable for clinical use. The high 
photon energy of Tc-99m sestamibi is optimal for gamma camera imaging and can 
produce higher quality images than those produced by Tl-201. Because of its short half-
life (6 hours), approximately 10 to 20 times larger doses can be administered than are 
feasible with Tl-201, yielding a higher count density in both planar and SPECT images. 
Furthermore, Tc-99m sestamibi produces less scatter and attenuation than Tl-201 and 
gated planar imaging can be performed using available multiple-gated acquisition software 
and hardware (71). 
Myocardial uptake of Tc-99m sestamibi is proportional to regional blood flow and non-
viable cells cannot concentrate the tracer. Since Tc-99m does not redistribute over time 
after intravenous injection, separate injections of the radionuclide have to be administered 
during stress and resting states. These separate injections are required to differentiate 
defects that represent stress-induced ischaemia from those that represent myocardial 
scarring. The most optimal protocol at present using this radionuclide agent could be 
performed over 2 days with performance of the exercise study first and the resting study 
24 hours later. Each imaging procedure employs 20 to 30 mCi of Tc-99m sestamibi. 
However in clinical practice this type of protocol is not very practical and same-day rest-
stress imaging procedures have been developed. An injection of 8 to 10 mCi is 
administered for the rest procedure with imaging performed 60 minutes later. A dose of 22 
to 30 mCi is then injected at peak exercise and images acquired 30 to 45 minutes post-
injection. The exercise injection should be administered at least 4 hours after the rest 
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injection. Like Tl-201, Tc-99m sestamibi is injected at symptom-limited endpoints, and 
exercise is encouraged for at least another minute. Some have advocated continuing 
exercise for another 1 to 2 minutes at a rate several stages lower than the stage that 
corresponds to the peak exercise to allow more complete initial uptake in the myocardium. 
Some laboratories require the patient to drink a glass of whole milk or eat a fatty meal 15 
minutes before commencing image acquisition, to stimulate enhanced Tc-99m sestamibi 
clearance from the gallbladder. 
Tc-99m sestamibi imaging showed good correlation to Tl-201 for detection of CAD using 
the planar approach and both procedures were concordant in differentiating ischaemia 
from scar (71). An overall sensitivity of 90% and overall specificity of 83% have been 
determined for Tc-99m sestamibi (71) .. As observed with planar imaging, both Tl-201 and 
Tc-99m sestamibi have comparable sensitivity and specificity for CAD detection. 
However, the SPECT technique was more sensitive than planar imaging in detecting 
stress-induced ischaemia but had lower specificity. Of 1285 segments that showed 
perfusion abnormalities following exercise stress by both agents, 84% were concordant for 
differentiating between ischaemia and scar (71). 
The higher photon energy, enhanced count rate, and decreased attenuation and scatter 
compared with Tl-201 make Tc-99m sestamibi most suitable for SPECT imaging. 
1.4.5 Risk stratification 
Admission of patients at higher risk of sudden death has m_ade necessary the development of 
a risk stratification system to identify the patient's risk for an early recurrent coronary event 
and long-term prognosis, and to guide the duration and extent of his/her supervision and 
monitori~g during exercise. The risk stratification process should form part of the routine 
assessment of patients admitted for cardiac rehabilitation. 
Guidelines for risk stratification are based on assessment of the extent of myocardial 
damage, left ventricular dysfunction, and presence or absence of residual myocardial 
ischaemia and ventricular arrhythmias. Although desirable, it is not always necessary to 
send patients for sophisticated and expensive studies since there is good correlation between 
the clinical and high-tech assessment of some of the above variables. Guidelines for risk 
stratification have been developed by the· American Association of Cardiovascular and 
Pulmonary Rehabilitation (73) (Annexure 1.4). 
1.5 Exercise prescription and exercise training 
1.5.1 Introduction 
Aerobic exercise is the key element in all cardiac rehabilitation programmes. It not only 
has the effect of enhancing physical and psychological wellbeing, but also provides the 
basis for other health activities and changes in lifestyle (74). 
The fundamental objective of exercise prescription is to aid participants in increasing their 
habitual physical activity. 
The exercise recommendation should be treated with the same seriousness and caution 
which is used in prescribing drug therapy and should always be under the control of the 
medical health care team. It should take into consideration several factors such as age, 
gender, medical status, previous physical activity, orthopaedic and musculoskeletal 
integrity and should be based on the physiological responses to a symptom-limited graded 
exercise lest. 
The important parameters determined from the test are peak heart rate and oxygen uptake 
( either measured directly or estimated from the exercise load), ventilatory threshold, rating 
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of perceived exertion, limiting signs or symptoms, any ischaemic ST-segment 
displacement, dysrrhythmias and an abnormal blood pressure response. 
A balance must be achieved between the patient's optimal improvement and his cardiac 
and orthopaedic safety, while the activity is made enjoyable enough for him to want to 
continue. 
1.5.2 The prescription 
The format for the exercise session should include a warm-up period (10 minutes), a 
conditioning phase which should involve aerobic exercise (30-45 minutes), an -optional 
muscle-conditioning programme and a cool-down period (5 minutes) . 
The warm-up facilitates the transition from rest to aerobic-endurance training and reduces 
the risk of cardiovascular and musculo-skeletal injuries (75-77). It should include 
musculo-skeletal exercises such as stretching and flexibility movements and cardio-
respiratory exercise, preferably the actual prescribed activity performed at a lower 
intensity. The cool-down involves slow walking or low intensity exercise and provides a 
gradual recovery from the conditioning phase. It allows for appropriate circulatory 
adjustments and return of the heart rate and blood pressure to near resting values, enhances 
venous return, reduces the potential for post-exercise hypotension, facilitates the 
dissipation of body heat and combats the deleterious effects of the post-exercise rise in 
plasma catecholamines (76,77). Of 61 cardiovascular complications reported during 
exercise training of cardiac patients, at least 72% occurred either during the warm-up or 
cool-down phases (10). 
The prescription of endurance exercise should take into account the type of activity, 
intensity, duration, frequency and progression. 
In order to achieve a training effect the exercise must be continuous, rhythmical and 
involve large muscle groups. Of the numerous activities which involve large groups of 
muscles, walking, jogging and cycling seem to be the most suitable because of the relative 
consistency of energy expenditure. In other activities like swimming, the energy 
expenditure is highly dependent on skill. Activities such as volleyball, basketball, etc are 
highly variable in intensity but can be useful when played non-competitively because of 
the enjoyment they provide (19). 
The exercise intensity is expressed as a percentage of the maximum heart rate achieved 
during the exercise test and should be above a certain level in order to induce a training 
effect and below the load that could evoke symptoms, ST segment or blood pressure 
abnormalities and orthopaedic injury (77). The optimal intensity occurs between 70 and 
85% of the maximal heart rate (77). If ST segment depression develops during the 
exercise test, the intensity must be set 10 to 15 beats per minute below the ischaemic 
threshold (19). Once the actual training heart rate has been established, the speed of 
walking or jogging must be calculated. Because various activities have been previously 
related to oxygen consumption and extensive data are available on these relationships, it 
becomes practical to state the training exercise loads in terms of oxygen consumption as 
opposed to heart rate. The oxygen consumption level for training can either be measured 
directly from the exercise test data, or estimated from the work rate of the protocol, at the 
appropriate training heart rate. The optimal level of intensity for exercise when related to 
oxygen consumption occurs at a level which lies between 57 and 78% of the maximal 
oxygen uptake. The relationship between training at a heart rate intensity between 70 and 
85% of the maximum heart rate and training at an oxygen uptake betwen 57 and 78% of 
the maximal oxygen uptake can be seen in Figure 1.1. There appears to be little additional 
training benefit at in_!_ensities above 78% of the maximal oxygen uptake, but a well-defined 
increased risk of cardiovascular complications (Figure 1.2). 
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Figure 1.1 Relationship between % maximal heart rate, % maximal 
oxygen uptake and rate of perceived exertion (185) 
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Once the training level is expressed in terms of oxygen consumption, standard tables such 
as those developed by Kavanagh (74) can be used to set an appropriate walking, walk/jog 
or jogging programme. These tables usually express the energy requirements of activities 
in terms of the basal oxygen uptake by giving a MET rating: Each patient is given his/her 
training heart rate and the speed and distance which he/she should walk, walk/jog or jog. 
Both patients and staff must monitor heart rate, speed and distance (19). Patients 
exercising on a bicycle ergometer should also be given the load for the bicycle expressed 
in Watts. The load is calculated according to the following formula: 
Watts= V02 (ml/min) - (5.8 x body mass (kg)) - 151 
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Patients should be encouraged to pedal at 60 revolutions per minute. 
Another way of prescribing the intensity of the exercise is to set the heart rate slightly 
below the ventilatory threshold which is defined as the point at which during incremental 
exercise the subject's ventilation deviates from linearity. The threshold usually occurs 
close to the middle of the prescribed range of optimal intensity for exercise training: 67 -
70% in the range of 57 to 78% of maximal oxygen uptake and about 75% in the range of 
70 to 85% of maximal heart rate (77). It is our experience at the Johannesburg Cardiac 
Rehabilitation Centre that exercise done at this level is well tolerated and still enhances 
fitness. 
The rating of perceived exertion (RPE) could also be a useful adjunct to the heart rate to 
guide the intensity of training (19). The RPE response to graded exercise correlates highly 
with cardio-respiratory and metabolic variables such as oxygen uptake, heart rate and 
ventilation. Using the 15-point scale which ranges from 6 to 20, a perceived exertion 
- -
rating of 12 to 13 corresponds to approximately 60% of the heart rate range. A rating of 16 
corresponds to approximately 85% of heart rate range. Consequently most participants 
should exercise within the RPE range of 12 and 16 ("somewhat hard" to "hard"). 
Corresponding ratings using the 10-point RPE scale would be between 4 and 6. 
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Duration interacts with intensity, total energy expenditure being the result of the product 
of the intensity and duration of exercise. Thirty to 45 minutes will be adequate to produce 
a training effect at the intensity prescribed. Three to four evenly spaced workouts a week 
appear to be the optimal frequency. When doing weight bearing exercise it is desirable to 
alternate a day of exercise with a day of rest. 
Each patient should progress slowly over a number of weeks up to his ultimately required 
duration and intensity of exercise. This allows the patient to become accustomed gradually 
to an increasing work rate. 
1.5.3 Role of resistance training 
Resistance training could complement traditional aerobic-only conditioning programmes. 
It is recommended that low-risk patients participate in this type of exercise. The 
contraindications for aerobic training also apply to resistance training. Patients with poor 
left ventricular function and/or residual myocardial ischaemia should be considered 
ineligible for resistance training (until proven otherwise) (78). Weight stations are 
preferred to free weights because they are safer and more time-efficient. The prescription 
with regard to weights is set between 30 and 50% of the maximum weight load. The latter -
is based on a test which assumes the maximum weight that the patients can lift at least 
twice but not three times to be 90% of his "one repetition maximum". Eight to ten weight 
stations are recommended. Patients should perform 10 to 15 repetitions in 1-3 sets. The 
improvement in muscle strength and endurance can be assessed by retesting for one 
repetition m~ximum on the circuit or by isokineti~ testing. 
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1.5.4 Interval training 
Meyer et al. (79) have recently introduced a new exercise training procedure for patients 
with chronic heart failure. The procedure includes interval exercise -training for 3 weeks on 
a cycle ergometer (30s work phases alternating with 60s recovery phases) and on a 
treadmill (60s work alternating with 60s recovery phases). The authors designed a specific 
steep ramp test to derive exercise intensity for the work phases. The rationale behind this 
new training modality is that short bouts of exercise allowed for intense stimuli of 50% of 
maximum work rate achieved during the steep ramp test to be applied to the working 
muscles with minimal cardiac strain. The authors stated that it is possible that the 
intermittent nature of the interval training allows the left ventricle to accommodate to an 
enhanced venous return associated with the high muscle work rates. This new training 
modality proved safe since no ST segment depression or serious ventricular arrhythmias 
occurred during testing or training and the clinical results suggested that there is no 
worsening of heart failure. The authors observed that higher work rates with significantly 
lower cardiac stress were achieved during interval training than during conventional 
steady-state exercise training at intensity levels of 75% of peak V02 and ventilatory 
threshold (79,80). A higher intensity stimulus might be more beneficial in reversing the 
alterations in skeletal muscle ultrastructure, biochemistry and fibre type as well as in 
peripheral perfusion that occurred in patients with heart failure. 
1.5.5 Contraindications for exercise training 
The following contraindications for participation in physical exercise have been suggested 
by the American Association of Cardiovascular and Pulmonary Rehabilitation Guidelines for 
Cardiac Rehabilitation Programmes (73): 
* Unstable angina 
* Resting systolic blood pressure over 200 mm Hg or resting diastolic 
blood pressure over 110 mm Hg 
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* Moderate to severe aortic stenosis 
* Acute systemic illness or fever 
* Uncontrolled atrial or ventricular arrhythmias 
* Acute/uncompensated heart failure 
* Third-degree heart block without pacemaker 
* Active pericarditis or myocarditis 
* Recent embolism 
* Thrombophlebitis 
* Uncontrolled diabetes or other metabolic conditions 
* Orthopaedic problems that would prohibit exercise 
1.6 The Physiological Effects of Physical Training 
1.6.1 The cardiovascular effects of physical training in normal subjects 
In healthy subjects exercise training increases V02 max by increasing both cardiac output 
and maximal arteriovenous oxygen difference (35,81). However cardiac output seems to 
contribute more to the increase in V02 max than does the increase in arteriovenous oxygen 
difference. The increase in cardiac output is mediated by an increase in stroke volume 
since maximal heart rate does not increase in trained healthy subjects (24,82,83). The 
increase in stroke volume at maximal exercise after training in the absence of an increase 
in ejection fraction is predominantly due to a better utilisation of the Frank-Starling 
mechanism leading to an increase in L V end-diastolic volume. This can lead in some 
(84,85) to training-indpced volume overload left ventricular:_ hypertrophy with proportional 
increase in left ventricular end-diastolic diameter and wall thickness, and without changes 
in the wall thickness-radius ratio, but this is not universally accepted (86). An increased 
left ventricular diastolic performance facilitating the filling during exercise may also 
contribute (84,87). 
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At any given submaximal workload, heart rate is usually reduced as a result of training 
(24) and this is compensated by an increase in stroke volume and/or arteriovenous oxygen 
difference. Both adaptive mechanisms may be operative since the submaximal stroke 
volume has been reported to be increased (88,89) or unchanged (90-92). 
In addition to its cardiovascular effects, aerobic training induces an increase in 
mitochondrial size and number as well as in the activity of aerobic enzymes, increased 
capillarization of the trained muscle, and enhanced oxidation of lipids and carbohydrates, 
adaptations which are geared to a greater aerobic production of ATP (93). 
1.6.2 The effects of physical training in patients with coronary artery disease 
Exercise training also produces an increase in peak V02 after training in patients with 
coronary artery disease (91,92,94,95). Most of the increase in peak V02 in these patients is 
mediated by an increase in the arteriovenous oxygen difference since most studies have 
not demonstrated an increase in stroke volume or ejection fraction in these patients (94-
99). These peripheral adaptations include an increase in peak muscle blood flow (97), an 
increase in capillary density, mitochondrial volumes and their aerobic enzyme content in 
skeletal muscle (100). The natural process of recovery after a myocardialjnfarction and 
the resumption of usual activities explains a major part of the improvement in V02 even in 
the absence of formal training (101-103). However studies have shown that patients 
randomly assigned to a programme of supervised physical activity could increase their 
exercise capacity by an average of 15-25% more than that which occurred spontaneously 
in a control group (104,105). The increase in peak V02 in patients post-myocardial 
infarction ranges from 11 to 56% and post-CABG patients from 14 to 6~ after 3-6 -
months of exercise training (106). The greatest improvement can be expected in those 
patients with the lowest initial V02 max values. 
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A lower heart rate at submaximal exercise is also seen in these patients, but unlike healthy 
subjects, they compensate for their lower post-training heart rate by an increased 
arteriovenous oxygen difference rather than by an increased stroke volume (94,96). 
However Frick and Katila and Clausen (107,108) reported an unchanged submaximal 
cardiac output with an increased stroke volume after physical training. At a submaximal 
workload and as a result of training, the blood pressure is unchanged or slightly reduced 
(81) resulting in a reduced double product which reflects a reduction in myocardial oxygen 
demand and an improvement in cardiovascular efficiency (109). Some of the largest 
increases in effort tolerance have been reported in patients with angina pectoris since 
exercise training delays the onset of symptoms by reducing the submaximal double 
product, so that some patients will no longer experience angina after physical training 
(110). 
Another possible explanation suggested by Franklin (111) is that exercise training could 
increase myocardial oxygen supply by promoting transient episodes of myocardial 
ischaemia which is the best stimulus for collateral development. Although animal studies 
have produced positive results (81), there is as yet no direct evidence that exercise 
stimulates development of coronary collaterals in humans (111-114). 
In contrast, high intensity, long-term training (1 year at an intensity between 70 - 90 % 
V02 max) can elicit central adaptations in selected patients with CAD, which res
ult in the 
ability to reach a higher double product before the onset of significant ST depression. 
These adaptations are characterized by an increase in stroke volume by means of an 
increase in end-diastolic volume as in healthy subjects as well as an increase in ejection 
fraction. (115). 
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1.6.3 The rationale for considering exercise training of patients with left ventricular 
dysfunction 
Congestive heart failure has been defined by Braunwald (2) as "the pathophysiological 
state in which an abnormality of cardiac function is responsible for failure of the heart to 
pump blood at a rate commensurate with the requirements of the metabolizing tissues 
and/or to be able to do so only from an elevated filling pressure". The definition implies 
that there is an alteration in the pumping function of the muscle of the heart. As a result 
there is a combination of underperfusion of vital organs, increased filling pressures of the 
le.ft ventricle and fluid accumulation in the lungs and venous system. Typical signs and 
symptoms of congestive heart failure are generalized fatigue, pulmonary congestion, 
shortness of breath, oedema, fluid retention, elevation in venous pressure and liver 
enlargement. 
The most common cause of chronic left ventricular dysfunction particularly in older 
patients is loss of heart muscle due to myocardial infarction secondary to coronary artery 
disease. Three other important conditions leading to heart failure are cardiomyopathies of 
known or unknown origin, valvular heart disease and poorly-controlled systemic 
hypertension. 
While the mortality from stroke and heart attack is declining in industrialised countries, 
the incidence and prevalence of heart failure is growing dramatically without reduction in 
annual mortality (116,117). This increase in incidence and prevalence probably reflects an 
improved survival of patients with angina, hypertension and acute myocardial infarction, 
better reporting and recognition of heart failure, and the progressive ageing of the 
population. 
Subjects with heart failure are at high risk for sudden death, mainly due to ventricular 
arrhythmias (118). Once the diagnosis of congestive heart failure has been established, 
even in the outpatient setting, the prognosis is ominous: 60% of men and 40% of women 
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died within 4 years of the diagnosis of congestive heart failure in the Framingham 
population (118). Survivors of acute myocardial infarction with a left ventricular ejection 
fraction of less than 40% had a 26% one year mortality if they showed clinical signs of 
heart failure while in the coronary unit, compared with 12% if they did not manifest such 
clinical signs (119). 
Patients with severe ventricular dysfunction may also experience greater psychological and 
emotional stress than other survivors of myocardial infarction (120). 
All these factors suggest that subjects with left ventricular dysfunction are a particular 
group of patients who require more intensive rehabilitative efforts and specialized 
monitoring. However, patients with left ventri_cular dysfunction were traditionally 
excluded from formal cardiac rehabilitation programmes on the basis that they were at a 
much higher risk of sudden death during exercise activity, even though supervised, and 
that exertion could adversely affect the natural history of ventricular dysfunction 
precipitating or accelerating the decompensation of the left ventricle. 
Rest is an essential component in the management of an acute episode of heart failure, but 
once the heart failure has been stabilized and the fluid overload and oedema have been 
adequately controlled, the patient should be mobilized (121). 
Any potentially deleterious role of exercise training for patients with heart failure has not 
been substantiated. Basic exercise physiology principles suggest that the physiologic 
adaptations seen after training could be beneficial to this type of patient, rather than 
harmful: Exercise involving large muscle groups is associated ~ith a reduction in 
peripheral vascular resistance (95). This reduction in afterload could allow some patients 
with abnormal ventricular function to increase their cardiac output and tolerate some 
degree of physical activity. The biochemical and morphological alterations that occur in 
the skeletal muscle (100) suggest that even patients with cardiac failure may be able to 
increase their maximal oxygen consumption and maximal work capacity through exercise 
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training. Improvements in cardiovascular efficiency, that is the ability to perform daily 
activities at a lower percentage of the peak oxygen consumption and lower myocardial 
oxygen consumption, seen in normal subjects and patients with coronary artery disease 
and normal left ventricular function (96) could be expected to offer physiological 
advantages especially to persons with heart failure. A small increase in exercise 
performance in these patients may have a profound effect on their quality of life. In animal 
models, physical training has been shown to increase the threshold for ventricular 
fibrillation (122) and may protect patients with heart failure from fatal ventricular 
arrhythmias and sudden death. Psychological benefits noted in patients participating in 
group rehabilitation exercise programmes (123,124) could favourably improve the well-
being of patients with heart failure. These patients could also benefit from the favourable 
changes in blood lipid profiles induced by exercise training and counselling and education 
in cardiac rehabilitation programmes (13,14). 
If we follow this line of reasoning, we could expect exercise training to be relatively safe 
for patients with left ventricular dysfunction and to produce favourable physiological and 
psychological adaptations. Extra benefit could be derived in these patients from the close 
medical surveillance available in the context of a formal rehabilitation programme and 
from the lifestyle changes normally induced by these programmes. 
All this is reinforced by the fact that, presently, patients with heart failure have fewer signs 
and symptoms of heart failure and better functional capacity due to the advent of new 
pharrnacologic agents. One of the most significant developments in the management of 
heart failure has come from the angiotensin converting enzyme inhibitors, mainly captopril 
and enalapril which have improved signs and symptoms of congestive heart failure, but 
which have also reduced mortality as shown in placebo-controlled trials. In patients with_ 
severe heart failure, captopril treatment resulted in a 17% higher survival compared to the 
placebo group (125). The CONSENSUS study (126) also demonstrated a survival benefit 
favouring enalapril over placebo in 253 patients with Class IV congestive heart failure. 
The addition of enalapril to standard regimens was associated with a 31 % reduction in 
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mortality at 1 year. Additional recent findings in 2569 patients with symptomatically 
milder degrees of heart failure (Class II) who were followed for approximately 3.5 years 
showed that treatment with enalapril reduced total mortality by 16% and cardiovascular 
mortality by 18% (127). The risk of progressive heart failure was reduced by 22% with a 
favourable downward trend in the risk of fatal myocardial infarction (28%). Furthermore, 
enalapril showed better survival statistics than the direct-acting vasodilators isosorbide 
nitrate and hydralazine (128). 
Over the last few years there has also been considerably interest in the use of beta-
adrenergic blocking agents for the treatment of heart failure, because such agents may 
prevent the adverse effects of sympathetic stimulation on the failing heart (129). A recent 
meta-analysis of double-blind, placebo-controlled, randomized trials concluded that there 
is persuasive evidence supporting a more favorable effect of beta-blockade on ejection 
fraction and the combined risk of death and hospitalization for heart failure than on the 
improvement on the New York Heart Association (NYHA) class (130). 
Digitalis remains an effective, safe, and inexpensive choice of therapy for the relief of 
symptoms of patients with heart failure. However, its inability to substantially influence 
morbidity and mortality relegates it to be prescribed for the treatment of persistent 
symptoms after the administration of drugs that do reduce the risk of- death and 
hospitalization such as angiotensin converting enzyme inhibitors and beta-adrenergic 
blockers (131). 
Exercise training could therefore complement the presently limited therapeutic options 
_available for patients with heart failu~e. 
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1.6.4 The effects of physical training in patients with left ventricular dysfunction: 
current knowledge 
Several studies have now suggested possible benefits of exercise training in patients with 
moderate or even severe left ventricular dysfunction without evidence of clinically 
manifest congestive heart failure. 
Letac and colleagues (98) were the first to report the effects of exercise training in patients 
with some degree of left ventricular dysfunction due to coronary artery disease. They 
evaluated the effects of 2 months of exercise training in 15 patients, 12 convalescent from 
a myocardial infarction and 3 suffering from angina. Only 8 of those patients had an 
ejection fraction below 45%. In the total group and in those patients with moderately 
depressed systolic function, they found an improvement in maximal exercise capacity, a 
reduction in heart rate, blood pressure and rate-pressure product at submaximal exercise 
and no changes in left ventricular end-diastolic pressure, ventricular volume and ejection 
fraction. They concluded that training had no direct influence on the myocardium, either 
beneficial or detrimental. 
In 1979 Lee and associates (132) performed symptom-limited exercise testing and cardiac 
catheterization studies-before and after 12 to 42 months of exercise training in 18 patients 
with left ventricular ejection fractions of 40 percent or less. As a result of training, there 
was a significant reduction in the mean functional aerobic impairment which decreased 
from 32% to 23% (p<0.01) and resting and submaximal heart rates were significantly 
lower (p<0.01 and 0.05 respectively). Similar to the previous study, there were no changes 
in resting left ventricular ejection fraction, left ventricular dimensions or intracardiac 
pressures after exercise training. 
In 1982 Cohn and co-workers (133) evaluated the effects of an exercise training 
programme with a follow-up duration of 4 to 37 months (mean 13 months) in 10 patients 
with a prior myocardial infarction and severely depressed left ventricular function with a 
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resting left ventricular ejection fraction of less than 27 % (range 13 to 26) determined by 
radionuclide ventriculography. Maximal exercise capacity improved in 6 of the patients 
after exercise training, while 4 patients showed no changes. Overall, maximum exercise 
capacity increased significantly from 7 to 8.5 METs (p=0.05) and oxygen pulse showed an 
almost uniform increase from 12.8 to 15.7 ml/beat (p<0.01). No correlation was found 
between left ventricular ejection fraction at rest and exercise capacity. No adverse effects 
occurred during exercise testing or training sessions, although 2 patients died suddenly 
during the period of observation. 
While the studies of Letac et al. (98) and Lee et al. (132) demonstrated an improvement in 
maximal exercise capacity and a reduction in submaximal heart rates in patients with 
modest left ventricular impairment at rest, the study of Cohn et al. (133) showed that even 
patients with severely impaired left ventricular function at rest can achieve significant 
training effects. 
It was not until 1988 that investigators published the results of a more intensive evaluation 
of the role of exercise training in patients with chronic heart failure. Sullivan and 
colleagues (134) examined the effects of 4 to 6 months of exercise training in 16 patients 
with Class I-III chronic heart failure due to systolic left ventricular dysfunction. Mean left 
ventricular-ejection fraction in this group was 24± 10%. In 9 of the patients the heart failure 
was due to coronary artery disease and in seven it was idiopathic. Before and after 
training, patients underwent maximal bicycle exercise testing and direct measurement of 
central haemodynamic, leg blood flow and metabolic responses. Four patients dropped out 
of the programme prior to completion and were excluded from the analysis. One had an 
orthopaedic injury, two developed increasing symtoms of congestive heart failure and one 
died suddenly, unrelated to exercis-e. They demonstrated that exercise training 
significantly increased peak oxygen consumption from 16.8±3.8 to 20.6±4.7 ml/kg.min 
(p<0.01), peak leg blood flow from 2.5±0.7 to 3.0±0.8 1/min (p<q.01) and peak central 
arteriovenous oxygen difference from 13.1±1.4 to 14.6±2.3 ml/dl (p<0.05). There was a 
trend for an increase in cardiac output and stroke volume at maximal exercise (p=0.13 and 
p=0.12 respectively). Heart rate was reduced at rest and during submaximal exercise but 
did not change at max.imal exercise. Resting and exercise arterial, right atrial, pulmonary 
capillary wedge and pulmonary artery pressures were unchanged after training. Resting 
and exercise leff ventricular ejection fraction and left ventricular volumes were not 
significantly altered by training. Arterial and femoral venous lactate levels and leg lactate 
production were markedly reduced during submaximal exercise after training but were 
unchanged at rest or maximal exercise. The ventilatory threshold occurred at an increased 
oxygen consumption (10±:: 1.2 vs 12±::2.6 ml/kg.min, p<0.01). There was no correlation 
between the change in peak V02 after training and baseline haemodynamic variables. 
This study showed that exercise training can improve submaximal and maximal exercise 
capacity in patients with severely depressed left ventricular function. Peripheral 
adaptations played a major role in the training effect measured in these patients. However 
in some patients, increased peak cardiac output also contributed to improved exercise 
performance. 
The first controlled comparison of exercise training and restriction of physical activity in 
patients with stable heart failure secondary to coronary artery disease was reported by 
Coats and colleagues in a preliminary study in 1990 (135). Eleven patients with a mean 
left ventricular ejection fraction of 19+8% underwent a_ random-order, crossover 
comparison of 8 weeks of exercise training and 8 weeks of restriction of physical activity. 
Patients exercised at home on a stationary bicycle ergometer for 20 minutes 5 days a week 
at a training heart rate between 60 and 80% of their previously determined maximum. 
Training increased exercise duration from 14.8±:: 1 to 16.8±:: 1.3 minutes (p<0.01) and peak 
oxygen consumption from 13.5±::1.1 to 16.7±::1.3 ml/kg/min (p<0.01). Heart rate at 
submaximal work loads and rate-pressure products were signifi~antly reduced by training -
and there was also a significant improvement in patient rated symptom-scores. This study 
showed once again but in a controlled manner, that patients with severely depressed left 
ventricular dysfunction can improve submaximal and maximal exercise performance and 
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symptoms after physical training. This was in addition the first report of an entirely 
outpatient exercise training programme for this type of patient. 
Coats and co-workers extended their preliminary study and published a more 
comprehensive evaluation two years later (136). Nineteen patients entered the trial and two 
failed to complete the programme. Cardiac failure worsened in both dropouts while they 
were in the rest phase; one died and the other underwent cardiac transplantation. Seventeen 
patients completed the trial without complications. Similar improvements to those 
described in the preliminary report were seen in peak oxygen uptake and exercise duration 
after training. Training produced a significant vasodilatation associated with an increased 
cardiac output at submaximal and maximal exercise (5.9 vs 6.7 I/min, p<0.05 and 6.3 
vs7. l I/min, p<0.05 respectively). Minute ventilation and the slope relating minute 
ventilation to carbon dioxide production were significantly reduced after training. 
Autonomic function was evaluated by three methods: heart rate variability assessed by 24 
hours Holter monitoring, power spectral analysis and norepinephrine kinetics. Exercise 
training produced changes in autonomic balance shifting away from sympathetic toward 
enhanced vagal activity. They concluded that carefully selected patients with moderate to 
severe chronic cardiac failure can achieve significant improvements in exercise capacity, 
haemodynamics, ventilation and autonomic function. 
Other randomized studies followed Coat's research. They contributed to provide a better 
understanding of the effects of aerobic exercise training in reverting intrinsic muscle 
abnormalities produced by heart failure and showed that the improvement in functional 
capacity can lead to an improvement in quality of life and other outcomes like hospital 
readmi~sion and mortality rate. (137-142) 
In 1995, Hambrecht et al. (137) evaluated the effects of a combined hospital and home-
based 6 month exercise training programme on the oxidative capacity and ultrastructural 
morphology of skeletal muscle and its relation to central and perifpheral hemodynamic 
variables in 22 patients with stable chronic heart failure in NYHA class II and III. Twelve 
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patients (EF = 26 ± 9%) were randomized to the training group and ten patients (EF = 27 ± 
10%) to a physically inactive control group. Patients in the training group showed a 
significant increase in ventilatory threshold (23%: 0.86 ± 0.2 to 1.07 ± 0.2 L/min, p<0.05), 
in peak oxygen uptake (33%: 1.49 ± 0.4 to 1.95 ± 0.4 L/min, p<0.01), in total volume 
density of mitochondria (19%: 4.7 ± 1.5 to 5.6 ± 1.5 vol%, p<0.05) and in volume density 
of cytochrome c oxidase-positive mitochondria (41 %: 2.2 ± 1.0 to 3.1 ± 1.0 vol%, 
p<0.01), while there were no changes for those parameters in the control group. Cardiac 
output did not change at rest or during submaximal exercise but increased at peak exercise 
(11.9 ± 4.0 to 14.1 ± 3.3 L/min, p<0.05). Peak leg oxygen consumption also showed a 
significant increase as a result of training (510 ± 172 to 740 ± 254 ml/min, p<0.01). An 
important finding was that the significant increase in oxidative capacity of skeletal muscle 
after exercise training was significantly correlated with ventilatory threshold (r=0.82, 
p<0.00001) and with peak oxygen uptake (r=0.87, p<0.00001). The mechanism for the 
intrinsic muscle alterations remains unclear. Deconditioning appears to be a strong 
determinant, however it is not the only factor since muscle dysfunction can also occur in 
small hand muscles not expected to become deconditioned. 
In 1996, Kiilavuori et al. (138) showed a greater increase in exercise endurance at a 
submaximal workload (14.7 ± 2.0 to 27.8 ± 2.7 minutes, p<0.0-1.) than in peak exercise 
capacity (19.3 ± 1.6 to 21.7 ± 2.3 ml/kg/min, p=0.09) in 12 patients with _symptomatic 
congestive heart failure (NYHA Class II and III, EF<40%) randomized to training (n=l2). 
The training program consisted of 3 month supervised exercise of moderate intensity (50-
60% of peak V02) and 3 months unsupervised activity at home. This study was novel in 
the sense that their program had one of the lowest intensity used so far in the training of 
CHF patients and that by using a separate control group they could overcome the problem 
of the possible training effect of repeated exercise tests which could overestimate the 
effect of the intervention. 
In the same year, Keteyian et al. (139) compared the physiological adaptations of 21 men 
with compensated heart failure and LV dysfunction (NYHA class II or III, EF<35%) 
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randomized to a 6 month exercise training program of moderate to high intensity to those 
of 19 patients randomized to a non-exercise control group. Exercise training increased 
peak V02 (+231 ± 54 ml/min vs. +58 ± 38 ml/min), peak heart rate (+10 ± 4 vs. -2 ± 4 
bpm), peak ventilation ( + 12 ± 3 L/min vs. -4 ± 3 L/min), peak power output ( +20 ± 6 vs. 
+2 ± 5 Watts) and exercise duration (+2.8 ± 0.6 min vs. +0.5 ± 0.5 min) over time 
compared to the control group, but failed to increase the ventilatory threshold which 
translates in the ability to perform standard or routine daily activities with fewer or less 
severe symptoms. 
In 1997, Dubach et al. (140) evaluated the effects of a 2 month high-intensity exercise 
residential exercise training program in men with reduced L V function post-MI or CABG 
(NYHA class II and III, EF<40%) randomized to a training. Peak oxygen uptake increased 
significantly (19.4 ± 3.0 to 25.1 ± 4.8 ml/kg/min, p<0.05) in the intervention group only, 
by way of an increase in maximal cardiac output (12.0 ± 1.8 L/min to 13.7 ± 2.5 L/min, 
p<0.05) and a widening of maximal arteriovenous oxygen difference (13.1 ± 1.3 to 14.8 ± 
1.6 0/100 ml, p<0.05). 
In 1997 as well, Hambrecht et al. (141) in an expansion of their previous study published 
in 1995, demonstrated that a 6 month aerobic endurance training programme_ can correct 
the ultrastructural abnormalities found in the skeletal muscle of patients with chronic 
congestive heart failure and can also reshift the muscle fiber type distribution from type II 
to type I fibers. The improvement in peak oxygen uptake was positively correlated to the 
increase in the surface density of cytochrome c oxidase-positive mitochondria (r=0.66, 
p<0.01). They also demonstrated that femoral venous lactate accumulation during 
submaximal exercise was inversely related to changes in oxidative capacity of skeletal 
muscle assessed by volume density of mitochondria (r -0.66, p<0.01) and by surface 
density of the mitochondrial inner border membrane (r=-0.5, p<0.05). However venous 
lactate accumulation was not related to changes in submaximal leg blood flow (r=-0.4, 
p=NS). 
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In 1999, Belardinalli et al. (142) made a significant contribution by demonstrating that 
long-term moderate exercise training can improve the functional capacity and quality of 
life of 50 patients with chronic heart failure randomized to exercise training when 
compared to 49 patients receiving usual treatment. Exercise training was performed at 
60% of peak V02, three times a week during the first ·2 months and thereafter twice a week 
for 12 months. Both benefits were observed immediately after 2 months of physical 
training but more importantly and more novel they were maintained at 1 year with a 
programme of the same intensity but of a lower frequency. The other important finding of 
this study is that the improvement in functional capacity translated into a lower rate of 
hospital readmission for heart failure (RR=0.29, p=0.02) and a lower mortality rate 
(RR=0.37, p=0.01). Thallium activity scores improved by 2 months (24%, p<0.01) and 
were maintained for one year, partially explaining why an increased functional capacity 
could lead to improved outcomes. Peripheral factors may have also contributed to better 
the outcomes but were not assessed in this study. 
1.6.5 Physiological determinants of the impaired exercise tolerance of patients with 
left ventricular dysfunction 
1.6.5.1 Introduction 
A number of factors may contribute to exercise intolerance in chronic heart failure, 
including an increased pulmonary capillary wedge pressure, a reduction in cardiac output, 
decreased skeletal muscle blood flow, early altered cellular metabolism in muscle and 
excess pulmonary dead space__and ventilation (143). 
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1.6.5.2 An increase in pulmonary capillary wedge pressure 
Since pulmonary capillary wedge pressure (PCWP) is an important cause of dyspnoea in 
patients with acute congestive heart failure and it increases in some of these patients 
during exercise, it has been postulated that dyspnoea produced by pulmonary vascular 
congestion may be the factor limiting the exercise tolerance of patients congestive heart 
failure (144). Increased PCWP during exercise stimulates pulmonary I-receptors causing 
reflex hyperventilation and hypoxia which in tum causes dyspnoea (145). 
However several findings are against this postulated mechanism of exercise intolerance. 
Some patients with chronic congestive heart failure reach the point of fatigue during a 
symptom-limited exercise test without an increase in the pulmonary capillary wedge 
pressure above resting values, but still demonstrate major reductions in peak V02 (146) . 
The greater ventilatory response to exercise seen in patients with chronic heart failure is 
associated with an increase in pulmonary dead space probably caused by ventilation-
perfusion mismatching, resulting from pulmonary hypoperfusion due to a decreased 
cardiac output and not increased pulmonary wedge pressures (146). While resting 
pulmonary capillary wedge pressure is inversely associated to peak oxygen consumption 
(147), peak exercise pulmonary capillary wedge pressure is not related to peak oxygen 
uptake (148,149). 
1.6.5.3 Central haemodynamic factors 
Several investigators demonstrated a reduction in cardiac output during exercise in patients 
with L V dysf~nction and a significant correlation between cardiac output and oxygen 
uptake at peak (148-151) and submaximal (152) exercise levels. 
Diastolic left ventricular dysfunction, even m the presence of normal systolic left 
ventricular function may lead to significant reductions in exercise tolerance due to a 
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decrease m the submaximal cardiac output (153). These authors compared the 
haemodynamic response to exercise of 7 patients with chronic heart failure to that of 10 
age-matched normal subjects. They found that although left ventricular end-diastolic 
volume was not different at rest in the two groups, it was lower in the-patients during 
exercise and did not increase in this group from rest to exercise. However, this response 
was accompanied by a marked increase in left ventricular filling pressures in the patients 
suggesting left ventricular diastolic dysfunction with reduced left ventricular compliance. 
Because left ventricular end-diastolic volume did not change during exercise despite 
elevated left ventricular filling pressures, stroke volume failed to increase during exercise 
in the patients. 
Some patients with left ventricular dysfunction may develop secondary mitral 
regurgitation due to progressive ventricular dilatation. This condition may play an 
important role in determining the forward stroke volume response to exercise in some 
patients (143) and could be treated with vasodilator therapy (154). 
In spite of the above results, the lack of correlation between exercise left ventricular 
ejection fraction and peak V02 in patients with left ventricular dysfunction has been 
considered to show that abnormalities in cardiac function were not important in 
determining exercise tolerance. A possible explanation is that ejection fraction plays a 
small role in determining cardiac output in patients with low left ventricular ejection 
fractions (143). Cardiac output is the product of heart rate and stroke volume and is 
determined not only by L V contractility but by several other factors such as the end-
diastolic volume and the mitral regurgitation fraction as seen above: Cardiac Output = 
Heart Rate x End-Diastolic Volume x EF x (1-Mitral Regurgitation Fraction). The 
contribution of end-diastolic volume and mitral regurgitation fraction to the determination 
of cardiac output are accentuated in patients with chronic heart failure. 
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1.6.5.4 Chronotropic incompetence 
Szlachcic and co-workers (155) found a good correlation ·between maximal oxygen 
consumption and maximal cardiac index (r=0.82, p<0.001) in patients with CHF. Since 
stroke volume did not change, oxygen consumption correlated significantly with the 
exercise-induced increment in heart rate (r=0.77, p<0.001). However, Sullivan (150) 
showed that the heart rate response to exercise is much higher in normal subjects 
suggesting some degree of chronotropic incompetence in patients with CHF. 
Abnormalities of cardiocirculatory reflexes, lower catecholamine concentrations in the 
heart with congestive failure and a reduced sensitivity to beta-adrenergic receptor 
stimulation could explain the heart rate incompetence of these patients (149). 
1.6.5.5 Peripheral adaptations 
Recent studies have demonstrated that chronic peripheral adaptations play an important 
role in the exercise intolerance of patients with chronic heart failure. 
The findings that improvements in exercise performance do not accompany immediate 
improvements in central haemodynamics after inotropic (156) or vasodilator therapy (157) 
and that exercise capacity is increased over 3 to 6 months only after long-term therapy 
with angiotensin converting enzyme inhibition (158-160) suggest that chronic peripheral 
adaptations are responsible for this response. 
The earlier studies of Weber and Janicki (161) demonstrated that the onset of lactate - -
accumulation is an important predictor of submaximal exercise tolerance in chronic heart 
failure. Subsequent studies showed that exercise intolerance in patients with chronic heart 
failure is associated with an early increase in blood lactate concentrations in skeletal 
muscle. Two factors that could contribute to this respons·e in patients are reduced muscle 
perfusion during exercise (150,162,163), and reduced aerobic enzyme content in skeletal 
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muscle (164,165). However it is interesting to note that many of these alterations are 
consistent with the effects of exercise deconditioning and could be partly attributable to 
muscle wasting secondary to prolonged inactivity (136). 
Peak leg blood flow and peak cardiac output, both showed a good correlation with peak 
oxygen consumption in patients with this disorder (134). Several studies showed that 
skeletal muscle perfusion was reduced in patients with CHF compared with normal 
subjects (150,162,163). A reduced cardiac output during exercise reduces the perfusion of 
working skeletal muscle which in turn is a potent stimulus for increased oxygen 
independent metabolism in muscle. In contrast, others (166,167) reported abnormalities of 
high-energy phosphate metabolism in congestive heart failure without blood flow changes. 
Massie et al. (149) demonstrated that patients with CHF show greater declines in pH and a 
higher rate of lactate production and ATP consumption than normal subjects at 
comparable submaximal workloads, during exercise performed with the brachia! artery 
occluded by a cuff inflated to a pressure exceeding systolic blood pressure. Their study 
strongly suggested the existence of intrinsic skeletal muscle abnormalities in patients with 
CHF, unrelated to altered skeletal muscle perfusion during exercise. 
These abnormalities were more directly confirmed by muscle biopsy studies which 
showed decreases in skeletal muscle aerobic enzyme activity, muscle fibre changes and 
alterations in the vasodilator capacity of peripheral vessels (164,165). Mitochondrial 
enzymes involved in terminal oxidation such as enzymes mediating beta-oxidation of fatty 
acids, as well as glycogen content were also reduced. There was a decrease in slow twitch 
type 1 fibers which have a high potential for aerobic oxidation and an increase in fast 
twitch type 2b fibers (164,165). These biochemical and histological alterations in skeletal 
muscle are likely to modify exercise tolerance in these patients. 
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1.6.5.6 Neurohormonal activation 
Congestive heart failure promotes the activation of several neuroendocrine mechanisms 
largely in order to compensate for reduced flow. Alterations in the reflex control of the 
circulation are also seen (168). 
The sympathetic nervous system is uniformly activated while the renin-angiotensin system 
is variably activated in chronic heart failure (169). Both systems are potent vasoconstrictor 
stimuli which can increase the impedance to left ventricular ejection and influence the 
peripheral distribution of blood flow. In addition arginine vasopressin (170) and plasma 
atrial natriuretic peptide (171) levels are often increased in these patients. Vasopressin 
also has a vasoconstrictor effect, but this effect may be manifested only under the unusual 
circumstances when the circulating hormone level is very high (172). Atrial natriuretic 
peptide may exert a modulating effect on vasoconstrictor tone and on neurohormonal 
stimulation in heart failure (173). 
Activation of these neurohomonal systems relates to the severity of the clinical syndrome 
(169). Plasma norepinephrine, plasma arginine vasopressin and plasma atrial natriuretic 
peptide levels are increased even in patients with asymptomatic L V dysfunction while the 
renin-angiotensin system is activated only in symptomatic patients requiring treatment for 
heart failure (168). 
Furthermore, an impaired reflex responsiveness to baroreceptor and mechanoreceptor 
unloading is frequently seen in these patients, blunting the usual rise in plasma 
norepinephrine and renin activity in response to orthostasis (174) and _yasodilator drug 
infusion (175). 
The activation of these systems could impact directly on exercise tolerance by limiting 
exercise-induced vasodilation or by contributing to maidistribution of peripheral blood 
flow. 
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1.6.5.6.1 Role of resting neurohormonal activity 
Francis et al (176) have demonstrated an inverse relationship between resting plasma 
norepinephrine levels and peak exercise capacity in subjects with heart failure. On the 
other hand, other authors found a very weak correlation between peak oxygen 
consumption measured during a progressive bicycle ergometer test and blood hormone 
levels (177). 
1.6.5.6.2 Role of neurohormonal response to exercise 
During exercise all the neurohormonal vasoconstrictor systems are activated. 
In normal subjects, plasma norepinephrine levels rise modestly during exercise below the 
so-called "anaerobic" threshold but rise rapidly above this threshold (176), while in 
patients with chronic heart failure even modest workloads cause a substantial increase in 
the plasma norepinephrine level (178). When plasma norepinephrine levels were compared 
at the same relative work intensity expressed as a percentage of peak V02, patients with 
heart failure demonstrated a slower rate of rise of plasma norepinephrine suggesting an 
attenuated sympathetic response to exercise (178). Pharmacologic blockade of these 
systems by inhibition of alpha-receptor function or the formation of angiotensin II was 
unable to acutely improve the exercise tolerance of these patients (168). 
1.6.5.6.3 Role of cardiac innervation 
_ Resting plasma norepinephrine levels- and reflex responses to orthostasis and nitroprusside 
infusion returned toward normal in patients with congestive heart failure after cardiac 
transplantation (179) . However, peak exercise performance usually remains impaired in 
these patients after a heart transplant ( 180). One possible explanation for this is the 
immunosupressive therapy that these patients receive, but another possibility is the loss of 
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neural cardiac control since the donor heart is denervated. In this regard, there is evidence 
to suggest that gradual reinnervation of the heart occurs two or more years after orthotopic 
cardiac transplantation in some patients (181). However, maximal exercise capacity was 
not greater in these patients than in those who have not developed reinnervation. 
There is therefore no evidence to support the concept that neurohormonal activation is a 
factor limiting the exercise tolerance of patients with chronic heart failure (168). These 
abnormalities may however contribute to some of the signs and symptoms of the disease 
and retain an important role in its prognosis. 
1.7 The aim of the study 
1.7.1 Background 
In 1988 we started assessing left ventricular function in all patients enrolling into our 
programme at the Johannesburg Cardiac Rehabilitation Center in order to stratify them 
according to the risk of an exercise-cardiac related event and to establish the degree of 
their monitoring during exercise. We began to realise that many patients with low ejection 
fractions could actually perform very well from a functional point of view and lead an 
active and normal life. 
The subject of this thesis was conceptualised as a result of these personal observations at 
the Johannesburg Cardiac Rehabilitation Centre. However, it did not take long for our 
observations to be partially substantiated by studies done at large University Centres 
around the world. These studies showed that selected patients with depressed left 
ventricular systolic function following acute myocardial infarction could safely participate 
in supervised exercise training programmes and significantly improve their effort tolerance 
(134,135). In an attempt to understand the nature of these beneficial effects, researchers 
were also prompted to investigate the precise mechanism for the exercise intolerance of 
these patients (143) and the accu!1}ulated evidence started to suggest that it is multi-
factorial. Of special interest for cardiac rehabilitation practitioners was the finding that 
measurements of systolic left ventricular function could not predict the exercise tolerance 
of these patients (147,182). 
We were disappointed when some of these data were published before we could finish our 
studies and realized that our observ~tions were no longer absolutely unique. Although 
some of the questions were answered we could identify several important methodological 
limitations in those studies. As a result, our studies compliment a growing literature 
showing that exercise training should play an important role in the management of patients 
with left ventricular dysfunction. 
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1. 7.2 Limitations of previous studies 
Non-cardiac factors which could have had a confounding effect on effort tolerance were 
not considered when correlating measures of left ventricular dysfunction to measures of 
exercise tolerance. 
Only impairments in left ventricular systolic function have been related to exercise 
capacity even though it is known that congestive heart failure can exist in the presence of 
preserved systolic function and that left ventricular diastolic dysfunction may be a major 
determinant of effort intolerance in these patients (183,184). 
Most patients were accepted on these trials on the basis of their New York Heart 
Association (NYHA) functional class and left ventricular ejection fraction. The limitations 
of the use of the NYHA class have been demonstrated ( 185). Most studies categorized 
patients into two categories, one with an EF less than, and one with more than a certain 
value. But no study has yet evaluated a complete spectrum of patients with various degrees 
of left ventricular dysfunction. The majority were on NYHA classes III and IV and on 
treatment with diuretics and digitalis. 
Most patients enroiled into the studies have been evaluated while in hospital for an acute 
event, whether due to ischaemia or congestive heart failure and the reported left ventricular 
dysfunction was rarely a true reflection of their status during exposure to daily activities. 
The criteria for admission into these studies has been very restricted in terms of the 
patient's medical condition since only patients post-MI and patients with non-ischaemic 
cardiomyopathies have been enrolled. 
Since most cardiac rehabilitation programmes utilise exercise as their main instrument of 
therapy, measurement of changes in LV function during exercise rather than at rest, at 
entry to the programme, could provide information more 'representative of the adaptations 
that are likely to occur as a result of training. 
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Because of its prognostic value, resting ejection fraction has been widely utilised as an 
end-point to describe improvement or deterioration of function in this population group 
(186). It is possible that the poor correlation between EF and exercise tolerance is due to 
the lack of sensitivity of EF in estimating cardiac output. There is therefore a need to 
evaluate other parameters of systolic and diastolic L V function, as predictors of exercise 
tolerance. 
Patients joining a cardiac rehabilitation programme may not only have varying degrees of 
left ventricular dysfunction but also demonstrable myocardial ischaemia (187-189). It is 
well known that an imbalance between myocardial oxygen supply and demand can 
significantly affect the left ventricular function of patients but little is known about how 
exercise training can affect the association between ischaemia and left ventricular function. 
It has been suggested that patients with low EFs and associated myocardial ischaemia may 
not show improvements in maximal oxygen uptake as a result of exercise training (190). 
Furthermore, most studies including these type of patients utilised an electrocardiographic 
criterion of evaluation. The sensitivity of the use of the treadmill test as a measurement of 
myocardial ischaemia has been reported as 68% in a population with angiographically 
demonstrated coronary artery disease ( 191) and could be greatly enhanced with 
myocardial perfusion imaging techniques (192-194). 
The effects of exercise rehabilitation on the left ventricular performance of patients with 
coronary artery disease remain controversial. Most studies have shown little change in L V 
systolic function in patients undergoing conventional exercise training programmes 
(98,99,103,134,195-198) while others have reported training-induced central adaptations 
after high-intensity and prolonged endurance training programmes (115,196,197,199,200). 
Although it is well known that poor compliance with the exercise programme can lead to 
an inadequate training stimulus, researchers very seldom adjusted their data according to 
this important variable. Age-related deterioration in left ·ventricular function could have 
been another contributory factor to the lack of improvement in cardiac function seen by 
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some authors after training (201,202-204). Furthermore, little attention has been given to 
changes in diastolic function as a result of exercise training especially in this patient group. 
Most exercise rehabilitation programmes recommend that their cardiac patients exercise 3 
times a week for 30 to 45 minutes at an intensity between 70 to 85% of maximal heart rate, 
which corresponds to between 50 and 70% of V02 max, for a period of 3 to 6 months. In 
the USA the duration of the post-discharge exercise programme (Phase 2) is dictated by 
the patient's medical insurance company and never exceeds 3 months duration. Since 
patients are responsible of the programme costs thereafter, only a small percentage of these 
patients will continue exercising into a Phase 3 exercise cardiac rehabilitation programme. 
The progamme run by the Johannesburg Cardiac Rehabilitation Centre is fully sponsored 
by the Johannesburg City Council. Exercise is prescribed in the same way but since costs 
are not an issue most patients will remain on the programme for a duration of 6 months 
and 50% for 18 months. We are therefore in a unique position to assess the effects on long 
term exercise training in these patients. 
1.7.3 The need for and the purpose of the study 
Based on the above studies, we can conclude that the left ventricular functional profile of 
patients admitted to community-based cardiac rehabilitation programmes as well as the 
physiological adaptations to exercise training of patients with various degrees of left 
ventricular dysfunction remain to be fully established. 
Accordingly, the following needs for research of this topic were identified: 
1- To assess the left ventricular profile of a wider spectrum of patients with coronary 
artery disease enrelling into an outpatient cardiac rehabilitation programme. 
2- To use a method of evaluation of left ventricular function that accurately measures 
diastolic as well as systolic function at rest and during exercise. 
3- To include non-cardiac factors and parameters other than EF when correlating left 
ventricular function parameters to exercise tolerance. 
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4- To evaluate the physiological adaptations to exercise training in a wider spectrum of 
patients with L V dysfunction. 
5- To establish the impact of myocardial ischaemia on left ventricular function and 
adaptability to training by selecting patients on the basis of their ischaemic response to 
exercise testing and myocardial perfusion imaging studies. 
6- To evaluate the effects of exercise training of short and long term duration on the 
systolic and diastolic left ventricular function of patients with coronary artery disease, 
adjusting the results to the patient's adherence to the training regime. 
It is the purpose of this thesis to address the methodological limitations seen in the above 
studies and to evaluate the relationship between left ventricular function and exercise 
tolerance in a wide range of patients with coronary artery disease and with different levels 
of impairment in left ventricular function, before and after short and long term exercise 
training. The thesis is based on the hypothesis that if peripheral mechanisms play a major 
role in limiting the exercise tolerance of patients with left ventricular dysfunction, exercise 
training that enhances skeletal muscle function could improve their exercise tolerance, 
regardless of their initial limitations in myocardial function. 
Point 1 is addressed in Chapter 3 which reports an evaluation of the degree of left 
ventricular impairment of a wide variety of patients with coronary artery disease on 
admission to an outpatient community-based cardiac rehabilitation programme. Their data 
for left ventricular function were compared to those of a group of individuals without 
known cardiovascular disease. 
Point 2 1s addressed throughout the different studies by usmg radionuclide 
ventriculography at rest and during exercise as the method for assessing systolic and 
diastolic left ventricular function in these patients. 
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Point 3 is addressed in Chapter 4 using a multiple regression analysis that includes non-
cardiac as well as cardiac factors other than EF as possible predictors of the exercise 
capacity of these patients. 
Point 4 is addressed in Chapters 4, 5 and 7. In Chapters 4 the physiological and 
cardiovascular responses to exercise training are compared between patients with various 
degrees of asymptomatic left ventricular dysfunction. In Chapter 5 the effects of exercise 
training on the exercise capacity, cardiovascular efficiency and left ventricular function of 
a group of patients with more severe left ventricular dysfunction is reported. In Chapter 7 
the ventilatory responses to exercise are compared between patients with various degrees 
of left ventricular dysfunction. 
Point 5, the effect of myocardial ischaemia on left ventricular function and adaptability to 
training, is addressed in Chapter 4 in which the adaptations to training of patients with left 
ventricular dysfunction and myocardial ischaemia are reported and more selectively in 
Chapter 6 in which a population with myocardial ischaemia documented by radionuclide 
imaging and normal left ventricular function was evaluated. 
Point 6 is addressed in Chapter 8 by evaluating the effects of 6 and 18 months of exercise 
training on physiological variables and left ventricular function, categorizing patients 
according to compliance categories. 
In sumary, this thesis will: 
1) Establish th_e prevalence of systolic and diastolic L V function abnormalities in patients 
with coronary artery disease joining a cardiac rehabilitation programme; 
2) Identify predictors of exercise capacity in the patients above and evaluate their 
adaptability to training by comparing the physiological adaptations between categories 
of L V impairment; 
3) Evaluate the feasibility of exercise training in patients with severely depressed systolic 
L V function in South Africa, in terms of physiological adaptations and possible 
deleterious effects on L V function; 
4) Investigate the effects of exercise training on LV function and maximal and 
submaximal exercise capacity in patients with myocardial ischaemia with or without 
L V dysfunction; 
5) Study the mechanisms involved in the maintenance of cardiac output in patients with 
left ventricular dysfunction and/or myocardial ischaemia; 
6) Assess the ventilatory responses to effort in patients with depressed L V function as 
well as the effects of exercise training on these responses; 
7) Evaluate the effects of adherence to exercise training on the above adaptations. 
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Annexure 1.1 Levels of Cardiac Rehabilitation Requirements according to the World 
Health Organization Expert Committee (3). 
In establishing a cardiac rehabilitation programme, the following needs should be considered (3): 
• trained personnel 
• physical facilities, equipment, and educational materials 
• financial resources (within the context of the community and existing health care 
system) 
• programme of exercise and patient education 
These four elements are discussed below for each of the three possible levels of cardiac 
rehabilitation. The simplest level delivers cardiac rehabilitation at the local community level 
(basic facility). At the second level cardiac rehabilitation is developed within a local town or city 
hospital (intermediate facility). The third level is the establishment of a major cardiac 
rehabilitation centre ( advanced facility). 
A basic facility would be situated in a community and run by a part-time community health care 
worker trained in cardiac rehabilitation. The physical facility would require an exercise or 
walking area, with equipment limited to a sphygmomanometer and stethoscope, plus educational 
material. Low to moderate intensity exercise would be prescribed, requiring minimal or no 
supervision. This type of facility would be adequate for the provision of Phase III and IV services 
in a disadvantaged area, and could be run at a minimal cost. 
An intermediate facility would be located within or close to a hospital where general medical 
services are available. The services of a doctor trained in cardiology, cardiac rehabilitation or 
exercise physiology, and of health professionals trained in exercise prescription, monitoring and 
- -
patient education would be required. The personnel would usually work part-time and have other 
responsibilities within the hospital. Facilities required would be an office, an area for exercise 
testing, an area for exercise classes and monitoring and an area for group discussions. Equipment 
would consist of an electrocardiograph and monitor, a bicycle ergometer or treadmill, and 
aerobic, resistance training and resuscitation equipment. The exercise programme would include 
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low to moderate intensity exercise under supervision. Muscle strengthening would also be 
encouraged according to patients' specific requirements. Basic information and long-term 
compliance support would be provided. A small budget would cover the costs of equipment and 
consumables as well as the health professionals' time. This type of facility would be adequate for 
the provision of Phase I and II services. 
An advanced facility would be situated in a major city and have a cardiovascular disease referral 
system. Such a centre could be developed in a university teaching hospital or a private 
institution. Personnel would consist of a multidisciplinary team, including a medical director 
with .experience in cardiac rehabilitation; nursing sisters; exercise specialists, such as 
physiotherapists or biokineticists; a dietician; a psychologist; and an occupational therapist or 
social worker .. The physical facilities would be similar to, but more extensive than, the 
intermediate centre. Doctors' consulting rooms would be required in addition to the 
administration office. 
Desirable equipment includes exercise testing equipment with treadmill or bicycle ergometer, 12 
lead electrocardiograph and monitor; optional metabolic cart for gas exchange measurements; 
exercise training equipment such as treadmills, bicycle ergometers, combined arm and leg 
ergometers, circuit weight stations and free-standing weights; monitoring equipment such as 
blood pressure sets, time-clocks, telemetry and Holter. Resuscitation equipment, including 
oxygen, defibrillator and drugs would be on site. If the facility is located within a hospital it 
would be ideal for the provision of Phase I, II and III services, while if it is located within a 
community it would be more suitable for the provision of Phase III and N services. 
Supervised moderate to high intensity exercise would be prescribed, and a more complete 
educational programme would be- delivered in keeping with the greafer expertise available. 
Advanced facilities have other important responsibilities, such as teaching and training, and 
should have sufficient expertise to undertake research and evaluation of the effects of 
rehabilitation pro grammes. 
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Annexure 1.2 Summary Of Evidence For Cardiac Rehabilitation Outcomes: Effects Of Exercise 
Training (ET) and Education, Counselling And Behavioral Interventions (E,C & 
BI). 
STUDIES (ET I E,C & BI) 
OUTCOME NUMBER RANDOMIZED NON OBSERVATIONAL STRENGTH OF 
RANDOMIZED EVIDENCE 
Exercise tolerance 114 I 3 46 I l 25 I l 43 I l AIC 
Exercise tolerance 7 4 3 0 B 
( strength training) 
Exercise habits 15 10 2 3 B 
Symptoms 26 I 4 12 I 2 711 711 BIB 
Smoking 24 I 7 12 I 5 8 /1 411 BIB 
Lipids 37 I 18 18 I 12 613 13 I 3 BIB 
Body weight 34 I 5 11 I 3 7 /1 16 /1 CIB 
Blood pressure 18 I 2 910 612 310 BIB 
Psychosocial 20 I 14 916 816 312 BIA 
Wellbeing 
Social adjustment 6 2 2 2 B 
and functioning 
- -
Return to work 28 I 3 10 I 2 910 911 AIC 
Morbidity 42 I 3+2 15 I 3 14 I 0 13 I 0 AIB 
Mortality 30 I 8+2 16 / 8 8/0 6/0 B 
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Annexure 1.2 (Cont.) Effects of Exercise Training. 
STUDIES 
OUTCOME NUMBER RANDOMIZED NON OBSERVATIONAL STRENGTH 
RANDOMIZED OF EVIDENCE 
Changes in 9 5 1 3 A-B 
atherosclerosis 
--· 
Changes in 5 0 0 5 B 
haemodynamic 
measurements 
Changes in myocardial 11 6 2 3 B 
perfusion/ 
myocardial ischaemia 






Changes in cardiac 5 4 0 1 B 
arrhythmias 
Heart Failure patients 12 5 3 4 A 
Cardiac transplantation 5 0 1 4 B 
patients 
Elderly patients 7 0 1 4 B 
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Annexure 1.3 Risk of cardiovascular complications during the exercise 
Training of cardiac patients. 
HASKELL et al. (10) VAN CAMP et al. (11) 
Years of study 1960 -1977 1980 - 1984 
Number of programmes 30 167 
Number of patients 13 750 51 303 
Number of patient-hours 1 629 634 2 361 916 
of training (p/h) 
Cardiac arrests 50 (1 / 32 593) 21 (1 / 111 996) 
(Number (p/h)) 
Successful resuscitations 42 (84)% 18 (86) 
(Number(%)) 
Myocardial infarctions 7 (1 / 232 805) 8 (1 / 293 990) 
(Number (p/h)) 
Mortality 14 (1/116402) 3 (1 / 783 972) 
(Number (hip)) 
Number and Type of 8 - cardiac arrests 3 - cardiac arrests 
Complications 2 - myocardial infarctions 
2 - pulmonary embolisms 
1 - pulmonary oedema 
1 - cardiogenic shock 
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Annexure 1.4 GUIDELINES FOR RISK STRATIFICATION (73) 
Low Risk 
1. No significant left ventricular dysrfunction (ie. Ejection fraction> 50%) 
2. No resting or exercise-induced myocardial ischaemia manifested as angina and/or 
ST-segment displacement 
3. No resting or exercise-induced complex arrhythmias 
4. Uncomplicated myocardial infarction, coronary artery bypass surgery, angioplasty, 
or arthrectomy 
5. Functional capacity> 6 METs on graded exercise test 3 or more weeks after clinical 
event 
Moderate Risk 
1. Mild to moderately depressed left ventricular function (Ejection fraction 31 %-49%) 
2. Functional capacity < 5-6 METs on graded exercise test 3 or more weeks after 
clinical event 
3. Failure to comply with exercise intensity prescription 
4. Exercise-induced myocardial ischaemia (1-2 mm ST-segment depression) or 
reversible ischaemic defects ( echocardiographic or nuclear cardiology) 
High Risk 
1. Severely depressed left ventricular function (Ejection :fraction::: 30%) 
2. Complex ventricular arrhythmias at rest or appearing or increasing with exercise 
3. Decrease in systolic blood pressure of> 15 mm Hg during exercise or failure to rise 
with increasing workloads 
4. Survivor of sudden cardiac death 
5. Myocardial infarction complicated by congestive heart failure, cardiogenic shock, 
and/or complex ventricular arrhythmias 
6. Severe coronary artery disease and marked exercise-induced myocardial ischaemia 
(>2 mm ST-segment depression) 
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CHAPTER2 
MATERIAL AND METHODS 

2.1 Patient population 
Of patients admitted to the Johannesburg Cardiac Rehabilitation Centre, only patients with 
CAD were selected, thus excluding patients with other forms of heart disease or who were -
at risk for its development. Because of methodological problems during radionuclide 
ventriculography determinations, patients with CAD and atrial fibrillation or significant 
ventricular arrhythmias, or both were also excluded from our studies. Patients with 
handicaps unable to walk on a treadmill were also excluded. 
The subjects were admitted 12 weeks after myocardial infarction (MI) or coronary artery 
bypass surgery (CABG) and 4 weeks after percutaneous translurninal coronary angioplasty 
(PTCA) in order to reduce the effect of spontaneous recovery in the measures of left 
ventricular dysfunction. 
Several cohorts of patients were studied in chronological order between 1989 and 1993 on 
the basis of the subjects ' consent and availability to the performance of radionuclide 
ventriculography and radionuclide myocardial imaging studies (Annexure 2.1 ): 
1- Cohort 1 included 171 patients with CAD consecutively referred to the Johannesburg 
Cardiac Rehabilitation Center who had their left ventricular function measured at rest 
on admission. These patients were enrolled into the studies described in Chapters 4 and 
7. 
2- Cohort 2 included 118 consecutive patients with CAD who had their left ventricular 
function assessed at rest and during exercise, on admission and after 6 months of 
exercise training. Some of these patients also belonged to cohort 1. These patients were 
enrolled into the studies described in Chapters 3 and 8. Forty patients from this cohort 
had also left ventricular function studies at rest and during exercise after 6 months of 
exercise training. 
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3- Cohort 3 included 28 consecutive patients recovering from an acute MI and with a 
L VEF of 30% or less. Some of these patients were also part of cohort 1. The results of 
this study are reported in Chapter 5. 
4- Cohort 4 included 22 patients with planar or downsloping ST segment depression =::: 
1mm during exercise testing who underwent radionuclide imaging studies. Some of 
these patients were also part of cohorts 1 and 2. These patients were enrolled into the 
study reported in Chapter 6. 
Two control groups were used (Annexure 2.2): 
1- Thirty one volunteers without any history, signs or symptoms of cardiac disease and 
with normal results for an exercise test, were prospectively evaluated and selected as a 
control group for the measures of left ventricular function for the studies in Chapters 3, 
4 and 7. 
2- Fifty consecutive patients with CAD without signs and/or symptoms of myocardial 
ischaemia during exercise testing were selected as a control group for cohort 4 which 
consisted of patients with demonstrable myocardial ischaemia during exercise testing 
and radionuclide perfusion imaging. This group was used as a control group in Chapter 
6 only. 
All studies were approved by the Ethics Committee of the Johannesburg City Council's 
City Health Department and by the Research and Ethics Committee of the Faculty of 
Medicine of the University of Cape Town Medical School. Informed consent was obtained 
from all participants. 
The characteristics of patients and controls are described in the individual studies. 
80 
2.2 Medical assessment of patients admitted at the Johannesburg Cardiac 
Rehabilitation Centre 
2.2.1 Introduction 
Patients were fully assessed on admission to the programme, and again after 6 and 18 
months and at regular intervals thereafter. The assessment includes a full medical history 
and examination, full fasting lipogram, anthropometric evaluation (height and weight, 
skinfolds, body pletismography), lung function test, resting ECG, stress ECG including 
expiratory gas analysis, and a dietary and psychological profile. Patients are subsequently 
stratified according to risk and exercise is individually prescribed. 
2.2.2 Exercise testing at the Johannesburg Cardiac Rehabilitation Centre 
A full cardiopulmonary exercise test with expiratory gas analysis is performed at the 
Centre. In spite of being considered a safe procedure (18), the exercise test is always 
performed under the supervision of a doctor appropriately trained to conduct these tests 
and emergency equipment is always available. The author has personally supervised the 
majority of tests whose data has been used for the different studies. Patients are instructed 
not to eat for 3 hours prior to the test and to dress appropriately for exercise. A thorough 
physical examination is performed in all and contraindications for exercise testing (18) are 
ruled out. Patients are tested while taking their usual medications. They have the testing 
procedure explained to them and a demonstration of treadmill walking is performed. The 
areas for electrode placement are shaved and rubbed with alcohol-saturated gauze in order 
-
to lower the resistance of the skin, reducing the signal-to-noise ratio. Silver plate 
electrodes are used. A standard 12 lead ECG with the limb electrodes placed on wrists and 
ankles is performed at rest in the supine position and a Mason-Likar placement is used 
during exercise testing bringing the wrist and ankle electrodes to the base of the limbs 
(173). 
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The Chung protocol has b~en adopted for the testing of cardiac patients admitted to t~e 
Johannesburg Cardiac Rehabilitation Centre (27). Its reproducibility has been validated 
against the Bruce protocol in a previous report (205) and its metabolic requirements have 
been described in Chapter 1. 
The exercise test was performed on a motorized treadmill according to the Chung 
protocol. Leads SII, V2 and VS are continuously recorded during exercise and blood 
pressure was continuously monitored at each stage of the exercise test and during the 
recovery phase. 
Expired air was analysed throughout exercise using a metabolic cart (BOS-Sprint, Erich 
JAEGER GmbH&CoKG, Wurzburg, Federal Republic of Germany). Metabolic, 
ventilatory and haemodynamic variables were determined at rest, at submaximal (6 
minutes on the treadmill according to the Chung protocol) and maximal levels. As 
previously discussed in Chapter 1, peak oxygen uptake rather than V02 max was 
determined. 
The ventilatory threshold, expressed as absolute oxygen uptake, is defined as the first 
deviation in linearity of the ventilation plotted against the oxygen consumption. The 
limitations of this visually-determined technique are appreciated (206); these are less 
important in a longitudinal training study in which subjects act as their own controls. The 
accuracy in determining the ventilatory threshold as the point at which there is a non-linear 
increase in minute ventilation has been questioned by some due to a large inter observer 
variability (207). Others have reported that intraobserver and interobserver variation were 
very small for visual inspection in normal subjects and cardiac patients (208). This is in 
agreement with our experience (unpublished results) that the ventilatory threshold can be 
determined accurately from gas exchange variables. 
The ventilatory threshold was determined by the physician supervising the test, who had 
experience in performing such determinations. The author was the physician during most 
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tests. The graph relating minute volume to peak V02 was printed and the value obtained 
for ventilatory threshold was checked again by the physiotherapist or biokineticist 
responsible for the exercise prescription of the patient. In the very few occasions when 
there was a discrepancy between observers the graph was plotted again on computer and 
the point re-evaluated by a third person. Physicians were generally blinded to whether the 
patient was a compliant or a not-compliant, however knew when the test was a pre or a 
post-test. 
The end-points for fatigue during maximal exercise were one or more of the following: 
physical exhaustion, development of marked angina pectoris, ST segment depression of 
more than 3mm, sustained ventricular tachyarrhythmias or a drop in systolic blood 
pressure of more than 10 mm Hg. The test was considered positive for ischaemia if 1mm 
horizontal or downsloping ST segment depression, persisting 80 msec after the J point, 
was observed (173). The limitations of ST segment analysis alone in predicting ischaemia 
are appreciated. The sensitivity of the method was enhanced by including in the model the 
ST segment time course in the post-effort period. The sensitivity of the exercise test in 
detecting myocardial ischaemia was further increased in selected patients by the addition 
of myocardial perfusion imaging. 
2.2.3 Resting and exercise myocardial perfusion imaging: method used in this study 
Myocardial perfusion imaging with Tc-99m sestarnibi (Tc-MIBI) superceded the use of 
Thallium-201 in Johannesburg and was the method of choice. 
Myocardial_ perfusion studies were performed first at rest and then during exercise according 
to the protocol set by the Department of Nuclear Medicine of the Johannesburg Hospital, 
University of the Witwatersrand. Twenty to 30 mCi of Tc-MIBI per average 70 kg patients 
were injected in an antecubital vein at rest, after four hours of fasting. Imaging was started 
not earlier than one hour from the time of the injection. On a separate day patients underwent 
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symptom-limited exercise testing and at peak exercise, 10 to 30 mCi of Tc-MIBI were 
injected intravenously. After the injection the patient was encouraged to exercise for another 
30 to 45 seconds. Imaging began not earlier than half an hour from the time of the injection 
and 15 minutes after patients had taken a fatty drink. Data were acquired at rest and post-
exercise both by ECG gated planar and SPECT methods on an Anger scintillation camera. 
The author personally conducted all exercise tests for this study and injected the radiotracer 
in the patients' veins. 
2.2.4 Method used in this study for the assessment of left ventricular function 
2.2.4.1 Introduction 
At the time the study was initiated, resting and exercise radionuclide techniques were fully 
developed in Johannesburg while stress echocardiography was not yet perfected so that very 
few technicians were fully trained in its use. Furthermore the interpretation of the results is a 
very subjective exercise. 
It was therefore concluded that radionuclide ventriculography should be selected as the 
method of evaluation of left ventricular function and that the equilibrium method should be 
the method of choice because of its advantages over the first transit method. It was felt that 
this method could provide an excellent noninvasive means of serially assessing the effects of 
a cardiac rehabilitation programme on left ventricular systolic and diastolic function. 
2.2.4.2 Resting radionuclide ventriculography 
Radionuclide ventriculography, using the equilibrium multi-gated blood pool technique ( 44) 
was performed at rest in all patients (Department of Nuclear Medicine of the Johannesburg 
Hospital, University of the Witwatersrand). Red blood cells were labelled in vivo by 
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injecting unlabelled stannous pyrophosphate in an antecubital vein, followed by injection 
of 15 to 25 mCi of Technetium 99m 15 to 20 minutes later. A mobile scintillation camera 
(Elscint Apex 409M, Haifa, Israel) equipped with a low energy, medium resolution and 
medium sensitivity collimator (Elscint A.PC 3) was used to determine the number of 
counts during each phase of the cardiac cycle. Cardiac images were acquired in a modified 
left anterior oblique position to allow for good separation between right and left ventricles. 
Acquisitions were gated to the R wave of the ECG and collected at 24 frames per cardiac 
cycle. The left ventricular region of interest in each frame was identified using a second 
derivative technique and time-activity curves were generated from these regions. 
2.2.4.3 Exercise radionuclide ventriculography 
After a radionuclide ventriculogram performed at rest, selected patients were exercised in 
the supine position on a Quinton 845T bicycle ergometer table. They were instructed to 
minimize upper body motion whilst under the camera and a Technetium marker was placed 
on the chest during exercise to detect excessive movement. The exercise protocol began at a 
work rate of 200 kg.rn/min. Patients were asked to pedal in the range of 50 to 70 rpm. 
Exercise work rates were increased by 100 kg.m/min every minute until 85% of the patient's 
maximal heart rate obtained on the symptom limited exercise test, had been reached. Patients 
then exercised for 3 minutes at that work rate. The test was stopped prematurely if any of the 
other end-points, previously described, were also reached. Radionuclide scanning was 
performed in the last 3 minutes of exercise and during the early (0 to 5 minutes) and late (5 
to 10 minutes) post-exercise periods. The author personally conducted all exercise 
radionuclide ventriculography studies at the Johannesburg Hospital with the help of a 
technician. 
Indices of systolic and diastolic -left ventricular function were derived from the time-
activity curves (Fig 2.1): end-diastolic counts (EDC), end-systolic counts (ESC), stroke 
counts (SC), EF, time to peak ejection rate (T-PER), peak ejection rate (PER), average 
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ejection rate (AV-ER), time to peak filling rate (T-PFR), peak filling rate (PPR) and 
average rapid filling rate (AV-RFR) (46). Ejection fraction was calculated according to the 
formula: EDC - ESC / EDC after substraction for background activity. Average ejection 
rate was calculated after substraction of background activity by dividing the stroke volume 
(EDC - ESC) by the ejection time (T3 - Tl), and normalizing for EDC. Average rapid 
filling rate was calculated after substraction of background activity by dividing the rapid 
filling volume (RFC - ESC) by the rapid filling time (TS - T3) and normalizing for EDC. 
Radionuclide measurements usmg the gated equilibrium approach rely on the well 
established proportionality between ventricular counts and volume. As previously reported 
in Chapter 1, Borer and co-workers ( 44) demonstrated the feasibility of radionuclide 
determination of ejection fraction during supine bicycle exercise using the equilibriuµi 
technique and Sorensen and co-workers (64) validated the use of count-derived changes in 
cardiac output as accurately reflecting true haemodynamic changes determined by the Fick 
technique. Count-volume relationships are linear for a given subject but discordant when 
comparisons are made between subjects because of inter-individual differences in 
attenuation, scatter, radioisotope dosage and timing of study. Furthermore counts are a 
relative rather than an absolute manifestation of volume changes. Therefore, because of 
these reasons, comparison of radionuclide data using counts is best made using percentage 
changes from baseline (64). We evaluated the change from rest to exercise by the use of 
the percentage change from rest to exercise, calculated as the value during exercise minus 
the value at rest divided by the value at rest x 100. A computer algorhythm reduced inter 
and intraobserver variability, but to minimize this factor even more, all studies were 

















Schematic left ventricular time-activity curve 
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AV-ER = EDC - ESC 
T3 - T1 / EDC 
AV-AFR = RFC - ESC / EDC 
T5-T3 
ED = end-diastolic counts measured at time T1; ES = end-systolic counts measured at time T3 and 
RF = rapid filling counts measured at time TS. 
T3 - T1 defines the ejection period and TS - T3 the rapid filling perion. 
T2 = time at which peak ejection rate occurs; T4: time at which peak filling rate occurs 
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2.3 Exercise prescription and exercise training at the Johannesburg Cardiac 
Rehabilitation Centre 
After the initial assessment, all patients underwent a 6 month medically supervised 
programme of aerobic exercise and attended weekly discussion sessions about lifestyle 
modification. Some of these patients continued exercising at the centre for 18 months. 
The exercise prescription and monitoring of patients was controlled by a physiotherapist or 
a biokineticist with the help of other members of the health care team. 
The intensity of exercise was set using the heart rate achieved at the ventilatory threshold 
identified in the initial exercise test. Typically this occurred at 70-85% of the maximal 
heart rate. Patients were required to exercise at their prescribed heart rates three times per 
week continuously for 30-45 minutes. 
Exercise sessions consisted of a warm-up period, aerobic exercise and a cool-down period. 
Prescribed activities were aerobic and emphasized walking, walking-jogging and cycling. 
Stationary cycling was prescribed for high risk patients or in those for whom weight-
bearing exercise was contraindicated. The exercise intensity for each patient was progressed 
gradually over a number of weeks until the required intensity of exercise was achieved 
(Table 2.1). Patients were given a training heart rate and the speed and distance which they 
had to walk or walk/jog. For instance, starting with 2 km of walking at a pace aimed at 10 
minutes per km, the distance was increased to 3.5 km after 2 weeks and to 5 km after a 
further 2 weeks. Once up to 5 km, the pace was increased by means of a faster walking speed 
or the addition of brief periods of jogging. Depending on their conditions, patients on the 
bicycle ergometer were asked to-cycle between 5 and 15 minutes at their prescribed load 
calculated using the formula described in the previous Chapter. They were progressed by 1 
minute per session until they were able to cycle for 30 minutes. Further increases in load 
were achieved via 5 watt increments every week until they reached an appropriate level. 
Patients were not allowed to exceed 85% of their maximal heart rates. 
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Patients were carefully monitored by the staff during their exercise sessions. The patients' 
compliance with the programme was monitored on a daily basis in terms of attendance at 
exercise sessions and the intensity of their training programmes. The day they attended as 
well as their maximal heart rate, wattage on the bicycle ergometer or distance walked or 
walked/jogged and duration of the effort were all recorded by the patients on a log card 
(Table 2.2). The information on the log card was captured on a computer. Reasons for 
dropout were obtained telephonically. Unless stated otherwise, compliance was monitored 
to ensure that subjects completed at least 60% of the exercise sessions during the 6-month 
period. We (209) and others (24) have previously found that a compliance of 60% or 
higher provides an adequate stimulus for a training effect in patients with cardiac 
diagnoses and in healthy subjects. 
The exercise protocol was the same for patients with or without left ventricular 
dysfunction and/or myocardial ischaemia. Patients developing ST segment depression 
during exercise testing had their intensity set 10 to 15 beats per minute below the 
ischaemic threshold as previously described. 
Our protocol for conditioning differs from a number which have been used by others in 
that the conditioning period was of 6 or 18 months rather than the usual 3 or 4 months. 
This is an important consideration because the cardiovascular effects of training in any 
subject are related to the intensity of the programme and its duration. Because patients 
with coronary disease are very deconditioned and have to be advanced slowly, the duration 
of a conditioning programme is an important factor in determining the cardiovascular 
response. In the design of a study to test the effects of exercise conditioning, it is important 
to allow time for the patient to achieve a near maximal benefit from training, and this is a 
matter of months or even a year in subjects with coronary-artery disease. 
Although resistance training activities were started in 1992 for selected patients, patients 
enrolled in this study participated only in aerobic activities. 
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Table 2.1 Progression of exercise 
WALKING 
2 km/ 2 weeks--•.- 3,5 km/ 2 weeks--.. 5 km 
5-8 min 
at prescribed 
load in watts 
1 




---- + 1 min / session 30 min 
! 
+ 5 watts / week 
WALKING PRESCRIPTION: Patients started by walking 2 km at a prescribed speed. Progression was achieved 
by increasing distance after 2 weeks to 3.5 km and after a further 2 weeks to 5 km. Further progression took 
the form of an increase in the speed of walking or by the addition of brief periods of jogging. 
CYCLING PRESCRIPTION: Patients started by cycling 5 to 8 minutes, depending on their physical status, at a 
load determined by the formula: Watts= (V02 ml I min - (5.8 x Weight in kg) - 151)/10.5. Duration was 
progressed one minute per session until they reached 30 minutes. Further increases in load were achieved by 
























































































































































































































































































2.4 Statistical methods 
All the studies were done prospectively. Except for the study described in Chapter 3 which 
was an observational cross-sectional study, all other studies were experimental and tested 
the intervention exercise training on different variables. 
The study lacks a control study of patients not undergoing exercise training because, based 
on our knowledge at the time the study was conceptualized, it would have been unethical 
not to accept a patient for cardiac rehabilitation. 
One maJor source of bias is the selection of the patient population. Only a small 
percentage of the population suffering from coronary artery disease in Johannesburg is 
actually referred to the Centre for cardiac rehabilitation. The referral pattern reflects the 
doctor's perception that a particular patient could benefit more from cardiac rehabilitation 
than another. Subjects were included into the studies not only on the basis of their personal 
consent, but also their doctor ' s consent and their availability for radionuclide studies. 
Another source of bias is the fact that those who adhered better to the programme may 
represent a subgroup of the self-selected small group of patients who join exercise 
programmes and who are perhaps more committed to long term lifestyle changes. 
The statistical tests performed are described in detail within each study for better 
understanding and in order to avoid duplications. 
The studies will be presented in a logical order and not necessarily in the chronological 
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DIFFERENCES IN LEFT VENTRICULAR 
FUNCTION BETWEEN PATIENTS WITH 
CORONARY ARTERY DISEASE AT ENTRY TO A 




Since patients with more severe degrees of heart disease are presently being accepted to 
current cardiac rehabilitation programmes, it would be expected that these patients would 
have various degrees of systolic and/or diastolic left ventricular dysfunction. However, 
little information is available on the range of left ventricular impairments in patients at 
entry to a community-based cardiac rehabilitation programme. Most of the available data 
describing the left ventricular function of cardiac patients comes from measurements 
obtained at rest, in hospital, at the time of the acute event. Most measurements evaluated 
only systolic function and had little value in predicting the patient's status during an 
exercise training programme which commenced some time later when some degree of left 
ventricular functional recovery might have been expected. 
Radionuclide ventriculography has proved to be an effective tool in the nonmvas1ve 
evaluation of systolic and diastolic left ventricular function at rest and during exercise in 
both patients with coronary artery disease and in normal subjects (44,210,211). Since the 
hemodynamic adaptations to exercise could be masked by an increase in heart rate during 
exercise, the evaluation of left ventricular function in the recovery period as heart rate 
decreases could provide additional insight into the mechanisms by which the healthy and 
diseased hearts adapt to exercise (211-213). 
The aim of this study was therefore to evaluate the systolic and diastolic left ventricular 
function of patients with coronary artery disease at entry to a Phase III cardiac 
rehabilitation program, at rest, during exercise in the supine position and after exercise. 
We wished to compare cardiac function in that group to that of a group of normal subjects 
without known heart disease to test the hypothesis that patients admitted for cardiac 
rehabilitation at present have a high incidence of left ventricular abnormalities. 
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3.2 Methods 
One hundred and eighteen patients, 110 males and 8 females with documented coronary 
artery disease consecutively referred to the Johannesburg Cardiac Rehabilitation Center were 
included in this study. Fifty four patients were post-myocardial infarction, 36 post-coronary 
artery bypass surgery, 19 post-percutaneous transluminal coronary angioplasty and 9 had 
chronic stable angina. The infarct was located in the anterior wall in 51 % and in the inferior 
wall in 49%. 
In addition 31 men matched for age, without any history, signs or symptoms of cardiac 
disease and with normal results for an exercise test, were selected as a control group for 
the measures of left ventricular function. Their coronary risk profile was as follows: none 
of the subjects were smokers; none had a history or were on treatment for a high 
cholesterol; two subjects suffered from hypertension and were on treatment for it: one was 
on enalapril and the other on amlodipine; none of the subjects had diabetes; eleven 
subjects exercised regularly at least 3 times per week, including those who were 
hypertensives; all had a Broca index within normal limits; 5 had a family history of 
coronary artery disease. 
The age of the patient group ranged from 36 to 85 years with a mean of 63 + 7 .5 years, and 
that of the control group from 42 to 64 years with a mean of 52 + 8.1 years (p=0.001). 
Eighty percent of patients were of Caucasian origin, 19% Asian and 1 % African. Subjects in 
the control group were all of Caucasian origin. Twenty five % of patients were on 
angiotensin converting enzyme inhibitors, 26% on beta-blockers, 32% on calcium channel 
blockers, 18% on nitrates, 13 % on diuretics, 1 % on digitalis and 87% on aspirin. 
All patients underwent a treadmill symptom-limited exercise test according to the Chung 
protocol before being accepted onto the exercise cardiac rehabilitation program. The test was 
considered positive for ischaemia in 9 patients who showed 1 mm or more horizontal or 
102 
downsloping ST depression, 80 milliseconds after the J point. Seven patients showed an 
upward ST segment displacement in the area of previous infarction. 
Radionuclide ventriculography, using the equilibrium multi-gated blood pool technique ( 44) 
was performed at rest in all patients and controls and during exercise in the supine position in 
93 patients and all controls. Radionuclide scanning was performed at rest, during the last 3 
minutes of exercise and during the early (0 to 5 minutes) and late (5 to 10 minutes) post-
effort periods. As previously described in the Methods section, we derived the following 
indices from time activity curves: EDC, ESC, SC, EF, T-PER, PER, AV-ER, T-PFR, PFR 
and A V-RFR. We evaluated the change from rest to exercise by the use of the percentage 
change from rest to exercise, calculated as the value during exercise minus the value at rest 
divided by the value at rest x 100. A computer algorithm reduced inter and intraobserver 
variability, but to minimize this factor even more, all studies were processed by one 
observer. 
Statistical analysis 
The entire cohort of patients studied was divided into 3 groups for additional analysis so 
that, in total, four population groups were evaluated: Group O (GO) included all 118 
patients irrespective of their left ventricular systolic function; Group 1 ( G 1) included 73 
patients with normal left ventricular systolic function (EF:2:50%); Group 2 (G2) included 
27 patients with moderately depressed systolic function (EF:2:35 and <50%) and Group 3 
(G3) included 18 patients with severely depressed systolic function (EF<35%). 
-
Patients and normal subjects were compared with respect to their systolic and diastolic left 
ventricular function at rest and during exercise. 
A mixed model ANOVA and Fisher's LSD tests were used to assess the significance of 
the differences between groups. Significance at the 5% level or lower is reported. 
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3.3 Results 
Significant differences in left ventricular hemodynarnics and systolic and diastolic 
function were seen between patients and controls. 
3.3.1 In all patients with coronary artery disease irrespective of degree of left 
ventricular dysfunction 
3.3.1.1 At rest. (Table 3.1) 
There was no difference m heart rate between patients and controls. ESC were 
significantly increased in the patients (p=0.019) and SC significantly decreased 
(p=0.0006), while there were no differences in EDC between the two groups. EF, PER, 
AV-ER, PFR and AV-RFR were significantly reduced in patients compared to controls 
(p=0.0004, p=0.006, p=0.0004, p=0.023 and p=0.0001 respectively). 
3.3.1.2 During exercise. (Table 3.1) 
Heart rate increased significantly during exercise m patients and controls but the 
percentage increase was significantly higher in the control group (98.7% vs 62.7%, 
p=0.0001). EDC and ESC were significantly increased during exercise in the control 
group, without significant changes in SC; while in the patients group, only ESC increased 
significantly during exercise. There were;;: no significant differences in the volJ.1me changes 
from rest to exercise between both groups. EF was significantly reduced in patients during 
exercise while it did not change in the control group. The percentage change in EF from 
rest to exercise was not significantly different between the groups. T-PER was 
significantly shortened in both groups, the change being of a similar magnitude. PER, AV-
ER, PFR and AV-RFR were significantly increased during exercise in both groups, while 
1 p 
T-PFR was significantly reduced during exercise only in the control group. PER, AV-ER, 
and PFR increased significantly more in controls than in patients (p=0.0001, p=0.007 and 
p=0.003 respectively). 
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Table 3.1 D~fferences in resting and exercise left ventricular function between patients 
with coronary artery disease and healthy individuals without known cardiac 
disease. 
CONTROL 
CAD CONTROL vs 
CAD 
pVALUE 
VARIABLES Rest Exercise 8.R-E Rest Exercise 8. R-E Rest 
n=ll8 n=93 n=93 n=31 n=31 n=31 Exercise 
* * 8.R-E 
HEART RATE 66.1 104.7 -62.7 62.4 121.9 -98.7 NS 
(bpm) (1.2) (1.7) (3.2) (2.4) (2.5) (5.5) 0.00001 
p=0.0001 p=0.0001 0.0001 
EDC 496969 507217 -4.5 454895 541477 -20.4 NS 
(16840) (31203) (5 .5) (32856) (52420) (9.5) NS 
p=NS p=0.034 NS 
ESC 263663 303999 -21.6 180400 244226 -40.9 0.019 
(16049) (26179) (6.8) (31312) (26493) (11.8) NS 
p=0.002 p=0.001 NS 
SC 233305 203218 10.0 274494 297251 -10.0 0.0006 
(5320) (13475) (5.9) (10379) (30211) (10.2) 0.002 
p=NS p=NS NS 
EF% 51.2 45.6 10.0 61.1 58.4 3.8 0.0004 
(1.2) (1.6) (2.0) (2.4) (1.6) (3.4) 0.0001 
p=0.0001 p=NS NS 
T-PER (sec) 0.15 0.08 46.1 0.15 0.07 50.1 NS 
(0.00) (0.00) (2.6) (0.00) (0.00) (4.5) NS 
p=0.0001 p=0.0001 NS 
PER (EDV/sec) 2.44 3.43 -44.5 2.86 5.00 -77.4 0.006 
(0.07) (0.12) (4.1) (0.13) (0.21) (7.2) 0.00001 
p=0.0001 p=0.0001 0.0001 
AV-ER 1.53 1.73 -14.6 1.86 2.53 -37.8 0.0004 
(EDV/sec) (0.04) (0.08) (4.2) (0.08) (0.11) (7.3) 0.00001 
p=0.0001 p=0.0001 0.007 
T-PFR (sec) 0.18 0.13 20.3 0.16 0.10 37.2 NS 
(0.01) (0.01) (5.1) (0.01) (0.01) (8.8) 0.0008 
p=0.0001 p=0.0001 NS 
PFR (EDV/sec) 2.04 4.05 -116.7 2.39 6.27 -167.3 0.023 
(0.07) (0.17) (8.4) (0.13) (0.28) (14.6) 0.00001 
- p=0.0001 p=0.0001 0.003 
AV-RFR 1.37 2.80 -124.9 1.81 4.46 -157.7 0.0001 
(EDV/sec) (0.05) (0.13) (10.9) (0.09) (0.27) (18.8) 0.00001 
p=0.0001 p=0.0001 NS 
Values are expressed as Mean (Standard Error) . * p values: rest vs exercise.8. R-E: % change from rest 
to exercise; AV-ER: average ejection rate; AV-RFR: average rapid filling rate; CAD: coronary artery 
disease; EDC: end-diastolic counts; EDV/sec: end-diastolic volumes per second; EF: ejection fraction; 
ESC: end-systolic counts; PER: peak ejection rate; PFR: peak filling rate; SC: stroke counts; T-PER: 
time to peak ejection rate; T-PFR: time to peak filling rate. 
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3.3.1.3 Post-effort. (Tables 3.2 and 3.3) 
Heart rate was still significantly increased compared to the resting period in both groups, 
being higher in the control group for both post-effort periods (p=0.001 and p=0.0001, 
respectively). There was a significant increase in EDC and SC which was greater in 
controls than in patients (Post-Effort 1: p=0.04 and p=0.041 respectively; Post-Effort 2: 
p=0.023 and p=0.028 respectively) . ESC were lower than during exercise in both groups. 
A greater increase in SC than EDC led to a significant and similar increase in EF in both 
groups. Similarly, PER and AV-ER were significantly higher post-effort than during 
exercise and rest, the magnitude of the change in PER being greater for the control group 
in the immediate post-effort period (p=0.004). PFR and AV-RFR although higher than at 






















Differences in left ventricular function at rest and post-effort between patients 
with coronary artery disease and healthy individuals without known cardiac 
disease. 
CAD CONTROL CAD vs 
CONTROL 
p value 
Rest Post-El Post-E2 Rest Post-El Post-E2 Post-El Post-E2 
n=118 n=93 n=93 n=31 n=31 n=31 
* * * * 
66.1 103.1 83.7 62.4 112.8 92.4 0.01 0.003 
(1.2) (1.9) (92.4) (2.4) (3.2) (2.5) 
p=0.0001 p=0.0001 p=0.0001 p=0.0001 
496969 611242 508153 454895 666223 551219 NS NS 
(16840) (32981) (25891) (32856) (57124) (44845) 
p=0.0001 p=NS p=0.0001 p=0.002 
263663 297929 253393 180400 210477 180772 NS NS 
(16049) (25886) (20329) (31312) (44836) (35211) 
p=0.023 p=NS p=0.048 p=NS 
233305 313312 254761 274494 455746 370447 0.0001 0.0001 
(5320) (14658) (11953) (10379) (25388) (20703) 
p=0.0001 p=0.006 p=0.0001 p=0.0001 
51.2 56.5 54.6 61.1 70.1 67.3 0.0001 0.0001 
(1.2) (1.4) (1.5) (2.4) (2.5) (2.5) 
p=0.0001 p=0.0001 p=0.0001 p=0.0001 
0.15 0.11 0.13 0.15 0.10 0.12 NS NS 
(0.00) (0.00) (0.00) (0.00) (0.01) (0.01) 
p=0.0001 p=0.003 p=0.0001 p=0.013 
2.44 3.68 3.04 2.86 5.13 3.89 0.0001 0.0001 
(0.07) (0.13) (0.09) (0.13) (0.22) (0.16) 
p=0.0001 p=0.0001 p=0.0001 p=0.0001 
1.53 2.09 1.78 1.86 2.63 2.37 0.0002 0.0001 
(0.04) (0.07) (0.06) (0.08) (0.12) (0.10) 
p=0.0001 p=0.0001 p=0.0001 p=0.0001 
0.18 0.17 0.18 0.16 0.15 0.19 NS NS 
(0.01) (0.01) (0.01) (0.01) (0.01) (0.01) 
p=NS p=0.032 p=NS p=0.023 
2.04 3.25 2.78 2.39 4.32 3.53 0.0001 0.0001 
(0.07) (0.12) (0.09) (0.13) (0.21) (O.J6) 
p=0.0001 p=0.0001 p=0.0001 p=0.0001 
1.37 1.82 1.64 1.81 2.32 2.07 0.0005 0.001 
(0.05) (0.07) (0.06) (0.09) (0.12) (0.11) 
p=0.0001 p=0.0001 p=0.003 p=0.038 
Values are expressed as Mean (Standard Error). * p values: rest vs post-effort. 
Post-El: 1st post-effort period; Post-E2: 2nd post-effort period. Other abbreviations as per Table I. 
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Table 3.3 Differences in left ventricular function response post-effort between 
patients with coronary artery disease and healthy individuals without 
known cardiac disease. 
CAD CONTROL CAD vs CONTROL 
n=93 n=31 pVALUE 
VARIABLES ~R- ~R- ~R- ~R- Post-El Post-E2 
Post-El Post-E2 Post-El Post-E2 
HEART RATE (bpm) -60.2 -28 .7 -84.2 -50.4 0.001 0.0001 
(3 .6) (2.0) (6.2) (3.5) 
EDC -25 .5 -3.9 -47.7 -21.5 0.04 0.023 
(5.3) (3.8) (9.2) (6.6) 
ESC -12.2 4.3 -18.4 -2.7 NS NS 
(5 .3) (3 .6) (9.2) (6.2) 
SC -40.3 -13.1 -66.5 -34.0 0.041 0.028 
(6.3) (4.7) (11.0) (8.1) 
EF% -12.7 -8.0 -15.4 -10.7 NS NS 
(1.7) (1.5) (3.0) (2.6) 
T-PER (sec) 26.0 11.3 33.4 13.2 NS NS 
(3.5) (3.0) (6.1) (5.2) 
PER (EDY/sec) -54.9 -28.4 -81.1 -37.6 0.004 NS 
(4.4) (3.1) (7.7) (5.4) 
AV-ER (EDY/sec) -39.5 -19.8 -42.7 -28.4 NS NS 
(3.7) (2.8) (6.4) (4.8) 
T-PFR (sec) -1.3 -10.0 0.9 -18.3 NS NS 
(4.4) (4.6) (7.6) (8.0) 
PFR (EDY/sec) -74.6 -48.9 -83 .8 -50.1 NS NS 
-
(6.2) (4.6) (10.7) (7.9) 
AV-RFR (EDY/sec) -50.5 -32.7 -34.9 -19.3 NS NS 
(6.6) (5 .3) (11.5) (9.2) 
Values are expressed as Mean (Standard Error). 
~ R-Post-El: % change from rest to 1st period post-effort;~ R-Post-E2: % change from 
rest to 2nd period post-effort; Post-El: 1st period post-effort; Post-E2: 2nd period post-
effort. Other abbreviations as per Table I. 
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3.3.2 In patients with coronary artery disease according to degree of left 
ventricular dysfunction 
An example of the differences in the time-activity curve between patients is shown in 
Figures 3.1-3.3. 
3.3.2.1 At rest 
G 1 differed from the control group only in EDC and SC which were significantly lower 
(p=0.017 and p=0.0174 respectively). 
In G2, EDC and ESC were significantly higher (p=0.03 and p=0.00001 respectively) and 
SC significantly lower (p=0.0061) than in the control group. EF, PER, AV-ER, PFR and 
AV-RFR were all significantly lower in G2 than controls (p=0.0001, p=0.00001, 
p=0.0001, p=0.00001, p=0.0001 respectively). 
In G3, heart rate, EDC and ESC were significantly higher (p=0.012, p=0.0001 and 
p=0.0001 respectively) and SC significantly lower (p=0.00001) than in the control group. 
As in G2, EF; PER, AV-ER, PFR and AV-RFR were all significantly reduced when 
compared to the control group (p=0.00001, p=0.0001, p=0.0001, p=0.00001 and p=0.0001 
respectively) . 
End-diastolic and end-systolic counts were significantly higher in Group 3 compared to 
Groups 2 and 1 (p<0.001 respectively) and in Group 2 compared to Group 1 (p<0.01 and 
p<0.001 respectively). Stroke· counts were- significantly lower in Groups 3 and 2 when 
compared to Group 1 (p<0.01 and p<0.05 respectively). The time to peak ejection rate and 
the time to peak filling rate were not different between the three groups._ Ejection fraction, 
peak ejection rate, average ejection rate, peak filling rate and average rapid filling rate 
were significantly lower in Group 3 compared to Group 2 (p<0.001, p<0.001, p<0.001, 
0 
p<0.01 and p<0.001 respectively) and Group 1 (p<0.001 respectively) and in Group 2 
compared to Group 1 (p<0.001 respectively). 
3.3.2.2 During exercise 
In G 1, all parameters had a similar trend in the change from rest to exercise to that in the 
control group except for EDC which did not increase significantly during exercise and EF 
which fell significantly (p=0.0001). However, the magnitude of the change during exercise 
was greater in controls, who achieved higher heart rates (p=0.0001), PER (p=0.0001), AV-
ER (p=0.004), PFR (p=0.0002) and AV-RFR (p=0.02) than the patient's group. 
In G2, left ventricular parameters changed also in the same direction as in the control 
group during exercise, except for EDC and ESC which failed to increase. The magnitude 
of the change was greater for controls than patients for heart rate (p=0.0001) and PER 
(p=0.027). 
In G3, similarly to G2, apart from EDC and ESC which failed to increase significantly 
during exercise, and AV-ER that did not change, all the other variables moved in a 
direction similar to that of controls. The magnitude of the change was only greater for 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1 Patient with coronary artery disease and normal left ventricular 
systolic function (Group 1) 
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Figure 3.2 Patient with coronary artery disease and moderately impaired 
left ventricular systolic function (Group 2) 
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Figure 3.3 Patient with coronary artery disease and severely impaired left 
ventricular systolic function (Group 3) 
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The first important finding of this study was that systolic and diastolic function were both 
impaired at rest as evidenced by significant lower mean values in EF, PER, AV-ER and 
PFR, AV-RFR respectively in patients on admission to our cardiac rehabilitation program, 
compared to controls. The second important finding was that there were also significant 
differences in left ventricular systolic and diastolic function during exercise between the 
two groups as demonstrated by an attenuation in the increase in PER, AV-ER and PFR in 
response to exercise in patients compared to controls. 
Of interest was the finding that the changes in left ventricular EF between rest and exercise 
seen in this study were not able to adequately discriminate between normal individuals and 
patients with coronary artery disease. Some studies have shown that the exercise EF is 
reduced only in patients with double or triple vessel coronary disease (214,215), while 
others suggested that a drop in EF during exercise could be indicative of subclinical 
myocardial ischaemia ( 44). The lack of increase in EF from rest to exercise in our control 
group conflict with the results of some researchers (44,211,216) who reported a rise in all 
normal subjects, but are in agreement with those of other (217,218) who reported 
unchanged or even a slight decrease in EF during exercise. A postural effect, since all 
participants were exercised on a supine bicycle ergometer, could explain some of the 
differences in these results (219), probably as a result of an increased venous return when 
supme. 
PER and AV-ER were more sensitive parameters than EF during exercise to detect systolic 
abnormalities, being able to differentiate patients from healthy subjects, showing a 
significantly attenuated increase in response to exercise. In Bacharach et al's series (216), 
PER increased from rest to exercise in controls, falling in patients with coronary artery 
disease. This different response to exercise could be explained by the difference in status 
of the patients included in the studies: Bacharach et al ' s · patients were more likely to be 
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patients with acute problems while patients joining a cardiac rehabilitation program are 
more likely to have stable left ventricular function. 
Since cardiac output is the product of heart rate and stroke volume and stroke volume is 
determined by the product of the ejection fraction and end-diastolic volume, the formula 
Cardiac Output= Heart Rate x End-Diastolic Volume x EF can be used to compare the 
determinants of cardiac output between patients and controls. 
The percentage changes in EF and end-diastolic volume from rest to exercise were similar 
for both patients and controls indicating that both groups increased their cardiac output 
during exercise through an increase in heart rate. The greater heart rate in the control group 
resulted in the higher cardiac output during exercise in normals than in patients with 
coronary artery disease. 
EDC were moderately increased in the control group and unchanged in all patient groups. 
Two factors may have contributed to the moderate increase in EDC in response to exercise 
in the control group: 1- The sedentary nature of our control group. Ahmad and Dubiel 
(220) showed that the Frank Starling mechanism plays a more prominent role in the left 
ventricular response to exercise in trained healthy subjects. 2- The "masking effect" of the 
Frank-Starling mechanism produced by exercise tachycardia. The presence of this is 
confirmed by the fact that fixed atrial pacing during exercise in experimental animals and 
normal subjects unmasks an increase in end-diastolic dimensions of the left ventricle (211-
213). Furthermore, Stein et al. (213) were unable to observe a change in the left ventricular 
end-diastolic dimension measured with M-mode echocardiogram during exercise, but as 
the heart rate decreased post-effort the increase in end_-diastolic dimension became 
apparent indicating that the Frank-Starling mechanism of cardiac adaptation may have 
been masked by increases in heart rate during exercise. In our study, as the heart rate 
decreased p9st-effort, we showed an increase in EDC of 25% in the patient group and an 
increase of 48% in the control group. The difference in conditioning between patients who 
1 ') r, 
were recovering from a recent cardiac event and normal individuals could explain a greater 
increase in EDC in the latter group. 
It is interesting that as many as 38% of patients admitted to the Centre had impaired 
systolic left ventricular function. The high prevalence of this special population is in 
keeping with recent studies showing that patients with chronic left ventricular dysfunction 
can benefit from participation in cardiac rehabilitation programmes (134,136,221). These 
results should encourage cardiac rehabilitation practitioners to systematically use risk 
stratification algorithms since patients with left ventricular dysfunction are at moderate to 
high risk of exercise-related complications, requiring more intense supervision and 
monitoring (73). 
We noted that the more depressed the systolic function, the higher the end-diastolic and 
end-systolic counts and the lower the stroke counts. As systolic dysfunction progressed 
and the EF became lower, the cardiac output at rest was maintained mainly by an increase 
in end-diastolic volume with a small contribution of a higher resting heart rate. The 
changes from rest to exercise were similar in all groups irrespective of the degree of left 
ventricular systolic dysfunction, cardiac output being maintained in all groups by an 
increase in heart rate. However the masking effect of the Frank Starling mechanism 
produced by tachycardia needs to be considered. 
The alterations in diastolic function seen in our patients at rest are probably due to fibrosis 
as a consequence of previous myocardial infarction, since they are only seen in patients 
with impaired left ventricular function and not in those with normal EF. The attenuation in 
the increase of the rate of filling of the left ventricle during exercise seen in patients with 
normal syst.2_lic function could occur as a result of regional asynchronous relaxation due to 
ischemia. In this regard, improvements in diastolic function have been reported after 
successful percutaneous transluminal coronary angioplasty suggesting that silent 
subclinical ischemia is a major determinant of diastolic dysfunction (222). Furthermore, 
the majority of patients with exercise-induced myocardial ischemia enrolled into our study 
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were in the group with normal left ventricular function at rest. However, ageing (223) and 
essential hypertension (224,225) especially in the presence of left ventricular hypertrophy 
cannot be excluded as contributing factors since they are also known to alter the rate and 
extent of left ventricular filling: our patients were significantly older than controls and 
thirty six percent were on treatment for hypertension although not investigated for the 
presence of left ventricular hypertrophy. 
3.5 Conclusions 
Patients with coronary artery disease joining a cardiac rehabilitation program had profound 
alterations in systolic and diastolic function at rest and during exercise. Ejection fraction 
and peak filling rate were significantly reduced at rest while peak ejection rate, average 
ejection rate and peak filling rate had an attenuated increase in response to exercise. 
During exercise, parameters other than the ejection fraction were able to discriminate 
better between healthy subjects and patients with coronary artery disease. 
The analysis of left ventricular function according to the degree of left ventricular 
dysfunction allowed identification of the compensatory mechanisms used to increase 
cardiac output in these patients. Patients with left ventricular dysfunction used the Frank 
Starling mechanism at rest, therein maintaining their cardiac output at rest through an 
increase in end-diastolic volume, whereas an increase in heart rate played the more 
important role during exercise. 
The high prevalence of left ventricular abnormalities emphasizes the possible need for 
systematic risk stratification as a tool to guide the monitoring of patients and prevent a 
possible increase in exercise-related complications as the referral for cardiac rehabilitation 
of this special population with left ventricular dysfu~ction continues to increase. 
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CHAPTER4 
CORRELATION BETWEEN SYSTOLIC AND 
DIASTOLIC LEFT VENTRICULAR FUNCTION 
AND EXERCISE CAPACITY IN PATIENTS WITH 
CORONARY ARTERY DISEASE 
Published: 
Digenio AG, Noakes TD, Cantor A, Groeneveld H, Daly L, Mavunda D, Esser 
JD. 
Predictors of exercise capacity_ and adaptability to training in pc!tients with 
coronary artery disease. 
J Cardiopulmonary Rehabil 1997; 17: 1-11. 

4.1 Introduction 
We have showed in Chapter 3 that patients currently admitted for cardiac rehabilitation 
have a high prevalence of systolic and/or diastolic L V function abnormalities. The next 
logical question will be whether these patients can derive physiological benefits from 
exercise cardiac rehabilitation programmes. 
We have discussed in Chapter 1 that the mechanism of exercise intolerance in patients 
with left ventricular dysfunction is probably multifactorial and may include an increased 
pulmonary capillary wedge pressure (144), a reduction in cardiac output (143), 
abnormalities of ventilation and of ventilation-perfusion matching (146), neurohormonal 
abnormalities (168), a reduction in skeletal muscle blood flow (134) and altered skeletal 
muscle metabolism (164, 1167). 
The lack of correlation found between EF and exercise tolerance in patients with left 
ventricular dysfunction and the importance of the role of peripheral factors as part of the 
multi-factorial mechanism of exercise intolerance in these patients, has led to the 
hypothesis that these patients could benefit from exercise training programmes by 
enhancing their skeletal muscle function regardless of their initial degree of L V 
dysfunction. 
However, in these studies, only left ventricular EF was used as the measurement reflecting 
changes in central haemodynamics. Possible confounders such as non-cardiac factors were 
excluded as were measures of LV diastolic dysfunction which could also be a major 
determinant of the exercise intolerance of these patients. Furthermore only an 
homogeneous group of patients with an EF below a certain value where included in these 
studies. 
Accordingly there were two principal aims of this chapter of the thesis. First, the study 
aimed to determine physiologic and other predictors of exercise capacity of patients with 
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coronary artery disease and various degrees of left ventricular systolic dysfunction at entry 
to a Phase III, community-based cardiac rehabilitation programme and after 6 months of 
supervised aerobic training. Second, the investigation attempted to evaluate the effects of 
this exercise training programme on their effort tolerance. Non-cardiac factors as well as 
measures of left ventricular diastolic function were included into the analysis and a wider 
spectrum of patients was studied by classifying them into groups according to their 
baseline ejection fraction. 
4.2 Methods 
One hundred and seventy one patients with .documented CAD, consecutively referred to 
the Johannesburg Cardiac Rehabilitation Centre between 1989 and 1991, were enrolled in 
the study. 
On admission to the programme, patients underwent a full medical evaluation which has 
been discussed in detail in Chapter 2 and which included a multistage, symptom-limited 
exercise test and resting radionuclide ventriculography. The exercise test was performed 
on a motorized treadmill according to the Chung protocol (27). Expired air was analysed 
throughout exercise using a metabolic cart. Peak V02, ventilatory threshold (VT), minute 
volume (VE) and treadmill time to exhaustion (TT) were determined. The VT was defined 
as the first deviation in linearity of ~he ventilation plotted against the oxygen consumption. 
The end-points for fatigue have been described previously in Chapter 2. 
Radionuclide ventriculography was performed at rest in all pati~nts, using the equilibrium 
multi-gated blood pool technique as described in Chapter 2 ( 44) and EDC, ESC, SC, EF, 
T-PER, PER, AV-ER, T-PFR, PFR and AV-RFR were derived from time-activity curves 
as previously s};l.own. 
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Thereafter, all subjects underwent a 6 month supervised programme of aerobic exercise 
including risk factor modification. The type, intensity and duration of exercise have 
already been described in Chapter 2. Patients were carefully monitored by the staff at the 
rehabilitation centre during all their exercise sessions. Compliance was monitored to 
ensure that subjects completed at least 60% of the exercise sessions during the 6-month 
period. Reasons for dropout were obtained telephonically. The complete set of 
investigations was repeated after 6 months in those 117 subjects who attended more than 
60% of the possible sessions. 
Statistical analysis 
The entire cohort of patients studied was divided into three groups for additional analysis. 
Four population groups were then evaluated: Group O (GO) included all patients 
irrespective of their left ventricular systolic function at rest, Group 1 (Gl) included 106 
patients with normal resting left ventricular systolic function (EF~50%); Group 2 (G2) 
included 38 patients with moderately depressed resting systolic function (EF~35 and 
<50%) and Group 3 (G3) included 27 patients with severely depressed resting systolic 
function (EF<35%). 
The characteristics of patients on admission to the programme were compared within each 
group between compliers and dropouts. 
To determine which factors predicted the effort tolerance of patients on admission to the 
exercise programme, simple linear regression and stepwise logistic regression analyses 
were performed in Go: Peak V02, VT and TT were used as dependent variables and all 
measures of left ventricular diastolic and systolic function were used as explanatory 
variables. Age, gender, medical condition, number of myocardial infarctions, infarct 
location, medication, degree of ST segment depression and its duration in recovery, ST 
segment elevation, haemoglobin content, Broca index, forced vital capacity (FVC %) and 
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the ratio of forced expiratory volume in I second to forced vital capacity (FEVI/FVC %), 
expressed as percentages of predicted values, were considered as possible confounders. 
In addition, to determine if variables relating to left ventricular function could predict the 
changes in submaximal and maximal exercise capacity induced by a 6 month exercise 
training programme, simple linear and stepwise logistic regression analyses were 
performed on the data of all patients in GO who complied with the programme for 6 
months. The percentage changes between admission and 6 months for Peak V02, VT and 
TT, calculated as the value at 6 months minus the value on admission divided by the value 
on admission x I 00, were used as dependent variables. Percentage attendance was added 
as an explanatory variable. 
To determine if the predictors of exercise tolerance at entry and after exercise training 
were different in the three patient groups, simple linear regression and stepwise regression 
analyses were performed for groups I through 3 using the same explanatory and dependent 
variables. 
The effect of exercise training on exercise tolerance and haemodynamic variables was 
evaluated at submaximal and maximal intensities from the data collected during the 
maximal exercise test, before and after exercise training. 
Any subjects who had missing data for certain variables were excluded from the analysis 
for those variables. Indices of resting systolic and diastolic function and physiological 
parameters measured during exercise were expressed as least square means after adjusting 
for confounders and their differences were interpreted using estimated partial regression 
coefficients. The significance of the model was assessed through analysis of yariance and 
the differences between samples was assessed with individual Fisher's least significance 
differences test. Significance at the 5% level or lower was reported. 
4.3 Results 
4.3.1 Characteristics of patients on admission 
The baseline characteristics of the 171 patients admitted to the trial, are listed in Table I 
for all groups. The patients' ages in GO ranged from 34 to 82 years (mean 56.3 ::!: 10 years) 
with a male/female ratio of 11: 1. Sixty six percent of patients had suffered a myocardial 
infarction, 41 % had undergone coronary artery bypass surgery and 24% percutaneous 
transluminal coronary angioplasty. The infarct was located in the anterior wall in 49% of 
patients and in the inferior wall in 51 %. All patients were classified in the New York Heart 
Association classes I a11d II. Twenty seven percent of patients used beta blockers, 29% 
calcium blockers, 22% nitrates and 28% angiotensin converting enzyme inhibitors. FVC 
and FEVl/FVC ratio, hemoglobin content and the Broca Index were within the normal 
population range. Patients in G3 were significantly older than patients in G2 (p<0.05), but 
were of similar age to patients in G 1. Although a greater percentage of patients with 
hypertension were in G 1 than in G2 and G3, the difference was not significant. 
Haemoglobin concentrations on admission to the programme were similar in Gl,G2 and 
G3. G3 and G2 included more patients with MI than Gl (p<0.001 and p<0.001 
respectively); patients in these groups had also experienced a greater number of MI 
(p<0.001 and p<0.05 resp_ectively). More patients in G3 than in G2 or Gl had an anterior 
infarct (p<OOl respectively), whereas more patients in Gl had an inferior infarct than did 
patients in Groups 2 or 3 (p<0.001 respectively). Medication use was different in the three 
groups, with G 1 using mainly beta blockers and calcium antagonists and G2 patients using 
calcium antagonists and angiotensin converting enzyme inhibitors, while G3 patients used 
more nitrates and angiotensin converting enzyme inhibitors. Patients in G2 and G3 had 
significantly lower FVCo/q__ than those -in Gl (p<0..()5 and p<0.05 respectively). The 
FEV1/FVC% ratio was normal in the three groups but significantly higher in G3 than in 
G2 (p<0.05). The Broca index was within the normal range in the three groups. 
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Table 4.1 Characteristics of all patients on admission. 
Group 0 Group 1 Group 2 Group 3 P Value 
n = 171 n= 106 n=38 n=27 
AGE (years) 56.3 (10.0) 56.0 (9.8) 54.5 (8.7) 60.0 (11.8) <0.05 * 
SEX No.(%) -
MALE 156 (91) 97 (91) 33 (87) 26 (96) NS 
FEMALE 15 ( 9) 9 ( 8) 5 (13) 1 (4) NS 
HYPERTENSION No. (%) 61 (36) 42 (40) 11 (29) 8 (30) NS 
HAEMOGLOBIN 15 .3 (1.5) 15.3 (1.4) 
(g/100ml) 
15.5 (1.5) 15.1 (1.7) NS 
MI No.(%) 113 (66) 58 (55) 31 (82) 24 (89) <0.001 & 
<0.001 # 
NUMBER MI 0.8 ( 0.8) 0.7 ( 0.7) 1.0 ( 0.8) 1.3 ( 0.8) <0.001 & 
<0.05 # 
MI POSITION No. (%) 
ANTERIOR 55 (49) 17 (29) 16 (52) 21 (87) <0.001 * 
<0.001 & 
INFERIOR 58 (51) 41 (71) 15 ( 48) 3 (12) <0.001 * 
<0.001 # 
CABG No.(%) 70 (41) 45 (42) 18 (47) 7 (26) NS 
PTCA No.(%) 41 (24) 28 (26) 9 (24) 4 (15) NS 
MEDICATION No.(%) 
BETA BLOCKERS 46 (27) 36 (34) 9 (24) 1 ( 4) <0.01 * 
<0.001 & 
CALCIUM BLOCKERS 50 (29) 27 (25) 14 (37) 9 (33) NS 
NITRATES 37 (22) 18 (17) 6 (16) 13 (48) <0.001 * 
<0.001 & 
ACE INHIBITORS 48 (28) 20 (19) 11 (29) 17 (63) <0.001 * 
<0.001 & 
PVC% 88.5 (18.5) 91.4 (18.6) 84.4 83.1 (20.7) <0.05 & 
(15.3) <0.05 # 
FEVl/FVC % 98.8 98.5 (10.1) 97.4 102.0 (7.7) <0.05 * 
( 9.4) ( 8.2) 
BROCAINDEX - 110.0 110.6 (14.4) 109.2 108.4 NS 
(13 .9) (13 .7) (12.2) 
Ml: myocardial infarction; CABG: coronary artery bypass graft; PTCA: percutaneous transluminal coronary 
angioplasty; ACE: angiotensin converting enzyme; FVC %: forced vital capacity, percentage of predicted value; 
FEVl/FVC %: forced expiratory volume in 1 second/ FVC, percentage cffpredicted value. 
Values are expressed as Mean (Standard Deviation) unless otherwise stated as number (No.(%)) . 
Group 0: all patients; Group 1: ejection fraction ::::50%; Group 2: ejection fraction ::::35 and <50%; 
Group 3: ejection fraction <35%; * Group 3 vs Group 2; & Group 3 vs Group 1; # Group 2 vs 
Group 1. 
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The physiological parameters measured during the initial exercise test in the same patients 
are shown in Table 4.2. Patients in G3 had a significantly lower mean rate-pressure 
product during exercise testing than patients in Gl (p<0.05). Peak V02, VT and treadmill 
time were significantly lower in G3 than in the other two groups. There were no 
significant differences in the three variables between patients in Groups 1 and 2. 
Thirty eight patients showed ST segment depression greater than 1mm and 8 patients 
showed ST segment elevation during the exercise or in the recovery period. Patients with 
ST segment depression greater than 1mm were evenly distributed among the three groups. 
A greater number of patients in G3 showed ST segment elevation than in the other groups. 
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Table 4.2 Exercise test variables of all patients on admission. 
Group 0 Group 1 Group 2 Group 3 p value 
n = 171 n= 106 n=38 n=27 
Peak Oxygen Uptake 24.4 ( 6.3) 25.2 (6.1) 25.1 (6.5) 20.6 (5.4) <0.01 * 
(ml/kg.min) <0.001 & 
Ventilatory Threshold 16.5 ( 3.6) 17.0 (3.7) 16.6 (2.9) 14.3 (3.0) <0.01 * 
(ml/kg.min) <0.001 & 
Treadmill Time 11.0 ( 3.5) 11.3 (3.4) 11.4 (3.5) 9.2 (3.4) <0.05 * 
(min) <0.01 & 
Rate-pressure Product 25 .3 ( 6.4) 26.2 (6.4) 24.3 (6.5) 23.2 (5.7) <0.05 & 
(bpm.mmHg X 103) 
ST Depression 0.4 ( 0.9) 0.4 (0.9) 0.4 (0.7) 0.5 (0.8) NS 
ST Duration (min) 2.4 ( 4.7) 2.0 (4.2) 2.6 (5.3) 3.9 (5.3) NS 
-
ST Elevation 0.1 ( 0.5) 0.0 (0.2) 0.1 (0.4) 0.6 (1.1) <0.001 * 
<0.001 & 
All values are expressed as Mean (Standard Deviation) 
* Group 3 vs Group 2; & Group 3 vs Group 1; # Group 2 vs Group 1 
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The resting systolic and diastolic L V function of patients at entry to the programme are 
listed in Table 4.3. When patients were categorized according to their degree of left 
ventricular impairment, the more depressed the systolic function, the higher the end 
diastolic and end systolic counts and the lower the stroke counts. End diastolic and end 
systolic counts were significantly higher in G3 compared to G2 (p<0.001 respectively) and 
G 1 (p<0.001 respectively). Stroke counts were significantly lower in G3 and G2 compared 
with G 1 (p<0.01 and p<0.05 respectively). The time to peak ejection rate and the time to 
peak filling rate were not different among the three groups. Ejection fraction, peak ejection 
rate, average ejection rate, peak filling rate, and average rapid filling rate were 
significantly lower in G3 compared with G2 (p<0.001, p<0.001, p<0.001, p<0.01 and 
p<0.001 respectively and Gl (p<0.001 respectively) and in G2 compared with Gl 
(p<0.001 respectively). 
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Table 4.3 Resting left ventricular function of patients on admission. 
Group 0 Group 1 Group 2 Group 3 P Value 
- n = 171 n= 106 n= 38 n=27 
EDC 499 488 419 520 511 286 793 677 <0.001 # 
(225 212) (178 190) (185 391) (184 210) <0.001 & 
<0.001 * 
ESC 269 064 171 931 294 515 614 578 <0.001 # 
(212 056) (130 758) (129 095) (137 966) <0.001 & 
<0.001 * 
SC 230 424 238 106 209 104 189 781 NS # 
(70 522) (80 309) (78 183) (75 005) <0.01 & 
<0.05 * 
EF% 50.7 59.9 43 .1 24.9 <0.001 # 
(14.6) (9.4) (8.3) (8.4) <0.001 & 
<0.001 * 
T-PER 0.15 0.14 0.15 0.15 NS # 
(sec) (0.03) (0.03) (0 .03) (0.04) NS & 
NS * 
PER 2.45 2.83 2.18 1.51 <0.001 # 
(EDY/sec) (0.81) (0.58) (0.58) 0.58 <0.001 & 
<0.001 * 
AV-ER 1.53 1.74 1.31 0.84 <0.001 # 
(EDY/sec) (0.48) (0.41) (0.37) (0 .31) <0.001 & 
<0.001 * 
T-PFR 0.18 0.18 0.17 0.20 NS # 
(sec) (0.07) (0.07) (0.07) (0.07) NS & 
NS * 
PFR 2.08 2.28 1.78 1.27 <0.001 # 
(EDY/sec) (0.81) (0.72) (0.68) (0.68) <0.001 & 
<0.01 * 
AV-RFR 1.40 1.56 1.21 0.73 <0.001 # 
(EDY/sec) (0.53) (0.41) (0.43) (0.42) <0.001 & 
<0.001 * 
All values are expressed as Mean (Standard Deviation) 
# Group 2 vs Group 1; & Group 3 vs Group 1; * Group 3 vs Group 2. 
EDC: end-diastolic counts; ESC: end-systolic counts; SC: stroke counts; EF: ejection fraction; T-
PER: time to peak ejection rate; PER: peak ejection rate; AV-ER: average ejection rate; T-PFR: 
time to peak filling rate; PFR: peak filling rate; AV-RFR: average rapid filling rate; EDY/sec: end-
diastolic volumes per second. 
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4.3.2 Predictors of exercise tolerance on admission 
Statistically significant but minimal associations were found in GO between measures of 
resting left ventricular systolic and diastolic function and peak V02, VT and TT using 
simple linear regression analysis (Table 4.4). 
Stepwise logistic regress10n analysis usmg baseline exercise capacity parameters as 
dependent variables was performed in all groups. The following predictors were identified 
in GO (Table 4.4): Age and the Broca index showed a negative association with all 
exercise capacity variables whereas FVC% and AV-ER were positively correlated. SC 
showed a positive association only with VT. Gender was also a significant predictor, as 
men had significantly better effort tolerance than did women. Age was the strongest 
predictor of PV02 and TT, whereas SC were the best predictor of VT. Of all left 
ventricular systolic function variables, only AV-ER was a significant but weak predictor of 
exercise capacity. After adjusting for non-cardiac factors, left ventricular diastolic 












Predictors of effort tolerance in 171 patients with coronary artery disease and varying 
degrees of left ventricular dysfunction. 
PEAK V02 VENTILATORY TREADMILL TIME 
(ml/kg.min) THRESHOLD (minutes) 
(ml/kg.min) 
LR SR LR SR LR SR 
rl p r' p rL p rL p rz- p rL p 
0.03 0.02 0.03 0.02 
0.06 0.002 0.11 0.0001 0.13 0.0001 0.06 0.002 
0.04 0.007 0.06 0.002 0.03 0.03 
0.03 0.02 0.05 0.005 
0.05 0.003 0.04 0.001 0.07 0.0006 0.04 0.003 0.03 0.02 0.03 0.00•. 
0.07 0.0007 0.04 0.005 0.06 0.001 
0.02 0.04 0.04 0.006 
0.05 0.004 0.06 0.0008 0.04 0.009 
0.24 0.0001 0.08 0.0001 0.29 0.0001 
l 
' 
SEX 0.05 0.0002 0.03 0.005 0.05 0.0006 l 
BROCA 0.10 0.0001 0.08 0.0001 0.07 0.0001 
FVC% 0.11 0.0001 0.08 0.0003 0.06 0.0002 
MODELR" 0.54 0.44 0.50 
AV-ER: average ejection rate; AV-RFR: average rapid fill ing rate; EF: ejection fraction; ESC: end-systolic counts; FVC%: 
forced vital capacity, percentage of predicted value; LR: linear regression; Model R2: model coefficient of determination; 
PER: peak ejection rate; PFR: peak filling rate; r2: partial coefficient of determination; SC: stroke counts; SR: stepwise 
logistic regression; T-PFR: time to peak filling rate;. 
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4.3.3 Dropouts from the study 
Fifty four patients dropped out from the programme before 6 months, 33 from Gl, 14 from 
G2 and 7 from G3 . There were no differences in the baseline characteristics of G3 patients 
between compliers and dropouts. G2 dropouts had a greater number of MI (p=0.0001) and 
a higher Broca index (p=0.0476) than the compliers in that group. Gl dropouts had less ST 
segment depression (p=0.0001), higher VT (p=0.0310) and greater end-diastolic 
(p=0.0042) and stroke counts (p=0.0012) than Gl compliers. There was also a greater 
proportion of patients who had a coronary bypass operation (p=0.034) among G 1 
dropouts. 
There were also no differences in the reported reasons for dropout between the 3 groups. 
These were related mainly to work problems and the inconvenient location of the 
rehabilitation centre for certain patients. 
Two G 1 dropout patients showed progression of disease and one died from a non-cardiac 
disorder. One non-complier in G2 also died from a non-cardiovascular cause. Sudden 
death occurred in two G3 dropout patients, one before and the other 2 months after starting 
the exercise programme. No complications occurred in compliers in the 3 groups during 
exercise training. All G3 patients who completed the programme were alive 12 months 
after their initial cardiac event. 
4.3.4 Physiological adaptations induced by exercise training 
The effects of training on the 117 patients who completed the 6 month exercise training 
programme are shown in Table 4.5. Highly significant increases in peak V02, VT, 
treadmill time and peak minute volume were noted after 6 months of training in all groups. 
A significant increase in peak heart rate and a significant "decrease in submaximal systolic 
blood pressure were seen after training in all groups except G2 . All seven patients in G3 
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with exercise-induced ST segment depression showed an improvement in peak V02 (mean 
peak V02 % change was 16.8). One of six patients in G2 and three of seventeen patients in 
G 1 with an electrocardiographic ischaemic response did not show an improvement in peak 
oxygen uptake (mean peak V02 changes were 13.8 and 12.5, respectively). 
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Table 4.5 Effects of exercise training on exercise tolerance, haemodynamics and ventilation. 
Group 0 Group 1 Group 2 Group 3 
n= 117 n=73 n24 n=20 
Adm 6ms Adm 6ms Adm 6ms Adm 
Peak V02 24.6 28 .3 25.2 28.7 25 .1 30.5 20.6 
(ml/kg.min) (6.0) (7.1) (6.1) (7.1) (6.5) (6.3) (5.4) 
p<0.001 p<0.001 p<0.001 
VT 16.5 18.4 17.0 18.9 16.6 18.8 14.3 
(ml/kg.min) (3 .3) (4.2) (3.7) (4.4) (2.9) (3.4) (3 .0) 
p<0.05 p<0.001 p<0.01 
Treadmill Time 11.1 13.5 11.3 13 .6 11.4 14.7 9.2 
(min) (3.5) (3.9) (3.4) (3.9) (3.5) (3.4) (3.4) 
p<0.001 p<0.001 p<0.001 
Resting HR 76.0 73.6 73.9 71.4 76.1 75 .9 83.0 
(bpm) (14.1) (12.0) (13.0) (10.5) (18.7) (15.6) (9.8) 
p<0.05 NS NS 
Peak HR 142.3 147.6 142.5 146.9 143.5 150.3 140.8 
(bpm) (18.5) (17.2) (17.3) (16.2) (22.1) (22.7) (19.4) 
p<0.001 p<0.01 NS 
PeakRPP 25.7 25.3 26.6 26.1 24.1 25.2 24.3 
(bpm.mmHg X 103) (5 .7) (5 .7) (5 .5) (5.2) (5.9) (6.8) (5.9) 
NS NS NS 
Peak VE 80.2 89.7 80.3 89.7 85.0 95.3 74.2 
(L/min) (22.5) (23.2) (23.4) (24.7) (23.7) (24.1) (16.4) 
p<0.001 p<0.001 p<0.05 
Submaximal V02 17.2 17.5 17.4 17.6 16.8 17.6 16.8 
(ml/kg.min) (2.3) (2.7) (2.2) (2.7) (2.6) (2.3) (2.1) 
NS NS NS 
Submaximal HR 115.0 111.8 113 .2 109.5 113.6 109.7 122.9 
(bpm) (19.1) (19.0) (16.4) (18.9) (23.1) (19 .6) (21.7) 
NS p<0.05 NS 
Submaximal BP 166.5 151.1 171.3 152.8 151.8 148.5 167.0 
(mmHg) (31.8) (24.3) (31.3) (25 .1) (27.9) (23.2) (34.3) 
p<0.001 p<0.001 NS 
Submaximal VE 47.5 45.0 47.2 44.9 42.9 41.3 53.9 
(L/min) (14.6) (12.0) (15.4) (13.0) E8 .7) (7.1) (15 .8) 
NS NS NS 
All values are expressed as Mean (Standard Deviation). 
Adm: admission; ~P: blood pressure; HR: heart rate; ms: months; RPP: rate-pressure product; 




































4.3.5 Predictors of changes in exercise tolerance after exercise training 
There was no association in GO between baseline left ventricular function variables and the 
percentage change in peak V02, VT and TT as a result of 6 months of aerobic training. 
The magnitude of the improvement in peak V02, VT and treadmill time was the same in 
all patient groups regardless of their resting ejection fractions (Figure 4.1 ). The percentage 
increase in treadmill time was significantly greater than the increase in VT and peak V02 




























































































































































































The first important finding of this study was that, after adjustment for possible 
confounders, resting ejection fraction did not correlate with either peak oxygen 
consumption, ventilatory threshold or treadmill time to exhaustion in the overall 
population of patients with coronary artery disease. These results are consistent with those 
of most studies, which show that ejection fraction is unrelated to exercise tolerance in 
patients with chronic left ventricular dysfunction (226-228). Furthermore, when adjusted 
for possible confounders, left ventricular diastolic function was also unrelated to maximal 
exercise capacity. 
There is little information about the relationship between diastolic function and exercise 
tolerance in patients with preserved left ventricular systolic function. It has been suggested 
that left ventricular diastolic dysfunction in patients with heart failure, prevents a normal 
increase in stroke volume despite large increases in left atrial and pulmonary capillary 
pressures (184). However, these data suggest that left ventricular diastolic function does 
not influence exercise capacity in a mixed population of patients with coronary artery 
disease with various degrees of left ventricular dysfunction. 
The second relevant finding was that non-cardiac factors, including age, gender, the Broca 
index and forced vital capacity, explained nearly 50% of the variation in exercise tolerance 
variables in the total group of patients. 
The third important finding was that significant physiological adaptations to training were 
seen in all groups. A surprising finding was that most of these adaptations were identified 
mQ_st clearly during maximal exercise. Although there was a trend towards an 
improvement in all physiological parameters during submaximal exercise in all patient 
groups, only the ventilatory threshold increased significantly. 
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Of importance is the fact that patients with severely depressed left ventricular function and 
myocardial ischaemia also showed an improvement in peak oxygen uptake. This contrasts 
with the finding of Arvan and colleagues (190) who found that patients with an ejection 
fraction greater than 40% showed an improvement in peak oxygen uptake after training 
whether they had a baseline ischaemic exercise test or not, whereas patients with an 
ejection fraction less than 40% and associated exercise-induced ischaemia did not show 
any such improvement. In this study, however, the association of left ventricular 
dysfunction and an ischaemic exercise test was not a predictor of a poor response in these 
patients to training. 
Furthermore, all patient groups showed a similar degree of adaptation to training as shown 
by equivalent increases in peak oxygen uptake, ventilatory threshold and exercise time to 
exhaustion regardless of their degree of resting left ventricular systolic or diastolic 
dysfunction. Thus, the extent of the improvement in exercise capacity experienced by 
these patients after the 6-month exercise programme, was not predicted by baseline 
measurements of left ventricular systolic or diastolic function in any of the groups. 
Spontaneous recovery of left ventricular function during the training period was excluded 
as a potential factor, as patients were accepted on the programme only 3 months after their 
cardiac event. 
Although other studies have already shown that patients with chronic cardiac failure can 
benefit from a cardiac rehabilitation programme (133,134,136), this study appears to be 
the first to compare the magnitude of the improvement in maximal exercise capacity 
among groups of patients with different degrees of impairment in left ventricular systolic 
or diastolic function. An obvious limitation to these findings is the lack of a control group 
without exercise training for all levels of left ventricular impairment. 
As would be expected, patients with severely depressed left ventricular systolic function 
also showed a significantly lower exercise tolerance as measured by a lower oxygen 
uptake, a lower exercise time to exhaustion, and an earlier ventilatory threshold than did 
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patients with moderately depressed or normal left ventricular systolic function. These 
patients also showed greater abnormalities in left ventricular volumes and diastolic 
properties than patients in the other groups. 
The patient population in this study included a mixed group with coronary artery disease, 
including those receiving revascularization therapy and those with recent ischaemic 
myocardial events. This may appear to be a possible limitation, as the data could 
potentially be confounded by a mixed population with various degrees of ischaemia and 
ventricular dysfunction. However, all of the variables previously mentioned, including 
medical condition, and indices of myocardial ischaemia and ventricular dysfunction, have 
been included in a stepwise logistic regression analysis, which did not indicate that these 
variables could have predicted in any way the response to exercise training in these 
patients. The fact that the data in this study could be generalised to a wide population of 
patients with coronary artery disease, those who have had myocardial infarctions, or those 
undergoing revascularization, with various degrees of myocardial ischaemia and/or left 
ventricular dysfunction (either systolic or diastolic) strengthens the argument and is what 
differentiates this study from previous reports. 
4.5 Conclusions 
After adjusting for confounding factors, resting left ventricular systolic and diastolic 
function did not predict the exercise capacity of patients with coronary artery disease on 
admission to an exercise programme or the degree of improvement in these measures after 
6 months of exercise training. Non cardiac factors including age, gender, Broca index and 
forced vital capacity explained 50% of the v~ation in peak oxygen uptake. 
Patients with severe chronic heart failure showed improvements m exercise capacity 
similar to those in patients with normal and moderately impaired systolic function. Even 
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patients with left ventricular dysfunction and associated myocardial ischaemia were able to 
increase their maximal exercise capacity as a result of exercise training. 
CHAPTERS 
PHYSIOLOGICAL EFFECTS OF EXERCISE 
TRAINING IN PATIENTS WITH SEVERE LEFT 
VENTRICULAR SYSTOLIC DYSFUNCTION 
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Is severe left ventricular dysfunction a contraindication to exercise cardiac 
rehabilitation programmes ? 
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5.1 Introduction 
Patients with chronic congestive heart failure were previously not admitted for cardiac 
rehabilitation because of the hypothesis that they were at a much greater risk of sudden death 
during exercise and that exertion could adversely affect the natural history of the disease, 
precipitating or accelerating further decompensation of the left ventricle. 
In Chapter 3 we showed that left ventricular dysfunction is very prevalent among patients 
enrolling into a cardiac rehabilitation programme. In Chapter 4 we demonstrated that there is 
no correlation between the degree of L V dysfunction at entry to a cardiac rehabilitation 
programme and exercise capacity and that patients with severely depressed L V dysfunction 
could achieve similar adaptations to training during maximal exercise, than those derived by 
patients with moderately depressed or normal L V function. 
The hypothesis that patients with severe left ventricular dysfunction could safely derive full 
adaptations at both submaximal and maximal exercise levels remains to be evaluated. The 
measurement of EF not only at rest but also in response to acute exercise, will provide a 
valuable tool to quantify the effects of exercise training on the LV function of these patients. 
The aim of the present chapter of this thesis was to determine whether a 6 month exercise 
training programme could improve the exercise capacity and cardiovascular efficiency of 
high risk patients with severe left ventricular impairment, and whether it could be performed 
safely without any adverse effects on their left ventricular function. 
Since cardiac rehabilitation is just in its infancy in South Africa, the demonstration that 
exercise trainil!g could induce benefits in patients with chronic congestive heart failure 
without deteriorating their L V function could have important implications for the practice of 
cardiac rehabilitation in the country. 
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5.2 Methods 
Twenty eight patients recovering from an acute MI and with a left ventricular EF of 30% or 
less at rest were included in this study. They all had compensated, stable, non-oedematous, 
chronic heart failure. Their ages ranged from 44 to 71 years with a mean of 63.5 ± 7.5 years. 
The MI was located on the inferior wall in 5 patients and anteriorly in the remaining 23; four 
of these patients had also suffered a previous inferior wall infarction. Seven patients had 
clinical evidence of congestive heart failure, and 3 suffered pulmonary oedema during the 
acute phase of their illness. Functionally, 15 patients were classified in the NYHA Class I, 
10 in Class II and 3 in Class III. All patients were on angiotensin converting enzyme 
inhibitors, 76% on nitrates and 52% on calcium channel blockers. It is unknown whether the 
use of calcium channel blockers could have contributed to the depression in left ventricular 
function in some patients. Only one patient had a change of medication during the training 
period. This patient was on antiarrhythmic therapy, which was modified during the 
rehabilitation programme. 
Within 75 to 90 days after the MI, all patients underwent a treadmill symptom-limited 
exercise test using the Chung protocol (27), before being accepted onto the exercise cardiac 
rehabilitation programme. Respiratory gas analysis using a metabolic cart was carried out 
- and peak oxygen uptake was determined. Continuous heart rate and electrocardiogram were 
recorded and the blood pressure was monitored at every minute of the exercise test and in the 
recovery phase. The exercise end-points were previously described in Chapter 2. 
Radionuclide ventriculography, using the equilibrium multi-gated blood pool technique (44) 
was performed at rest in all patients and during exercise in the supine position in 18 patients. 
-Global EF at rest and during exercise was determined in these patients. All tests were 
repeated 6 months after the beginning of the exercise programme. A follow-up resting EF 
could not be obtained in one patient because of lack of ~onsent. 
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The exercise training programme was medically supervised and of 6 months duration. The 
intensity of exercise was set between 65 and 85% of each patient's maximal heart rate 
achieved during treadmill testing. Patients were required to exercise at their prescribed 
intensity 3 times a week continuously for 30-45 minutes. Aerobic exercise consisted of 
walking or jogging, or stationary cycling if weight-bearing exercise was contraindicated. The 
exercise session was preceded by a warm-up and followed by a cool-down period. The 
exercise intensity for each patient was progressed slowly over a number of weeks until the 
required intensity of exercise was achieved. 
Five patients showed 1.5-2.5 mm ST depression without chest pain during the exercise test; 
in these patients the training intensity was set 15-20 beats/minute below the heart rate that 
produced ST segment changes. 
The patients' compliance with the programme was monitored on a daily basis in terms of 
attendance at exercise sessions. Patients with a compliance below 60% of all prescribed 
sessions were excluded from the study. 
Haemodynamic, left ventricular function and effort tolerance parameters were compared 
before and after training using the Student's t test for paired samples. 
5.3 Results 
Twenty two patients completed the exercise training programme with an attendance greater 
than 60% of the possible sessions. Two patients in NYHA Class III died suddenly, one 
before starting exerc~ing and the other 2 months after starting the exercise programme. This 
death occurred whilst the patient was at home. Four patients dropped out for non-medical 
reasons. 
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The mean resting EF at the beginning of the study was 25.4 ± 5% (range 11 to 30%), 
increasing to 28.5 + 7.9% (range 12 to 50%) after 6 months of exercise training (p<0.05) 
(Fig 5.1). The mean exercise EF was 27.3 ± 7.7% (range 10 to 40%) at the beginning of the 
study and 29.9 ± 9.5% (range 11 to 45%) at the end of training (p=0.11) (Fig 5.1). The 
individual exercise EF increased in 12 patients, decreased in 4 and did not change in 2. The 
resting heart rate decreased significantly from the beginning to the end of the training period 
































































































































































































The peak oxygen consumption improved significantly from 19.4 + 3 (range 13.3 to 23.9 
ml/kg.min) to 21.8 ± 4.8 ml/kg.min (range 11.4 to 28. 7 ml/kg.min) after exercise training 
(p<0.05) (Figure 2). The exercise time to exhaustion on the treadmill increased significantly 
from 527 ± 171 (range 250 to 880) to 700 ± 186 seconds (range 330 to 1020) after 6 months 
of exercise training (p<0.001) (Figure 5.2). The exercise time on the treadmill increased by 
32.8% after exercise training whereas peak oxygen uptake improved by only 12.4%. Heart 
rate increased significantly at peak exercise from 138.2 ± 6.2 to 146.3 ± 7.4 bpm (p<0.01) 
and decreased during submaximal work from 129 ± 8.5 to 122 ± 9.0 bpm (p<0.05) as a result 
of exercise training. There were no changes in systolic or diastolic blood pressure at maximal 
or submaximal levels due to training. The maximal double product was significantly 
increased after training (p<0.05) (Figure 5.2), while the double product at the same 
submaximal work load was significantly reduced (214 ± 52 vs 194 ± 44 bpm.mmHg x 100, 
p<0.05). 
No correlation was found between the EF at rest or during exercise and peak oxygen 
consumption. 
Three of the 5 patients who showed ST segment changes on admission had a normal ST 
segment response during the second exercise test after exercise training. 
Training complications such as congestive heart failure, complex ventricular arrhythmias, 
accelerated angina pectoris, syncope, or new ischaemic changes were not observed. All 
patients who completed the exercise course were alive after a mean follow-up of 26 months 
(range 8-32 months). One was hospitalized for recurrent ventricular arrhythmias within the 
first two months of exercise training, and underwent major abdominal surgery without any 
complications, 24 months after the end of the training programme. Four oth~rs were 
hospitalized for chest pain during the follow-up period after training; myocardial ischaemia 
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Our observations demonstrate the feasibility of exercise training for patients with severe left 
ventricular dysfunction. After 6 months of exercise training our patients improved their 
exercise performance by increasing peak oxygen consumption, exercise time to exhaustion 
and the double-product at maximal effort. Furthermore cardiovascular demands during 
submaximal exercise were also significantly reduced. This is in agreement with other authors 
who have also shown that patients with severely depressed left ventricular systolic function 
can derive benefits from exercise training (98,132-134,138). 
As in Chapter 4 we found lack of correlation between EF at rest or during exercise and 
maximal exercise capacity. This is in keeping with the findings in the above studies and 
suggests that peripheral adaptations have ocurred. 
An increase in vagal tone could confer some protection regarding fatal ventricular 
arrhythmias (122). The reduction in resting heart rate seen in our patients could be some 
evidence of a training-induced increase in vagal activity. 
After 6 months of training no deterioration in left ventricular function was observed in our 
study, even in patients with the lowest EFs and with ST segment depression on admission. 
This is in agreement with the above studies (98, 132-134, 138) which showed a lack of change 
in left ventricular systolic function in patients without myocardial ischaemia but conflicts 
with the finding that patients with left ventricular dysfunction and ongoing myocardial 
ischaemia may show deterioration in left ventricular function after exercise training (190). 
The limitations of electrocardiographic ST segment analysis alone in predicting myocardial 
- -
ischaemia are appreciated. In our study, the sensitivity of the method was enhanced by also 
including an analysis of the ST segment time course in the post-effort period. Only patients 
with ST segment depression both during and post-effort were considered as having a 
possible ischaemic response. 
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There was a remarkable increase in EF after 6 months in two patients, perhaps indicating the 
presence of myocardium which was either "stunned" or "hibernating" at the time of the 
initial test (229). The former is more likely since none of these patients showed any 
electrocardiographic evidence of myocardial ischaemia during exercise testing. When those 
patients were excluded from the analysis, the difference between the mean EF before (25 .6 ±: 
4.7%) and after training (26.6 ±: 5.3%) was not statistically significant. It is unlikely that the 
improvement in ejection fraction seen in the above two patients could be attributed to the 
exercise programme since improvements in left ventricular function have only been noted 
with more intensive exercise training of greater frequency, intensity and duration (115,199). 
The EF of 2 subjects during exercise was lower after training but their values were still 
within the confidence interval for normal exercise EF from our laboratory. 
Two patients enrolled into the study died, one before starting the programme and the other 2 
months after starting the training. The latter patient attended very few sessions during those 2 
months and he failed to reach the prescribed training heart rate. His low peak V02 on 
admission (12.5 ml/kg.min) and his low exercise time to exhaustion (5.5 minutes) suggest 
that he was very sick prior to exercise training and that training was unlikely to have caused 
the deterioration in his condition. 
Whether physiological adaptations to exercise training will result in a better prognosis in this 
high risk group of patients is unknown. Patients with an EF below 40% had a 26% 1 year 
mortality if they showed signs of heart failure during their stay in hospital compared with 
12% if they did not show such clinical signs (119). All our patients were still alive between 8 
and 32 months after their cardiac event although 10 showed signs of congestive heart failure 
while in hospital. How~ver, myocardial ischaemia was dia~osed in three patients in the 
follow-up period after exercise training, suggesting progression of disease. 
All our patients were on angiotensin converting enzyme inhibitors and it is impossible to 
determine the extent to which these drugs contributed to the improvements seen in 
submaximal and maximal exercise capacity. A recent study which evaluated the effect of 
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physical training in patients with impaired left ventricular function showed only a small 
improvement when medical treatment was added, demonstrating the strong influence of 
endurance exercise (230). 
5.5 Conclusions 
Patients with severe left ventricular dysfunction in NYHA classes 1 and 2 were able to 
participate in and derive physiological benefits from a supervised exercise rehabilitation 
programme, without any deleterious effect on their left ventricular function. As a 
consequence of their participation in the programme, they achieved a significant 
improvement in peak oxygen uptake, treadmill time and maximal double product whilst they 
were able to reduce significantly the double product at a fixed submaximal load. We could 
speculate that patients with a severe impairment in L V function might benefit the most 
from a cardiac rehabilitation programme, since small increases in effort tolerance could 
represent a meaningful improvement in their quality of life. 
This suggests that whilst rest retains an essential role in the management of an acute episode 
of heart failure, once the patient has been fully stabilized, physical training could be used as 
part of their integral treatment together with medication or after revascularization procedures, 
even in patients with stable, compensated chronic heart failure. 
This would appear to be the first evaluation of the possible benefits and risks of exercise 
training in patients with severe left ventricular dysfunction enrolled in a community-based 




EFFECTS OF EXERCISE-INDUCED MYOCARDIAL 
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6.1 Introduction 
Patients with residual myocardial ischaemia post-myocardial infarction or 
revascularization procedures are more frequently accepted for exercise rehabilitation in 
modem programs. 
The diagnosis of myocardial ischaemia (191) is usually made by the demonstration of 
transient ST segment depression, horizontal or downward sloping, of O .1 m V or more for 
80 milliseconds in the electrocardiogram during an exercise test but could be greatly 
enhanced with myocardial perfusion imaging techniques (193,194). A common 
observation is that a high percentage of positive treadmill tests for ischaemia are not 
associated with reported chest pain (231,232). 
Exercise training may have special significance in this type of patient since previous 
research studies have shown that the physiological adaptations elicited by training are 
translated into a greater amount of work done before angina or ST segment depression 
occurs (110,233,234), leading to an improved quality oflife. 
In Chapter 3 we evaluated the compensatory mechanisms used by patients with left 
ventricular dysfunction to increase their cardiac output during exercise and in Chapter 5 
we evaluated the adaptability to training of patients with chronic left ventricular 
dysfunction. We know that myocardial ischaemia can have a deleterious impact on the left 
ventricular function of cardiac patients but we know little about the effect of exercise 
training on that relationship. 
The aim of this section of the thesis was therefore to evaluate the effects of exercis-e-
induced myocardial ischaemia -whether silent and/or symptomatic- on the left ventricular 
function and the adaptability to training of patients with coronary artery disease enrolled 
into an exercise cardiac rehabilitation programme. 
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6.2 Methods 
Seventy two consecutive patients with documented coronary artery disease were selected 
-
for the study after undergoing a symptom-limited exercise test on admission to our cardiac 
rehabilitation centre. Fifty patients without signs and/or symptoms of myocardial 
ischaemia during exercise testing were used as a control group for exercise training (CG-
ET). Patients showing planar or downsloping ST segment depression 2::lmm during 
exercise testing underwent radionuclide imaging studies using Technetium 99m methoxy 
isobutyl isonitrile (Tc-MIBI). Patients not showing at least one transient defect were 
excluded from the study. Twenty two patients showed a transient defect during 
radionuclide perfusion imaging and formed our experimental group (EG). Of those, 10 
patients had symptomatic ischaemia during exercise testing and 12 did not develop 
symptoms. Figure 6.1 shows the ECG tracings during and post-effort of a patient with 
silent ischaemia. Figure 6.2 shows the Tc-MIBI scintigram at rest and post-effort in the 
same patient. 
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Radionuclide ventriculography testing was subsequently performed in both groups EG and 
CG-ET at rest and also during exercise in EG. In addition, the ·control group used in 
previous Chapter composed of 31 volunteers (42 to 64 years, mean 52 ±: 8.1 years), without 
any history, signs or symptoms of cardiac disease and with normal results for an exercise 
test, were selected as a control group for the measures of resting and exercise left 
ventricular function (CG-LV). 
Both groups, CG-ET (n=50) and EG (n=22) underwent a 6 month exercise training 
programme. Exercise testing and radionuclide ventriculography tests were repeated at the 
end of the training period, the former in all patients and the latter in 12 patients with 
myocardial ischaemia. 
The stress ECG test consisted of a treadmill symptom-limited exercise test using the Chung 
protocol (27). Respiratory gas analysis using a metabolic cart was carried out and peak 
oxygen uptake was determined. Continuous heart rate and electrocardiogram were recorded 
and the blood pressure was monitored every 3 minutes of the exercise test and in the 
recovery phase. The test was considered positive for ischaemia if 1mm horizontal or 
down-sloping ST depression was observed 80 milliseconds after the J point. 
Myocardial perfusion studies were performed at rest and during exercise in all patients in 
EG according to the protocol of the Department of Nuclear Medicine of the Johannesburg 
Hospital, University of the Witwatersrand. 
Radionuclide ventriculography was performed at rest in all patients, using the equilibrium 
multi-gated blood pool technique as described in Chapter 2 ( 44) and EDC, ESC, SC, EF, 
T-PER, PER, AV-ER, T-PFR, PFR and AV-RFR were derived from time-activity curves 
as previously shown. Changes from rest to exercise were evaluated by the use of the 
percentage change from rest to exercise, calculated as the value during exercise minus the 
value at rest divided by the value at rest x 100. 
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The exercise training programme was of 6 months duration and the intensity of exercise was 
set at the ventilatory threshold identified in the initial exercise test which typically occurred 
· between 70 and 85% of each patient's maximal ·heart rate. Patients developing ST segment 
depression during exercise testing had their intensity set 10 to 15 beats per minute below 
the ischaemic threshold. The exercise training programme was described in detail in 
Chapter 2. 
The patients' adherence to the programme was monitored on a daily basis in terms of 
attendance at exercise sessions and the intensity of their training programmes and the data 
was captured on a computer. 
Statistical analysis 
The data for the EG on admission to the programme and the CG-LV were compared with 
respect to their systolic and diastolic left ventricular function at rest and during exercise, 
including the percentage change from rest to exercise. 
The data for EG and CG were compared regarding their adaptation to 6 months of exercise 
training. 
In the EG, patients with silent ischaemia were compared to those with symptomatic 
ischaemia with respect to their left ventricular function and adaptation to exercise training. 
Group comparisons were made by ANOVA or chi-square analysis where appropriate. If F 
was significant, differences between groups were determjned using Fisher' s LSD tests. 




There were no differences in subjects in CG-ET and EG groups on admission to the 
programme with respect to age, medical condition, medication and mean left ventricular 
ejection fraction (Table 6.1). 
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Mean AGE ± SD (years) 58 .2 + 6.9 59.3 + 7.1 -
MI 
• Anterior 35 (70%) 12 (54.5%) 
• Inferior 16 (46%) 5 (42%) 
• Lateral 19 (54%) 7 (58%) 
CABG 26 (52%) 9 (40.9%) 
PTCA 8 (16%) 4 (18.2%) 
MEDICATION 
• Beta Blockers 16 (32%) 12 (54.5%) 
• Calcium Blockers 13 (26%) 9 (40.9%) 
• Nitrates 5 (10%) 4 (18.2%) 
• ACE inhibitors 7 (14%) 4 (18.2%) 
• Diuretics 5 (10%) 6 (27.3%) 
Mean EF ± SD (%) 51.9+9.3 55.1 + 11.5 - -
Values are expressed as number(%) unless specified. 
ACE: angiotensin converting enzyme; CABG: coronary artery bypass graft surgery; CAD: 
coronary artery disease; EF: ejection fraction; MI: myocardial infarction; PTCA: percutaneous 
transluminal coronary angioplasty; SD: standard deviation. 
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The ischaemic response on admission assessed by electrocardiographic and nuclear 
imaging criteria is shown in Table 6.2 for all EG patients and for the subgroups with silent 
or symptomatic ischaemia. The average number of transient defects was 1.41 per patient. 
Patients with silent ischaemia had a maximum of two transient defects, whereas one 
patient with symptomatic ischaemia had three (p<0.001). 
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Table 6.2 Differences in the ischaemic response on admission to the trial in 22 
patients with coronary artery disease. 
MYOCARDIAL SILENT SYMPTOMATIC 
ISCHAEMIA ISCHAEMIA ISCHAEMIA 
n=22 n=12 n=lO 
ST DEPRESSION (mm) # 1.95 + 0.21 2.1 + 0.31 1.7 + 0.2 - - -
ST RECOVERY TIME (min)# 9.2 + 0.9 10.3 + 1.2 7.9 + 1.3 - -
NUMBER OF TDs 
• ONE 14 (64%) 8 (67%) 6 (60%) 
• TWO 7 (32%) 4 (33%) 3 (30%) 
• THREE 1 ( 5%) --- 1 (10%) * 




• RC 15 TD (48%) 8 TD (50%) 7 TD (47%) 
• ex 6 TD (19%) 3 TD (19%) 3 TD (20%) 
• LAD 10 TD (32%) 5 TD (31%) 5 TD (33%) 
# Values are expressed as mean~ standard error. Other values are expressed as number 
(percentage). 
TDs: transient defects defined as areas of decreased perfusion when comparing stress to resting 
scans; RC: right coronary artery; CX: circumflex; LAD: left anterior descending. 
* Patients with symptomatic ischaemia had more significant transient defects than patients with 
silent ischaemia, p<O.001. 
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The mean attendance at sessions was slightly better for the EG group than the CG group 
(EG: 80.6 ±: 14.9 % vs CG: 71.9 ±: 14.9 %, p=0.051). Although there was a trend towards a 
lower exercise intensity in the EG, there were no significant differences in training heart 
rate, percentage of the maximal heart rate, training oxygen uptake, percentage of peak 
oxygen uptake and kilocalories per session between EG and CG-ET (Table 6.3). 
17 1 
Table 6.3 Similarities in the training stimulus in patients with coronary artery 
disease with or without myocardial ischaemia. 
CAD CONTROL MYOCARDIAL p 
(CG-ET) ISCHAEMIA 
n=50 n=22 
PERCENTAGE 71.9 + 2.1 80.6 + 3.2 0.051 - -
ATTENDANCE 
TRAINING HR 106.5 + 2.2 99.5 + 4.2 NS - -
(beats per minute) 
%MAXIMAL HR 78.6 + 1.0 77.4+ 1.2 NS - -
TRAINING V02 17.6+2.6 17.2+3.8 NS - -
(ml/kg/min) 
%PEAK V02 71.0 + 1.4 69.3 + 2.2 NS - -
KCAL PER SESSION 268.6 + 11.2 261.8 + 17.3 NS - -
Values are expressed as mean :±: standard error. 
HR: heart rate; KCAL: kilocalories; V02: oxygen uptake. 
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Significant differences in left ventricular haemodynamics and systolic and diastolic 
function were seen between patients with myocardial ischaemia and CG-L V (Table 6.4). 
At rest. 
There were no differences in heart rate between the groups. SC were significantly 
decreased in patients with CAD, when compared to controls (p=0.007), while there were 
no differences in EDC and ESC between the two groups. EF, PER and AV-ER were 
significantly lower in patients than controls (p=0.03, p=0.035 and p=0.005 respectively). 
AV-RFR was also significantly reduced in patients compared to controls (p=0.01), while 
there were no differences in PFR between the two groups. 
During exercise. 
Heart rate was significantly increased during exercise in patients and controls (CG-LV) but 
the percentage increase was significantly higher in the control group (99% vs 67%, 
p=0.0001). EDC and ESC were significantly increased during exercise in both groups, 
without changes in SC. Although the magnitude of the change from rest to exercise 
appeared greater in patients than in controls, this was not statistical significant. EF was 
significantly reduced in patients during exercise (p=0.0001) while it did not change in CG-
LV. The percentage change from rest to exercise was not significantly different between 
the groups. T-PER and T-PFR were equally shortened in both groups. PER, AV-ER, PFR 
and AV-RFR were significantly increased during exercise in both groups, the magnitude 
of the change being greater in controls than in patients (p=0.0001, p=0.01, p=0.0001 and 
p=0.01 respectively). 
17 3 
Table 6.4 Differences in resting and exercise left ventricular function between patients 
with coronary artery disease and myocardial ischaemia (EG) and healthy 
individuals without known cardiac disease (CG-LV). 
MYOCARDIAL HEAL THY CONTROL p 
ISCHAEMIA (CG-LV) VALUE 
VARIABLES Rest Exercise ~R-E Rest Exercise ~R-E Rest 
n=22 n=22 n=22 n=31 n=31 n=3 1 Exercise 
* * ~R-E 
HEART RATE 62.3 101.7 -66.8 62.4 121.9 -98.7 NS 
(bpm) (2.8) (3.7) (6.2) (2.4) (2.5) (5 .5) 0.0001 
p=0.0002 p=0.0001 0.0001 
EDC 436401 557909 -34.1 454895 541477 -20.4 NS 
(27532) (48292) (13.3) (32856) (52420) (9.5) NS 
p=0.007 p=0.034 NS 
ESC 207737 298799 -57.4 180400 244226 -40.9 NS 
(23541) (32480) (14.0) (31312) (26493) (11.8) NS 
p=0.001 p=0.001 NS 
SC 228663 259096 -16.1 274494 297251 -10.0 0.007 
(11199) (49409) (13.6) (10379) (30211) (10.2) 0.02 
p=NS p=NS NS 
EF% 55 .1 47.5 7.6 61.1 58.4 3.8 0.03 
(2.4) (2.5) (1.2) (2.4) (1.6) (3.4) 0.0001 
p=0.0001 p=NS NS 
T-PER (sec) 0.13 0.07 42.1 0.15 0.07 50.1 NS 
(0.01) (0.01) (7.4) (0.00) (0.00) (4.5) NS 
p=0.0001 p=0.0001 NS 
PER (EDY/sec) 2.53 3.27 -32.0 2.86 5.00 -77.4 0.035 
(0.12) (0.18) (7.0) (0.13) (0.21) (7.2) 0.00001 
p=0.0001 p=0.0001 0.0001 
AV-ER 1.58 1.88 -19.5 1.86 2.53 -37 .8 0.005 
(EDY/sec) _ (0.07) (0.12) (6.6) (0.08) (0.11) (7.3) 0.00001 
p=0.03 p=0.0001 0.01 
T-PFR (sec) 0.18 0.11 35.7 0.16 0.10 37.2 NS 
(0.01) (0.01) (6.4) (0.01) (0.01) (8.8) NS 
p=0.004 NS 
PFR (EDY/sec) 2.19 4.21 -98.6 2.39 6.27 -167.3 NS 
(0.13) (0.33) (16.2) (0.13) (0.28) (14.6) 0.0001 
p=0.002 p=0.0001 0.0001 
AV-RFR 1.47 2.89 -106.1 1.81 4.46 -157.7 0.01 
(EDY/sec) (0.09) (0.22) (18A) (0.09) (0.27) (18.8) 0.002 
- p=0.0004 p=0.0001 0.01 
Values are expressed as mean (standard error). * p values: rest vs exercise. 
~ R-E: % change from rest to exercise; AV-ER: average ejection rate; AV-RFR: average rapid 
filling rate; CAD: coronary artery disease; EDC: end-diastolic counts; EDV/sec: end-diastolic 
volumes per second; EF: ejection raction; ESC: end-systolic counts; PER: peak ejection rate; 
PFR: eak filling rate; SC: stroke counts; T-PER: time to peak ejection rate; T-PFR: time to peak 
filling rate. 
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The effects of exercise training are shown in Table 6.5. 
Peak oxygen uptake, peak ventilation and ventilatory threshold were significantly 
increased in both EG and CG-ET groups (EG: p<0.02, p<0.006 and p<0.003; CG: 
p<0.001, p<0.002 and p<0.001; respectively), while treadmill time to exhaustion and 
maximal heart rate were increased only in the CG (p<0.001 and p<0.02 respectively). 
Heart rate, blood pressure and the rate-pressure product measured at a submaximal level (6 
minutes on the treadmill) were significantly reduced only in the CG (p<0.001, p<0.002 
and p<0.001 respectively). Resting heart rate was not significantly reduced in any of the 
two groups as a result of training. 
The subcategories of the EG, silent and symptomatic ischaemia failed to elicit any 
significant physiological adaptations to exercise training. The only differences found were 
that the treadmill time to exhaustion increased significantly more in the silent than in the 
symptomatic group (p<0.02) and that the respiratory quotient increased significantly more 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































There were no differences in the heart rate at the onset of ST segment depression or the 
treadmill time to ST segment depression before and after exercise training in the EG group 
and in the subgroups with or without myocardial ischaemia (Table 6.6). However, patients 
with symptomatic ischaemia had- a significantly lower heart rate at the onset of ST 







Heart rate and treadmill time at ST segment depression in patients with 
myocardial ischaemia and in the subgroups with or without symptoms, before 
and after exercise training. 
MYOCARDIAL SILENT SYMPTOMATIC 
ISCHAEMIA ISCHAEMIA ISCHAEMIA 
n=22 n=12 n=lO 
Admission 6 months Admission 6 months Admission 6 months 
119.8 + 4.7 119.7 + 4.7 122.3 + 5.9 124.6 + 6.7 116.8+8.l 113.8 + 6.8 - - - - - -
* * 
9.3 + 0.5 9.9 + 0.6 10.3 + 0.7 10.3 + 0.6 8.1 + 0.4 9.3+1.1 - - - - - -
HR-ST: heart rate at the beginning of ST segment depression; TIME-ST: treadmill time to ST 
segment depression. 
Values are expressed as mean + standard error. 
There were no significant differences as a result of training in any of the groups. 
* Silent vs symptomatic: p<0.02 
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The left ventricular function of the subgroup of 12 patients in the EG who underwent 
repeated radionuclide ventriculography testing after exercise training is shown in Table 
6.7. On admission to the programme, EDC and ESC did not increase during exercise, to 
the same extent, in these patients as in the whole group, but all other parameters were very 
similar. There were no significant differences before and after training in resting and 
exercise L V function and in the change from rest to exercise. However there was a trend 
towards a decrease in EDC and SC after training. 
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Table 6.7 Left ventricular function of coronary artery disease patients with myocardial 
ischaemia before and after 6 months of exercise training. 
ADMISSION 6MONTHS 
n=12 n=12 
VARIABLES REST EXERCISE LiR-E REST EXERCISE 
* * 
HEART 60.5 95.2 -61.7 61.9 95.6 
RATE (3.8) (3.7) (8 .8) (2.4) (3 .8) 
(bpm) p=0.00002 p=0.0001 
EDC 435723 476853 -13.4 467990 374190 
(34420) (51334) (12.2) (39583) (58856) 
p=NS p=NS 
ESC 213671 258978 -35 .3 229431 244811 
(35230) (35019) (17.6) (36186) (52736) 
p=NS p=NS 
SC 222052 217876 3.2 238559 166878 
(14105) (28890) (9.7) (16647) (26168) 
p=NS p=0.026 
EF% 52.8 45.9 7.0 52.7 43.6 
(3.5) (3.5) (2 .0) (3 .2) (3.3) 
p=0.01 p=0.003 
T-PER (sec) 0.14 0.07 52.7 0.13 0.08 
(0.00) (0.00) (4.5) (0.00) (0.01) 
p=0.00001 p=0.01 
PER 2.45 3.06 -30.8 2.43 3.13 
(EDY/sec) (0.17) (0.19) (12.2) (0.17) (0.35) 
p=0.01 p=NS 
AV-ER 1.44 1.70 -20.7 1.50 1.62 
(EDY/sec) (0.08) (0.13) (10.3) (0.10) (0.14) 
p=NS p=NS 
T-PFR (sec) 0.17 0.11 31.8 0.18 0.13 
(0.01) (0.01) (7.5) (0.01) (0.01) 
p=0.007 p=NS 
PFR 2.11 3.85 -90.9 2.05 3.73 
(EDY/sec) (0.19) (0.43) (24.4) (0.14) (0.36) 
p=0.003 p=0.001 
AV-RFR 1.44 2.73 -99.0 1.35 2.50 
-
(EDY/sec) (0.15) (0.31) (25.8) (0.10) (0.19) 
p=0.002 p=0.0001 
Values are expressed as mean (standard error). * p value: rest vs exercise. 
































































We investigated the effects of exercise-induced myocardial ischemia on the left ventricular 
function and adaptability to training of patients with coronary artery disease. 
The first important finding was that at rest, our group with myocardial ischemia showed 
significant abnormalities in systolic and diastolic left ventricular function when compared 
with normal controls and that these abnormalities were no different from that of other 
patients with coronary artery disease as described in Chapter 3. 
The effects of myocardial ischaemia on left ventricular function during exercise were our 
second important finding. There was a significant increase in end-diastolic counts leading 
to an acute ventricular dilatation and a tendency towards an increase in stroke counts 
during exercise. It is interesting to note that these results were similar to those seen in 
volunteers without coronary artery disease who also had a significant increase in EDC, 
although of a lesser magnitude, but were significantly different from those of patients with 
coronary artery disease without myocardial ischaemia in whom EDC did not increase 
during exercise and SC tended to fall. 
Our results are in agreement with the study of Rerych et al (211) who evaluated the effect 
of ischaemia on left ventricular function by comparing the left ventricular performance of 
patients with single (n=lO) and multi-vessel (n=20) coronary artery disease with that of 
normal individuals (n=30) using first transit angiocardiography at rest and during exercise 
in the erect position. Their results showed that the degree of cardiac dilatation during 
exercise was directly proportional to the severity of the ischaemia and emphasized the 
importance of an increase in preload as a basis for preservation of left ventricular function 
during exercise in this type of patients. 
Both -groups of patients with coronary artery disease; with and without myocardial 
ischaemia, showed a significant increase in maximal exercise capacity and ventilatory 
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threshold as a result of exercise training. However patients with myocardial ischaemia 
failed to show the expected reduction in heart rate, blood pressure and rate-pressure 
product during submaximal exercise and a reduction in heart rate or treadmill time at the 
onset of ST segment depression; changes which were present in the CAD groups of 
patients without myocardial ischemia. These are probably the most desirable training 
adaptations expected in this group of patients since this would have been translated into 
fewer symptoms and greater cardiovascular efficiency during their daily activities. This is 
in disagreement with some studies which have shown a significant submaximal training 
effect in patients with and without myocardial ischaemia (195,235-238). Such adaptations 
have been shown to be due to an increased arterio-venous extraction of oxygen rather than 
to changes in cardiac performance (94,112,195,239). 
A possible explanation for this discrepancy in training effect in the presence of myocardial 
ischaemia in our patients could have been an inadequate training stimulus. In this regard, 
in the experimental group the intensity of exercise was set below the ischaemic threshold 
in order to increase the safety and therefore reduce the likelihood of exercise-related 
cardiovascular complications. However, training heart rate, percentage of the maximal 
heart rate, training oxygen uptake, percentage of peak oxygen uptake and kilocalories per 
session, although slightly lower in patients with ischaemia compared to those in the 
control group without ischaemia, were not significantly different between the groups, 
leading to the conclusion that the training stimulus was similar for patients with or without 
myocardial ischaemia. 
Ades et al. (237) in a recent study evaluating the effects of exercise training of 3 and 12 
months duration in older coronary pat~ents, concluded that it appears that _a stimulus of 
sufficient intensity is required for patients to reach a training threshold at which 
submaximal changes are likely to occur. The authors trained their older population at a 
higher relative intensity (75-90% of maximal heart rate from preconditioning treadmill 
testing) than is commonly utilised in cardiac rehabilitation programmes, based on their 
previous observation that older coronary patients rarely exercise to a true physiological 
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maximum at baseline (240). Although our patients exercised at an intensity which falls in 
the lower end of the range proposed by Ades et al., this threshold hypothesis is an unlikely 
explanation for our findings since both groups, with and without myocardial ischaemia, 
were of a similar age and trained at the same relative intensity. 
The maximal rate-pressure product was unchanged after training in both groups with or 
without myocardial ischaemia and the exercise recommendations were of the conventional 
type for both groups of patients. Improvements in coronary blood supply have only been 
suggested in exercise programmes of much higher intensity, duration and :frequency (241) 
which showed a significant increase in the maximal rate-pressure product considered by 
many as an indirect indicator of changes in myocardial blood flow, and a reduction in the 
magnitude of ST segment depression. 
Although there were no statistical significant differences between the groups, medication 
usage seemed greater in the group of patients with myocardial ischaemia with respect to 
beta-blockers, calcium channel blockers and nitrates (Table 6.1). Suggestive evidence of 
more beta-blocker usage by the group with myocardial ischaemia is provided by a 
significantly lower heart rate and blood pressure at rest and at submaximal and maximal 
exercise levels (Table 6.5). Our results showed that the ability of this group of patients to 
increase their maximal oxygen consumption was not blunted by the use of these drugs. 
However reductions in myocardial oxygen consumption induced by pharmacologic 
therapy (242) could have attenuated the expected beneficial haemodynamic effects of 
exercise training at submaximal levels. 
When patients with myocardial ischaemia were separated into silent and symptomatic 
subcategories, neither showed any training effects. This is probably due to the -small 
numbers, but the trend was toward more favourable adaptations to maximal exercise in the 
group with silent myocardial ischaemia. Patients with symptomatic ischaemia had a lower 
heart rate at the onset of ST depression after training than patients with silent ischaemia, 
suggesting more progression of disease in this group of patients. Weisz et al (243) who 
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performed a second treadmill test after one year in patients with CAD found that treadmill 
parameters seemed to remain similar to those measured in the first test except for a longer 
exercise duration and a lower heart rate at the time of 1 mm ST depression. Our results 
could be consistent with the hypothesis that symptomatic ischaemia is of greater severity 
than silent ischaemia, although this interpretation is not shared by all (231,244). 
The twelve patients with myocardial ischaemia, in whom we were able to assess left 
ventricular function before and after training, showed no major changes in left ventricular 
function as a result of training. However, we noted a significant fall in stroke counts 
during exercise and a lack of increase in PER after training, changes which could be 
interpreted as early indicators of progression of disease. In any case, these results should 
be taken with caution because of the small number of subjects. 
If we accept that the general trend is towards deterioration, our results would conflict with 
those of Jiang et al. (245), who recently found that higher levels of physical fitness were 
associated with less transient myocardial ischaemia assessed in the laboratory (wall motion 
abnormalities at rest and during mental and exercise stress using radionuclide 
ventriculography and treadmill exercise testing), and during daily life (Holter monitoring) 
in 4 7 patients with CAD with a recent positive exercise test. The results of Schuler et al. 
(246) who adding a low fat diet to exercise training were able to demonstrate a 54% 
reduction in exercise-induced Thallium-201 scintigraphy relative to a matched control 
raise questions about what goals we should set for patients with coronary artery disease 
and myocardial ischaemia joining a cardiac rehabilitation programme. In this type of 
patients, aggressive coronary risk factor management leading to possible regression of 
disease could become more effective than exercise training, a strategy which was unable to 
produce improvements in cardiovascular efficiency or coronary blood supply in our study. 
This study antedated effective cholesterol-lowering trials and as consequence very few 
patients were on cholesterol lowering medications. It is possible that in the absence of 
significant cholesterol-lowering, exercise is of marginal benefit in improving or delaying 
progression of disease. 
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6.5 Conclusions 
Patients with coronary artery disease and myocardial ischaemia preserved their cardiac 
output during exercise through an increase in heart rate and by utilising the Frank Starling 
mechanism leading to acute ventricular dilatation. 
These patients showed improvements in maximal work capacity but failed to elicit 
physiologic adaptations at a submaximal workload or to increase the threshold for 
ischaemia after exercise training. Furthermore, the minor changes seen in left ventricular 
function after training may suggest progression of disease despite participation in an 
adequate exercise training programme. 
It is possible that the main emphasis in the management of this type of patient in a cardiac 
rehabilitation setting should be placed more on coronary risk factor modification to slow 
progression of disease than on an improvement in cardiovascular efficiency. It is possible 
that aggressive cholesterol lowering, which was not practised at the time of the study, 
could have altered the natural progression of the disease and improve some of the 
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7.1 Introduction 
Dyspnea is frequently a factor limiting the exercise tolerance of patients with chronic heart 
failure (148,247-249). It has been shown that for the same workload, patients with heart 
failure have a greater ventilatory response than healthy controls (250-234). This increased 
ventilation can be identified by examining the relationship between minute ventilation 
(VE) and minute carbon dioxide production (VC02). Although VE is linearly related to 
VC02 in both controls and patients with heart failure, the slope of this relation has been 
found to be greatly increased in the latter group (146,148,247,252,253). 
This relationship has been analysed for patients with chronic heart failure defined as in 
NYHA Classes II and III and ejection fractions (EF) below 50%, but has not been 
evaluated over a wide range of left ventricular impairment and in asymptomatic patients. It 
has been suggested that exercise training could favourably reduce the slope of this 
relationship in patients with chronic heart failure (250). 
It was the purpose of this chapter of the thesis to assess the ventilatory responses to effort 
in patients with coronary artery disease and various degrees of asymptomatic left 
ventricular dysfunction and to determine whether a 6 month exercise training programme 
could correct any measured ventilatory abnormality. 
7.2 Methods 
Of the original cohort of 171 patients enrolled into the study in Chapter 4, only 102 
patients were enrolled into the present study, -63 patients in Gl , 21 in G2 and 18 in G3. 
Fifteen patients were excluded because of the presence of lung disease on medical history, 
physical examination and/or lung function testing on admission to the program and 54 
because they failed to attend at least 60% of the possible sessions. 
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The medical evaluation, the patients' physical and physiological characteristics and the 
exercise training programme have been described in detail in Chapter 4. All patients were 
classified in the New York Heart Association classes I and II. Medication use was 
different between groups, with G 1 using mainly beta blockers and calcium antagonists and 
G2 patients using calcium antagonists and angiotensin converting enzyme inhibitors, while 
G3 patients used more nitrates, angiotensin converting enzyme inhibitors and diuretics. 
None of the patients was on digitalis preparations. None of the patients had clinical 
evidence of congestive heart failure. Twenty four patients showed ST segment depression 
greater than 1mm and 7 patients showed ST segment elevation during exercise testing or 
in the recovery period. Patients with ST segment depression were evenly distributed 
among the three groups whereas G3 had a greater percentage of patients with ST segment 
elevation than the other groups (p<0.01 respectively). 
Peak V02 and treadmill time were used to evaluate the maximal exercise capacity of 
patients and ventilation was assessed in all groups by VE, VC02 and by the VENC02 
ratio and the slope of that relationship. All parameters were determined at rest, as the 
average of the last two minutes' values, at 6 and 9 minutes of effort on the treadmill, and 
at maximal effort. The relationship between VE and VC02 was evaluated, its slope 
correlated to peak V02 and the VE/VC02 ratio correlated to treadmill time. As in Davey's 
study (230), we determined the point of maximal ventilatory efficiency, defined as the 
point at which patients required the least minute ventilation per unit of carbon dioxide 
excretion during the exercise test. 
Statistical analysis 
Comparisons between groups were made by analysis of variance. When significant 
differences were indicated in the analysis of variance, individual comparisons were made 
with Fisher's LSD tests. The relations between VE and VC02 , the VE/ VC02 slope and 
peak V02 and the VE/ VC02 ratio and treadmill time were studied using a simple 
regression analysis in each EF category before and after training, and using a multiple 
regression analysis including the EF category and the exercise training effect in the model. 
Data points were obtained during maximal treadmill testing for the former correlation and 
from the values at peak exercise for the latter two. Slopes were determined with a least 
square fitting procedure. All values were expressed as mean±: standard error. A p value of 
less than or equal to 0.05 was accepted as statistically significant. 
7.3 Results 
There were no differences in peak V02 and treadmill time to exhaustion between G2 and 
G 1 on admission to the programme. However both parameters were significantly reduced 
in G3 compared to G2 and Gl , as demonstrated by a lower mean peak V02 (p=0.001 and 
p=0.007 respectively) and a lower mean treadmill time (p=0.001 and p=0.01 respectively). 
In spite of these differences on admission, the tolerance to effort increased significantly in 
all groups as a result of training (Table 7 .1 ). 
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Table 7.1 Peak V02 and treadmill time before and after training according to 
ejection fraction category. 
GROUP 3 GROUP2 GROUP 1 p value 
EF<35% EF2::35 - <50% EF2::50% Differences between 
n=18 n=21 n=63 groups 
3 vs 2 3 vs 1 2 vs 1 
Adm 6ms Adm 6ms Adm 6ms Adm Adm Adm 
6ms 6ms 6ms 
Peak V02 20.2 22.4 24.6 29.0 24.2 27.6 0.001 0.007 NS 
(ml/kg/min) (0.9) (1.1) (0.9) (1.3) (0.7) (0.8) 0.001 0.001 NS 
p=0.008 p=0.0001 p=0.0001 
Range 13.3-28.9 14.5-30.7 13.3- 38.7 
TT 8.4 10.5 11.6 13.8 10.5 12.8 0.001 0.012 NS 
(minutes) (0.6) (0.7) (0.6) (0.5) (0.4) (0.4) 0.001 0.007 NS 
p=0.002 p=0.001 p=0.0001 
Range 4-12.3 6.3-16.3 4.3-18 
Except for the range on admission, all values are expressed as Mean (Standard Error). 
Adm: admission; EF: ejection fraction; 6 ms: 6 months; TT: treadmill time 






The ventilatory response to exercise before and after training is shown in Table 7.2 for all 
groups. There were no differences in minute ventilation and carbon dioxide excretion at 
rest, before or after training, and within groups. As exercise progressed, G3 patients 
showed a significantly lower VC02 and a significantly higher VENC02 , both before and 
after training than those in G2 and G 1. At 9 minutes of exercise, VC02 was significantly 
lower in G3 than in G2 on admission (p=0.011) and after 6 months (p=0.029), and also 
than in Gl on admission (p=0.028). At peak exercise, VC02 was significantly lower in G3 
than G2 and Gl, both before (p=0.012 and p=0.015 respectively) and after training 
(p=0.001 and p=0.004 respectively). The VENC02 ratio was significantly higher in G3 
patients than in G2 and G 1 patients, at 6 and 9 minutes of exercise and at peak exercise, 
both before (6 minutes : p=0.005 and p=0.002; 9 minutes: p=0.046 and p=0.026; peak: 
p=0.024 and p=0.002) and after training (6 minutes: p=0.001 and p=0.0003; 9 minutes: 
p=0.011 and p=0.005; peak: p=0.001 and p=0.001). 
Training produced a significant increase in VE and VC02 at 9 minutes (p=0.014 and 
p=0.016) and at peak effort (p=0.0001 and p=0.0001) in Gl patients and at peak effort 
only (p=0.002 and p=0.0001) in G2 patients. As a result of training patients in G3 also 
increased their peak ventilation (p=0.006) but without an increase in peak VC02• 
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Table 7.2 Differences in resting, submaximal and maximal ventilatory responses to exercise 
before and after training according to ejection fraction category. 
GROUP 3 GROUP 2 GROUP 1 p value 
EF < 35% EF ~35 - <50% EF ~ 50% Differences betwen 
N=18 n=21 n=63 groups 
Adm 6ms Adm 6ms Adm 6ms 3 vs 2 3 vs 1 2 vs 1 
adm adm adm 
6ms 6ms 6ms 
VE rest 12.8 13 .5 11.4 12.4 12.2 12.7 NS NS NS 
(0.5) (0.5) (0.6) (0.6) (0.4) (0.4) NS NS NS 
p=NS p=NS p=NS 
VC02 rest 0.22 0.23 0.22 0.23 0.22 0.23 NS NS NS 
(0.01) (0.01) (0.01) (0.01) (0.01) (0.01) NS NS NS 
p=NS p=NS p=NS 
VENC02 rest 59.8 59.8 54.2 55.0 55.1 55.6 NS NS NS 
(2.3) (2 .6) (2.5) (2.0) (1.3) (1.2) NS NS NS 
p=NS p=NS p=NS 
VE-6 43 .5 48 .6 40.4 40.7 41.9 42.5 NS NS NS 
(5.4) (3 .9) (2.7) (1.4) (2.1) (1.7) NS NS NS 
p=NS p=NS p=NS 
VC02 -6 1.03 1.13 1.12 1.12 1.13 1.13 NS NS NS 
(0.13) (0.09) (0.08) (0.04) (0.05) (0.04) NS NS NS 
p=NS p=NS p=NS 
VENC02-6 42.6 43.7 36.7 36.5 37.0 37.9 0.005 0.002 NS 
(2.3) (2.0) (1.1) (0.8) (0.7) (0.7) 0.001 0.0003 NS 
p=NS p=NS p=NS 
VE-9 31.5 46.1 48 .6 58.0 42.7 51.6 NS NS NS 
(8.2) (7.7) (5 .9) (2.2) (3.8) (3 .0) NS NS NS 
p=NS p=NS p=0.014 
VC02 - 9 0.76 1. 10 1.34 1.60 1.18 - 1.40 0.011 0.028 NS 
(0.20) (0.18) (0.16) (0.06) (0.10) (0.08) 0.029 NS NS 
p=NS p=NS p=0.016 
VE/ VC02 -9 41.2 42.1 36.3 36.8 36.4 36.9 0.046 0.026 NS 
(2.0) (1.8) (1.2) (1.2) (0.9) (0.8) 0.011 0.005 NS 
p=NS p=NS p=NS 
Peak VE 70.6 79.6 80.4 93.1 75 .7 87.0 NS NS NS 
(3.7) (3.6) (4.4) (5.2) (2 .7) (3.0) NS NS NS 
IJ=0.006 p=0.002 p=0.0001 
Peak VC02 1.56 1.69 2.00 2.35 1.92 2.16 0.012 0.015 NS -
(0.09) (0.09) (0.12) (0.14) (0.07) (0.08) 0.001 0.004 NS 
p=NS p=0.0001 p=0.0001 
Peak VE/ VC02 46.2 48 .3 40.8 40.4 40.1 40.8 0.024 . 0.002 NS 
(2.3) (2.3) (1 .3) (1.5) (0.9) (0.8) 0.001 0.0001 NS 
p=NS p=NS p=NS 
Values are expressed as Mean (Standard Error). Adm: admission; EF: ejection fraction; 6 ms: 6 months; VC02 : carbon 
dioxide production; VC02 - 6 and 9: carbon dioxide production at 6 and 9 minutes on the treadmill; VE: ventilation per 
minute; VE - 6 and 9: ventilation at 6 and 9 minutes on the treadmill. 
192 
The relation between minute ventilation and the rate of carbon dioxide production was 
linear in all patients by visual inspection and linear regression with correlation coefficients 
exceeding 0.90 in all groups (Figure 7.1 and Table 7.3). By multiple regression the model 
correlation coefficient was 0.96 (p=0.0001). Groups 1 and 2 had similar slopes but their 
slopes were significantly smaller than for Group 3 (p=0.0001 respectively). The slope of 
the relation between minute ventilation and the rate of carbon dioxide production showed a 
very modest and negative correlation with peak oxygen uptake (model r = -0.47, 
p=0.0001) (Figure 7.2 and Table 7.3). The slope was significantly higher for group 3 than 
for groups 1 and 2 (p<0.01 respectively). The ratio of the relation of minute ventilation 
and rate of carbon dioxide production showed a non linear correlation with treadmill time 
(model r = -0.70, p=0.0001) (Figure 7.3 and Table 7.3). There were no significant 
differences in the slopes as a result of training in any group. 
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Table 7.3 Relation between minute ventilation and carbon dioxide production, relation 
between its slope and peak oxygen uptake and relation between its ratio and 
treadmill time, before and after training according to ejection fraction category. 
Group 3 Group 2 Group 1 
EF<35% EF > 35 and< 50% EF > 50% - -
Adm. 6 months Adm. 6 months Adm. 6 months 
Relation: 
minute volume - carbon dioxide production 
Y = Po+ P1 X VC02 
Intercept 5.57 5.25 4.34 4.18 4.98 5.15 
Slope * 37.94 37.66 34.48 34.1 34.12 33 .3 5 
r 0.95 0.95 0.96 0.97 0.96 0.96 
p 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Model r = 0.96 -p=0.0001 
Relation: 
slope VENC02- peak oxygen uptake 
Y = Po + P1 x Peak V02 
Intercept 60.2 63.4 49.0 39.7 45.4 44.9 
Slope# -0.92 -0.90 -0.51 -0.12 -0.39 -0.30 
r -0.36 -0.46 -0.43 -0.13 -0.32 -0.33 
p NS 0.053 0.052 NS 0.011 0.007 
Model r = -0.47 - p=0.0001 
Relation: 
VE/VC02 ratio - treadmill time 
Y = Po + P1 X TT + P2 X TT2 
Intercept 56.25 55.91 51.25 52.42 52.64 52.46 
Slope1 -3.74 -3.00 -3.33 -3 .70 -3.80 -3.34 
r -0.49 -0.47 -0.49 -0.51 -0.54 -0.52 
p 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Slope2 0.22 0.15 0.17 0.20 0.20 0.17 
r 0.40 0.37 0.38 0.36 0.41 0.40 
p 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Model r = -0.70 - p=0.0001 
Adm: admission; Peak V02: peak oxygen uptake; TI: treadmi-ll time; VE: mmute ventilat10n; 
VC02: carbon dioxide production. 
* Groups 1 and 2 had similar slopes but significantly smaller than Group 3 (p<0.0001 respectively). 
# The slope in Group 3 was significantly higher than in Groups 1 and 2 (p<0.01 respectively). 














Example of the relation between minute volume and rate of 
carbon dioxide production on admission to the programme 
in 3 patients with normal, moderately depressed and 
severely depressed left ventricular function 
Patient EF = 14.9 % 
Group 2 6 
Group 3 
y = 4.34 + 34.48 X 
r = 0.96 
y = 5.57 + 37.94 X 
p < 0.0001 
r = 0.95 
p < 0.0001 Patient EF = 38.4 % 
Group 1 
y = 4.98 + 34.12 X 
r = 0.96 
p < 0.0001 
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ventilation and rate of carbon dioxide production and peak 
oxygen uptake on admission to the programme 
Group 3 
y = 60.2 - 0.92 X 
r = -0.36 
p= NS 
Group 2 
y = 49.0 - 0.51 X 
Group 1 r = -0.43 
y = 45.4 - 0.39 X p = 0.052 
r = -0.39 
p = 0.011 
j-o-- Group 1 -X- Group 2 --t::r- Group 31 
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Figure 7.3 Relation between the VENC02 ratio and exercise time 






















model r = -0.70 
p = 0.0001 
Group 3 
Y = 56.25 - 3.74 X + 0.22 x2 
Group 1 Group 2 
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The treadmill time and the ratio VE/ VC02 at the point of maximal ventilatory efficiency 
were determined and compared between groups before and after training (Table 7.4). The 
treadmill time was significantly delayed in groups 2 and 1 compared to group 3, both 
before (p=0.038 and p=0.009 respectively) and after training (p=0.025 and p=0.012 
respectively), but although there was a trend towards a delay in reaching maximum 
ventilatory efficiency after training, the differences were not significant for any group. The 
ratio VENC02 was significantly higher in Group 3 than in Groups 2 and 1, both before 
(p=0.016 and p=0.009 respectively) and after training (p=0.001 respectively). 
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Table 7.4 Treadmill time and ratio of minute ventilation and carbon dioxide production at 
the point of maximal ventilatory efficiency, before and after training, according 
to ejection fraction category. 
GROUP 3 GROUP2 GROUP 1 p value 
EF<35% EF ~:35 - <50% EF ~ 50% DIFFERENCES 
n=18 n=21 n=63 BETWEN GROUPS 
Adm 6ms Adm 6ms Adm 6ms 3 vs 2 3 vs 1 2 vs 1 
adm adm adm 
6ms 6ms 6ms 
TREADMILL 8.22 9.28 9.86 11.05 9.94 10.92 0.038 0.009 NS 
TIME (2.24) (2.93) (1 .85) (2.13) (2.47) (2.55) 0.025 0.012 NS 
p=NS p=NS p=NS 
VENC02 41.0 41.9 35.9 35.1 36.4 36.5 0.016 0.009 NS 
(2.0) (1.6) (1.1) (1.0) (0.8) (0.7) 0.001 0.001 NS 
p=NS p=NS p=NS 
Values are expressed as Mean (Standard Error) . 





We reported in Chapter 4 that exercise training was able to increase maximal exercise 
capacity in patients with severely depressed left ventricular dysfunction and that the 
magnitude of the improvement in this group of patients was similar to that of moderate or 
no left ventricular impairment (221). Using the same cohort of patients, but excluding 15 
patients because of pulmonary disease, we were able to replicate the above physiological 
adaptations to training. 
The analysis of the ventilatory responses to exercise on admission to the program allowed 
us to separate patients with severely depressed left ventricular impairment from those with 
a moderate impairment or normal function. VE and VC02 were significantly correlated 
(r=0.96, p<0.0001) in all groups, showing that ventilation is linked to carbon dioxide 
production in order to maintain eucapnia. However, patients with an EF<35% showed a 
higher VENC02 ratio during submaximal and maximal exercise and a higher VENC02 
slope (p=0.0001) than the other two groups. These results confirm the findings of other 
authors (147,148,247,250,251,254) that the ventilatory response to exercise is significantly 
increased in patients with severely depressed left ventricular function. However this is the 
first study, to our knowledge, that shows these changes in asymptomatic patients in 
NYHA functional classes_! and II without clinical signs or symptoms of congestive heart 
failure, since all other studies have included patients in classes II and III, with overt 
compensated heart failure who were on treatment with diuretics and digoxin 
(134,250,252,253,255,256). 
This excessive ventilation was only seen below a certain threshold of left ventricular 
impairment which in our se.r_ies was EF<35% and of peak oxygen uptake since patients in 
G3 also had the lower maximal oxygen consumption. Patients with moderate left 
ventricular impairment (EF:::35% and <50%) had a ventilatory response and values of peak 
oxygen uptake similar to those of patients with normal left ventricular function. A good 
correlation between peak oxygen uptake and the slope of VENC02 would therefore be 
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expected as previously shown by Fink et al. (147), r= -0.59, p<0.01, Buller et al. (254), r= 
-0.86, p<0.001 and Davies et al. (253), r= -0.53, p<0.002. We found a significant but weak 
negative correlation, however, between the slope of VEN CO2 and peak V02 in our study 
(model r=-0.47, p=0.0001). This is possibly due to higher peak V02 in our patients (range 
13.3 to 28.9 ml/kg/min) since Davies (253) clearly showed that the association becomes 
stronger when chronic left ventricular dysfunction exceeds a critical level of severity as 
assessed by a peak V02 falling below 20 ml/kg/min. 
The ratio VENC02 showed a negative non-linear correlation with treadmill time. The 
curve correlating these two variables represents ventilatory efficiency by giving the minute 
ventilation at any workload once it has been standardized for carbon dioxide production 
(250). In our study, patients with moderately impaired or normal L V function had lower 
VENC02 ratio and longer treadmill time at the point of maximal ventilatory efficiency 
than those with severe left ventricular impairment indicating a greater ventilatory 
efficiency. 
The precise mechanisms for the increased ventilation during exercise and lower ventilatory 
efficiency in patients with chronic heart failure remain unclear. Early oxygen independent 
metabolism, an abnormal respiratory pattern, an increased pulmonary capillary wedge 
pressure-and an increase in dead space ventilation have all been implicated as possible 
pathophysiologic factors. An increase in pulmonary capillary wedge pressures during 
exercise in patients with valvular disease can cause a reduction in pulmonary compliance 
and stimulation of juxtacapillary receptors leading to an exaggerated ventilatory response 
(257) . However Sullivan et al. (146) and Fink et al. (147) failed to show any relationship 
between the increase in the VENC02 ratio during exercise and elevated pulmonary wedge 
pressures iB patients with chronic heart failure. 
No correlation was found either between plasma lactate levels and the VENC02 ratio 
during exercise (146) in patients with chronic heart failure in spite of those patients 
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showing an earlier increase in blood lactate concentration when compared to healthy 
controls. 
Several studies have suggested that this excessive ventilation in patients with heart failure 
is due to an increase in the ventilation of the dead space (146,249,251,252,254). Sullivan 
et al. (146) who demonstrated a strong correlation between the VENC02 ratio and the 
dead space per breath, concluded that the increase was likely due to an increase in 
physiological dead space rather than in the anatomical dead space which should have 
increased in a similar fashion between patients and controls during exercise. Buller et al. 
(254) showed that an increased anatomical dead space only contributes about 1/3 to the 
increase hyperventilation and that the other 2/3 are explained by an increased 
physiological dead space. Similarly Wasserman et al. (251) proposed that an increase in 
physiological dead space is a more important mechanism than the altered respiratory 
pattern of higher respiratory rate and lower tidal volume seen in these patients. 
An inverse relationship between cardiac output and the VENC02 ratio and the ventilation 
of dead space (146) suggests that an inadequate cardiac output leading to lack of perfusion 
of certain ventilated areas of the lungs could accentuate ventilation perfusion mismatching 
in patients with severe left ventricular dysfunction producing an increase in their 
ventilatory response to exercise. 
Thus, a combination of the above can probably explain the abnormal ventilatory responses 
in patients with severely depressed left ventricular dysfunction seen in our study. An 
increase in physiologic dead space due to a ventilation perfusion mismatch probably was 
the main mechanism in patients with low peak oxygen uptake values. An altered 
-
respiratory pattern with a lower tidal volume due to mild restrictive pulmonary 
abnormalities as demonstrated by a significantly lower FEV1 and a normal FEV1 ratio in 
this patient group could partially explain the ventilatory abnormalities in some patients. -
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Our results differ from those of Davey et al. (250) in that exercise training failed to reduce 
the slope of the relation of minute ventilation and carbon dioxide production in patients 
with severely or moderately depressed left ventricular function. Training also failed to 
reduce the VENC02 ratio at the point of maximum ventilatory efficiency and/or to 
increase the exercise duration required to reach this point. The same investigators 
suggested that the changes associated with exercise training in patients with heart failure, 
such as an increase in the blood supply to the working muscles and an improvement in 
muscle aerobic metabolism could revert some of the changes associated with the condition 
decreasing the production of carbon dioxide and delaying acidosis leading to a reduction in 
submaximal minute ventilation. If exercise training did not alter this relationship then we 
could speculate that either it does not increase muscle blood flow or, more likely, the 
increased ventilatory response seen in patients with heart failure is unrelated to a reduction 
in muscle blood flow. It is possible that for these changes to occur patients have to be 
more severely compromised since Davey's patients were in NYHA classes II and III and 
had a mean peak V02 of 14.1 ± 2.8 ml/kg/min, while our patients were all NYHA classes 
I and II and their mean peak V02 was higher (20.2 ± 3.8 ml/kg/min). 
7.5 Conclusions 
A higher ventilatory response to exercise and lower ventilatory efficiency can differenciate 
patients with severe left ventricular dysfunction from those with moderately impaired or 
normal left ventricular function. 
Exercise training increased maximum oxygen uptake and maximum ventilation in all 
patients irrespective of their degree of left ventricular impairment, but -was ineffective in 




THE EFFECT OF ADHERENCE TO EXERCISE 
TRAINING OF 6 AND 18 MONTHS DURATION ON 
THE EXERCISE CAP A CITY AND .LEFT 
VENTRICULAR FUNCTION OF PATIENTS WITH 





There are conflicting reports about the effects of exercise training on L V function in 
persons with CAD undergoing cardiac rehabilitation. A number of conventional exercise 
training programmes (98,99,103,1134,195-198) have not shown changes in resting LV 
function with exercise training whereas reports from high-intensity, high-frequency and 
high-duration programmes (115,199,200) demonstrated improvements in LV systolic 
function. Age-related deterioration in left ventricular function could be another 
contributory factor to the lack of improvement in cardiac function seen by some authors in 
training studies (201-204). 
A careful recording of the patient's adherence with the training programme was often 
lacking in some of the above studies. Furthermore, little attention was given to changes in 
diastolic function as a result of exercise training. It has also been suggested that 
measurement of L V function during exercise may be a more sensitive means for detecting 
beneficial effects of a treatment programme than resting measures (58). 
Most conventional exercise rehabilitation programmes recommend that their cardiac 
patients exercise 3 times a week for 30 to 45 minutes at an intensity between 70 to 85% of 
_ maximal heart rate, which corresponds to between 50 and 70% ofV02 max, for a period of 
3 to 6 months. Exercise is prescribed in a similar way at the Johannesburg Cardiac 
Rehabilitation Centre with the difference that we recommend a minimum duration of 6 
months and preferably a duration of 18 months. 
Chapter 5 showed that exercise training improved exercise capacity in patients with L V 
_Qysfunction and Chapter 6 showed that training improved exercise capacity but not L V 
function in patients with myocardial ischaemia. 
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The aim of this chapter of the thesis is to assess the effects of adherence to exercise 
training of 6 and 18 month duration on the exercise capacity and left ventricular function 
of patients with coronary artery disease. 
8.2 Methods 
Patients with documented coronary artery disease consecutively referred to the Johannesburg 
Cardiac Rehabilitation Centre between 1990 and 1993 were considered for the trial. All 
patients are encouraged to attend our programme for 18 months. Only patients who stayed in 
the programme for at least 6 months were enrolled into the study. One hundred and eighteen 
patients entered the 6 month exercise training programme (ET6) and.40 of those completed 
the 18 month programme (ET18). Patients who suffered an MI or a CABG were enrolled 3 
months after the event to ensure that the spontaneous recovery in L V function which 
occurs as part of the healing process, did not confound the interpretation of training-
induced adaptations. Patients who underwent a percutaneous transluminal coronary 
angioplasty were enrolled 4 weeks after the revascularization procedure. 
In addition, a group of 31 volunteers matched for age, without any history, signs or 
symptoms of cardiac disease and with normal results for an exercise test, was selected as a 
control group for the evaluation of LV function variables at rest and during exercise. 
The characteristics of patients and controls have been discussed previously in Chapter 3. 
On admission all patients underwent a symptom-limited treadmill exercise test using_ the 
Chung protocol (27), before being accepted onto the exercise cardiac rehabilitation 
programme. Respiratory gas analysis using a metabolic cart was carried out and peak oxygen 
uptake was determined. 
Radionuclide ventriculography, using the equilibrium multi-gated blood pool technique ( 44) 
was performed at rest in all patients and controls and, during exercise, in the supine position 
in all but 26 ET6 patients using the protocol previously discussed. As in previous studies, 
EDC, ESC, SC, EF, T-PER, PER, AV-ER, T-PFR, PFR and AV-RFR were derived from 
time-activity curves. The use of counts and particularly of their percentage change from 
rest to exercise as an expression of volume change, has previously been validated. 
All tests were repeated 6 and 18 months after the beginning of the exercise programme. 
The exercise training programme was medically supervised and of 6 and 18 months duration. 
The intensity of exercise was set at the heart rate achieved at the ventilatory threshold 
measured during the initial treadmill testing. Patients were required to exercise at their 
prescribed intensity 3 times a week continuously for 30-45 minutes. Aerobic exercise 
consisted of walking or jogging or stationary cycling if weight-bearing exercise was 
contraindicated. The exercise session was preceded by a warm-up and followed by a 
cool-down period. Each patient was progressed slowly over a number of weeks up to his 
ultimately required intensity of exercise. 
Each patient's compliance with the programme was monitored on a daily basis and recorded 
on a computer. The following variaj:)les were recorded: training heart rate expressed in 
absolute values and as a percentage of the maximal heart rate, training oxygen uptake 
expressed in absolute values and as a percentage of peak V02, attendance expressed as a 
percentage of the possible sessions, and caloric expenditure per session expressed in 
kilocalories (kcal). Kilocalories per session were calculated as the product of the intensity of 
the exercise session in METs multiplied by body weight in kg and by the duration of the 
exercise session expressed as minutes/62_: 
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Statistical Analysis 
For the purposes of this study percentage attendance was used as a measure of compliance 
and patients were classified into compliance categories. The cohort ET6 was divided into 4 
compliance categories: 16 patients, <40% attendance (Cl 6); 23 patients, ~40-<60% (C26); 33 
patients, ~60-<80% (C36); and 46 patients, ~80% (C46). The cohort ET18 was divided into 3 
compliance categories by averaging the attendance between admission and 6 months and 
between 6 and 18 months: 11 patients, <60% (Cl, 8); 14 patients, ~60-<80% (C2 18); and 15 
patients ~80% (C3 ,8). 
Normal subjects were compared to patients in all compliance categories, on admission to 
the programme, with respect to their systolic and diastolic left ventricular function at rest 
and during exercise. 
The effect of exercise training on physiological and left ventricular function variables was 
evaluated separately in the two cohorts of patients ET6 and ETl 8, by analysis of variance 
using the Wilks' Multivariate Lambda criterion, according to compliance category. When 
significant differences were indicated in the analysis of variance, pairwise comparisons 
were made with t tests. All data are expressed as mean~ standard error. A p value of less 
than or equal to 0.05 was 11ccepted as statistically significant. 
Because of the great variability in individual responses when dealing with L V parameters, 
we calculated the interval mean + 2 standard deviations for all left ventricular variables in 
the control group, at rest and during exercise and determined the number of patients below, 




There were no differences in medical condition and medication use between patients in the 
different compliance categories for both cohort of patients. 
8.3.1 Compliance with the exercise programme 
The compliance data for the ET6 cohort is shown in Table 8.1 and for the ET18 cohort in 
Table 8.2. 
In ET6, the only differences were that patients in C36 and C46 exercised at a higher 
percentage of the maximal heart rate than did patients in Cl 6 and C26. 
In ET18, patients exercised at a higher intensity but attended less during the second period 
between 6 and 18 months than during admission and 6 months. Between 6 and 18 months 
patients exercised at a higher training heart rate (p=0.001), at a higher percentage of the 
maximal heart rate (p=0.039), at a higher oxygen uptake (p=0.001), had a higher caloric 
expenditure per session (p=0.004) and a lower percentage attendance (p=0.001). A higher 
oxygen uptake during exercise sessions as well _as a lower attendance were consistent in all 
compliance categories during the same period. 
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Table 8.1 Compliance data for the cohort-6 of patients with coronary artery disease per 
compliance category. 
ET-6 C16 C26 C36 C46 p 
0-6 ms <40% :?:40 - <60 % :?:60-<80 % :?:80% 
n=l 18 n=16 n=23 n=33 n=46 
THR (bpm) 112.1 109.0 113.7 111.7 112.7 NS 
(15 .2) (16.5) (15.1) (13.4) (16.4) 
%MHR 78.3 75.8 76.2 79.5 79.3 0.047 # 
(6.1) (6.8) (6.5) (5.6) (5.7) 
TV02 (ml/kg/min) 18.2 17.7 17.7 18.8 18.3 NS 
(4.7) (3.4) (5.0) (4.3) (5.3) 
%PEAK V02 71.3 71.1 70.7 72.6 70.7 NS 
(7.8) (7.6) (6.7) (7.9) (8.5) 
% ATTENDANCE 67.8 24.4 49.9 68.4 91.3 0.0001 * 
(24.3) (12.3) (5.5) (6.1) (6.7) 
KCAL/SESSION 267.5 261.8 269.3 272.1 265.4 NS 
(93.9) (107.4) (107.8) (86.3) (89.8) 
Values are expressed as Mean (Standard Deviation) 
# 1 vs 2, p=NS; 1 vs 3, p=0.052; 1 vs 4, p=0.047; 2 vs 3, p=0.048; 2 vs 4, p=0.044; 3 vs 4, p=NS. 
* p=0.0001 for all. 
C: compliance; KCAL: kilocalories; ms: months; %MHR: -percentage of maximal heart rate;% PEAK V02: 













Compliance data for the cohort-18 of patients with coronary artery disease 
per compliance category. 
ET-18 Cl1s C21s C31s 
n=40 <60% ~60 - <80 % ~80% 
n=ll n=l4 n=l5 
0- 6 ms 6-18 ms 0- 6 ms 6-18 ms 0-6 ms 6-18 ms 0-6 ms 6-18 ms 
110.4 117.9 111.5 118.1 111.6 119.4 108.3 116.5 
(12.4) (15.7) (5.8) (15.4) (11.0) (14.4) (17.0) (17.9) 
p=0.001 p=NS p=0.034 p=NS 
78.9 81.1 76.6 80.9 81.9 81.7 77.8 80.8 
(5.7) (4.2) (5 .9) (3.7) (3.1) (4.0) (6.5) (4.9) 
p=0.039 p=0.042 p=NS p=NS 
18.4 22.6 18.2 21.9 18.0 21.1 19.0 24.5 
(4.9) (6.7) (4.4) (4.6) (4.4) (6.6) (5.9) (7.9) 
p=0.001 p=0.003 p=0.015 p=0.008 
72.4 75.6 73.0 78.6 73 .5 72.1 70.8 76.7 
(8.5) (8.2) (9.7) (5.3) (7.1) (9.2) (9.1) (8.2) 
p=NS p=NS p=NS p=NS 
76.6 70.3 58.6 45 .6 74.2 58.9 93~5 84.6 
(16.6) (16.3) (9.5) (14.8) (9.8) (12.2) (8.2) (10.3) 
p=0.001 p=0.053 p=0.007 p=0.031 
71.0 52.1 66.6 89.1 
(16.5) (7.5) (6.6) (5.4) 
-
-
281.8 314.1 269.0 319.0 282.0 317.1 290.0 307.7 
(94.8) (98.3) (97.9) (119.9) (93.6) (94.8) (99.1) (90.8) 
p=0.004 p=NS p=NS p=NS 
Values are expressed as Mean (Standard Deviation) 
C: compliance; KCAL: kilocalories; ms: months; %MHR: percentage of maximal heart rate;% PEAK 
V02: percentage peak oxygen uptake; THR: training heart rate; TV02: training oxygen uptake. 
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8.3.2 Physiological adaptations after exercise training 
8.3.2.1 In patients attending for 6 months (ET6 cohort) (Table 8.3) 
After 6 months of exercise training, significant increases in peak V02 (Cl 6 : p=0.015, C26, 
C\ and C46 : p=0.0001) and peak ventilation (Cl 6 : p=0.004, C26: p=0.001, C36 : and C46: 
p=0.0001) were seen in all compliance categories. C26, C36 and C46 patients had an 
additional significant increase in ventilatory threshold (p=0.008, p=0.009 and p=0.0001 
respectively). Furthermore C26 and C36 patients had significant increases in treadmill time 
(p=0.001 and p=0.003 respectively) and peak heart rate (p=0.04 and p=0.035). C26 and 
C46 patients showed a significant decrease in blood pressure (p=().013 and p=0.023) and 
rate-pressure product (p=0.017 and p=0.0003) at a submaximal level. C46 patients in 
addition showed a significant reduction in resting and submaximal heart rate (p=0.004 and 
p=0.006 respectively) and a significant increase in submaximal V02 (p=0.006). C26 
patients showed a significant reduction in the Broca index (p=0.025) ) while C36 patients 
showed a significant increase in ST segment depression (p=0.014) and its duration in the 
post-effort period (p=0.004). 
8.3.2.2 In patients attending for 18 months (ET18 cohort) (Table 8A) 
The 3 compliance groups showed significant increases in peak V02 and peak ventilation 
after 6 months of exercise training which were maintained but not further increased by 18 
months of training. Significant increases in ventilatory threshold were also observed in 
C2 18 and C3 18 (p=0.003 and p=0.004 respectively) by 6 months, being also maintained by 
18 months (p=0.036 and p=0.043 respectively). Paradoxically only- Cl 18 showed 
significant reductions in heart rate (p=0.04), blood pressure (0.006) and rate-pressure 
product (p=0.009) at submaximal effort, probably because the initial test values were 
abnormally high. 
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Table 8.3 Effects of 6months of exercise training on physiological parameters of the 
cohort-6 of patients with coronary artery disease according to compliance category. 
C16 C26 C36 C46 
<40 % Attend. >40 - <60 % Attend. >60 - <80 % Attend. >80 % Attend. 
n=16 n=23 n=33 n=46 
VARIABLES Adm. 6 months Adm. 6 months Adm. 6 months Adm. 6 months 
Broca % 106.9 107.4 113.9 111.8 * 105.6 104.6 106.2 106.4 
(3.3) (3.3) (2.9) (3.0) 1.6 2.0 1.7 1.8 
Treadmill Time 11.5 12.2 11.3 13.6 # 11.5 13.2 # 11.5 12.3 
(min) (0.7) (0.6) (0.8) (0.7) 0.5 0.5 0.6 0.5 
Resting HR 71.7 70.4 72.6 69.8 72.2 73 .0 75.0 70.8# 
(bpm) (3 .0) (3.3) (2.7) (2.6) 2.8 2.4 2.4 2.2 
Peak HR 144.1 149.4 148.6 154.4 * 139.2 145.7 * 142.2 145.6 
(bpm) (5.2) (4.7) (3.9) (3.1) 3.1 3.7 3.1 2.9 
VT 16.8 16.7 16.5 18.6 # 17.4 19.0 # 16.4 19.1 # 
(ml/kg.rriin) (0.8) (0.8) (0.7) (0.8) 0.6 0.6 0.5 0.5 
Peak V02 24.8 26.9 * 24.4 28.7 # 25 .8 29.7 # 26.1 29.7 # 
(ml/kg.min) (1.3) (1.7) (1.3) (1.4) 1.0 1.1 0.9 1.1 
Peak VE 84.3 93.3 # 83 .2 98.4 # 81.6 96.1 # 84.7 96.9 # 
(L/min) (5.0) (5.2) (6.0) (5.9) 3.9 4.8 3.1 3.5 
PeakRPP 28.2 26.2 25.7 24.6 24.7 25.8 24.4 24.6 
(bpm.mmHg x 103) (1.5) (1.5) (1.3) (0.9) 1.1 1.1 0.9 0.8 
ST depression 0.50 0.44 0.61 0.50 0.27 0.61 * 0.51 0.58 
(mm) (0.30) (0.22) (0.20) (0.20) 0.10 0.16 0.11 0.13 
ST duration 1.25 2.62 2.00 2.61 1.06 3.61 # 2.63 2.76 
(min) (0.82) (1 .39) (0.77) (1.07) 0.45 0.94 0.74 0.64 
PeakRQ 1.06 1.09 1.07 1.07 1.06 1.08 1.05 1.07 
(0.02) (0.02) (0.02) (0.01) 0.01 0.01 0.01 - 0.01 
Submaximal HR 110.7 111.1 116.3 110.7 107.6 106.2 113.5 108.3 # 
(bpm) (4.1) (4.1) (4.2) (2.8) 3.3 3.2 3.4 3.1 
Submaximal BP 169.4 154.7 * 159.6 142.2 * 160.7 154.4 156.8 147.8 * 
(mmHg) (5.1) (6.1) (6.9) (4.7) 6.2 5.1 4.4 3.7 
Submaximal VE 43 .0 46.3 45.5 42.9 42.2 42.4 47.2 47.4 
(L/min) (2.8) (2.8) (2 .2) (1.6) 1.7 1.5 1.9 1.5 
Submaximal V02 16.4 17.6 16.9 17.5 17.6 18.5 17.7 19.1 # 
(ml/kg/min (0.8) · (0.7) (0.3) (0.7} 0.5 0.6 0.3 0.4 
Submaximal RPP 18.8 17.2 18.7 15.8 * 17.7 16.7 18.0 lfhO # 
(bpm.mmHgx 103) (1.0) (1.0) (1.1) (0.8) 1.1 0.9 0.9 0.6 
Values are expressed as Mean (Standard Error) 
* p<0.05; # p<0.01 (admission vs 6 months) 
Adm.: admission; Attend.: attendance; BP: blood pressure; C: compliance; HR: heart rate; RPP: rate-pressure product; 
RQ: respiratory quotient; SE: standard error; VE: ventilation; V02: oxygen uptake; VT: ventilatory threshold. 
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Table 8.4 Physiological parameters of the cohort-18 of patients with coronary artery disease on 
admission and after 6 and 18 months of exercise training according to compliance category. 
Cl1s C21s C31s 
<60 % Attendance >60 - <80 % Attendance >80 % Attendance 
n=ll n=14 n=15 
VARJABLES Adm. 6ms 18 ms Adm. 6ms 18 ms Adm. 6ms 18 ms 
Broca % 107.3 104.2 104.1 107.3 107.6 107.5 102.0 101.9 100.8 
(2.4) (3.1) (3.1) (4.5) (4.8) (4.6) (2.9) (2.8) (3.1) 
Treadmill Time 10.7 13.0 * 12.6 10.8 12.9 # 12.0 12.1 13.2 12.0 
(min) (1.0) (0.6) (0.5) (0.8) (0.9) (0.6) (1.1) (1.0) (0.7) 
Resting HR 71.4 69.2 70.7 78.3 79.2 75.8 71.3 67.4 67.7 
(bpm) (4.0) (3 .3) (3.8) (4.7) (3 .5) (3.2) (3.1) (2.9) (2.1) 
Peak HR 146.6 145.4 143.4 136.0 146.0 * 147.6 * 139.4 144.0 150.1 
(bpm) (3.7) (6.2) (5.3) (3.9) (4.8) (4.6) (4.9) (4.6) (4.3) 
VT 17.4 18.9 17.6 16.1 19.1 # 17.7 * 16.9 20.1 # 19.6 * 
(ml/kg.min) (0.8) (1.1) (0.7) (0.6) (1.1) (0.9) (0.8) (0.9) (1.1) 
PeakV02 24.6 28.2 # 27.5 # 24.7 29.0 # 28.7 # 27.4 31.8 # 32.0 # 
(ml/kg.min) (1.3) (1.5) (1.6) (1.6) (2.0) (2.0) (1.7) (1.9) (2.1) 
Peak VE 80.8 90.2 * 89.3 * 79.6 97.2 # 99.0 86.2 100.8 # 111.2 # 
(L/min) (6.8) (8.1) (6.6) (4.3) (6.9) (7.8) (5.9) (5.8) (9 .3) 
PeakRPP 27.6 24.3 24.6 23.4 24.3 25.2 24.2 24.7 24.8 
(bpm.mmHg x 103) (1.5) (1.7) (1.3) (1.6) (1.4) (1.5) (1.8) (1.8) (1.3) 
ST depression 0.27 0.32 0.27 0.14 0.36 0.25 0.37 0.07 0.07 
(mm) (0.14) (0.17) (0.19) (0.14) (0.17) (0.14) (0.20) (0.07) (0.07) 
ST duration 2.18 2.91 1.00 0.21 2.86 3.07 2.00 0.00 0.00 
(min) (1.13) (1.51) (0.75) (0.21) (1.45) (1.64) (1.45) (0.00) (0.00) 
PeakRQ 1.03 1.06 1.06 1.06 1.08 1.07 1.07 1.06 1.07 
(0.02) (0.02 (0.03) (0.03) (0.01) (0.03) (0.02-) (0.03) (0.03) 
Submaximal HR 115.9 105.0* 106.4 106.1 108.3 110.9 109.3 100.8 107.8 
(bpm) (6.2) (4.5) (4.7) (4.5) (4.6) (4.3) (5.1) (4.2) (4.3) 
Submaximal BP 173.4 146.0 # 149.9 148.7 148.3 149.9 158.4 149.3 145.4 
(mmHg) (7.7) (4.5) (10.8) (6.8) (7.6) (7.1) (11.1) (7.9) (6.6) 
Submaximal VE 47.5 43.6 40.7 47.7 43.1 41.2 43.3 50.2 52.7 
(L/min) (4.1) (2.5) (2.4) (3.1) (2.6) (2.3) (2.4) (2.5) (2.8) 
Submaximal V02 18.2 18.2 17.8 18.2 18.2 17.5 17.1 20.4 20.4 
(ml/kg/min (0.3) (0.8) (0.8) (0.6) (1.0) (1.1) (0.5) (0.6) (1.0) 
Submaximal RPP 20.3 15.4 # 17.3 16.0 16.3 16.8 17.8 15.0 - 15.6 -
(bpm.mmHgx 103) (1.7) (0.9) (2.0) (1.2) (1.4) (1.3) (1.8) (1.0) (0 .8) 
Values are expressed as Mean (Standard Error). 
* p<0.05; # p<0.01 (admission vs 6 months and admission vs 18 months). 
No significant changes were seen when comparing 6 months vs 18 mon'ths for all groups. 
Adm.: admission; ms: months. Other abbreviations as per Table III. 
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8.3.3 Left ventricular function after exercise training 
8.3.3.1 In patients attending for 6 months (ET6 cohort) (Table 8.5) 
Apart from a significant reduction in resting heart rate in C26 (p=0.035) and in EDC in C46 
(p=0.035) there were no changes in resting left ventricular function after 6 months of 
exercise training. 
During exercise, cardiac output was increased before and after training in all compliance 
categories through a significant increase in heart rate (p=0.0001 respectively). However in 
C46, the magnitude of the increase was greater after, than before training (p=0.036). EDC 
and SC tended to be further reduced during exercise after training, the magnitude of the 
change being significant only in C3 6 (p=0.037) for the former and in Cl 6 (p=0.027) and 
C36 (p=0.028) for the latter. EF fell during exercise in all groups, both before and after 
training. However, the magnitude of the change from rest to exercise showed a trend 
towards a lower decrease in C36 and C46, a similar decrease in C26 and a further decrease 
in Cl 6 after exercise training. T-PER and T-PFR were reduced to a similar extent before 
and after training. In C26, C36 and C46, PER increased significantly during exercise and to 
the same extent before and after training. In Cl 6, PER did not show a significant increase 
during exercise after training. AV-ER tended to increase further during exercise after 
training in C26, C36 and C46, while it was significantly reduced after training in Cl 6 
(p=0.027). PFR and AV-RFR increased significantly during exercise before and after 
training in all compliance categories. The magnitude of the change was significantly 
greater after training for both parameters in C46 (p=0.037 and p=0.046 respectively) and 
for PFR in C26 (p=0.04). 
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8.3.3.2 In patients attending for 18 months (ET18 cohort) (Table 8.6) 
After 18 months of exercise training and at rest, HR was significantly reduced in C3 18 
(p=0.039) and PFR and AV-RFR significantly reduced in C2 18 (p=0.032 and p=0.042 
respectively). 
ETl 8 patients had a very similar response in left ventricular function from rest to exercise, 
before and after 6 and 18 months of training. Cl 18 and C3 18 patients showed no changes. 
C2 18 patients showed a significant reduction in the percentage change from rest to exercise 
in EDC and SC by 6 months (p=0.02 and p=0.028 respectively), a reduction which was 
maintained by 18 months for SC (p=0.019). In the same group, in PFR and AV-RFR the 
exercise-induced increase was_ greater after training particularly after 18 months (p=0.033 
and p=0.012 respectively). 
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8.3.4 Individual responses to exercise training 
The wide variation in individual responses as a result of exercise training in cardiac 
patients suggests that means should be interpreted with caution. 
However, in all compliance categories and for both cohorts, there were very few changes 
in individual left ventricular function responses to exercise training when expressed as a 
function of the responses of the control group (Chapter 3). Furthermore, there were no 
differences in individual responses between compliance categories before or after training. 
8.3.5 Differences in physiological and left ventricular function variables between 
compliance categories 
There were no substantial significant differences between compliance categories for both 
physiological and resting and exercise left ventricular function variables, on admission or 
after 6 and 18 months of exercise training. In ET6, the Broca index was significantly 
higher in C26 than in the other compliance categories (p<0.05), and heart rate rose more in
 
C26 and C36 at 6 months than in C46 (p=0.0009 and p=0.049 respectively) 
during the 
exerci~e radionuclide ventriculography test. In ET 18, the only significant differences 
between compliance categories were seen for resting heart rate that was higher in C2 18 
than in Cl 18 and C3 18 at 6 months (p=0.044 and p=0.011 respectively), submaximal 
ventilation that was higher in C3 18 than in Cl 18 and C2 18 at 18 months (p=0.003 and 
p=0.002 respectively), heart rate during exercise radionuclide ventriculography that was 
higher in C2 18 than in Cl 18 and C3 18 at 6 months (p=0.018 and p=0.029 respectively) and 
than C3 18 at 18 months (p=0.008), _and resting SC that were lower in C3 18 than in C2 18 on 
admission (p=0.049). 
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8.3.6 Prevalence of systolic dysfunction in patients with different levels of 
compliance to the training programme (Table 8.7) 
There were no significant differences in the number of patients with severely depressed 
(EF<35%), moderately depressed (EF ~35 - <50%) and normal (EF ~50) systolic left 
ventricular function between compliance categories for both cohorts of patients. 
8.3. 7 Differences in left ventricular function between patients and controls 
On admission to the programme, all compliance groups for both cohorts, ET6 and ET18, 
showed similar significant differences in systolic and diastolic left ventricular. function to 
the control group. These differences were similar to those previously reported for the 
whole ET6 cohort in Chapter 3. 
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COMPLIANCE <35 % ?:35 - <50% ;?:50% TOTAL 
<40% 3 2 11 16 
18.7 12.5 68 .7 
16.7 7.4 15.1 
;?:40 - <60% 2 6 15 23 
8.7 26.1 65 .2 
11.1 22 .2 20.5 
;?:60 - <80% 4 5 24 33 
12.1 15.1 72.7 
22.2 18.5 32.9 
;?:80% 9 14 23 46 
19.6 30.4 50.00 
50.0 51.8 31.5 
TOTAL 18 27 73 118 
Likelihood Ratio Chi-Square= 0.367 
COHORTET18 
EJECTION FRACTION 
COMPLIANCE <35 % ;?:35 - <50% ;?:50% TOTAL 
<60% 1 0 10 11 
- 9.1 0 90.9 
12.5 0 40.0 
;?:60 - <80% 3 3 8 14 
21.4 21.4 57.1 
37.5 42.9 32.0 
280% 4 4 7 15 
26.7 26.7 46.7 
50.0 57.1 28.0 
TOTAL 8 7 25 40 
-
Likelihood Ratio Chi-Square= 0.103 
Values are expressed in the following order: frequency (top); row percent (middle) and 
column percent (bottom) 
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8.4 Discussion 
The design of our study, by companng individuals with different attendance to the 
exercise programme, allowed patients to decide for themselves whether they wanted to 
attend exercise sessions or not. The conclusions derived from such design are obviously 
not as powerful as those derived from a controlled randomised study, which could be 
considered unethical, today, in the light of our knowledge about the benefits derived from 
exercise rehabilitation programmes. 
Our approach in terms of compliance categorization led to a small number of individuals 
in each group but it is this same stratification by compliance category that constitutes the 
greatest strength of the study allowing us to establish a threshold level above which 
patients can obtain maximal favourable physiological adaptations. 
Prevalence of myocardial infarction, medication use, presence of residual myocardial 
ischaemia, peak oxygen uptake and left ventricular function were no different between 
patients in the different compliance categories upon enrollment into the cardiac 
rehabilitation programme. These similar baseline characteristics between compliance 
categories support the hypothesis that the results seeing in this study are a consequence of 
the differences in attendance rather than the result of self-selection of healthier subjects to 
the better adherence group. 
The first important finding of this study was that exercise training of 6 months duration 
resulted in the most favourable physiologic adaptations during both maximal and 
submaximal exercise. Exercise training of 18 months duration only served the purpose of 
maintaining the changes in maximal exercise tolerance obtained at 6 months, as well as the 
favourable changes in ventilatory threshold, but was unable to sustain the beneficial 
submaximal changes in haemodynamics that were seen at 6 months. A lower attendance 
during the period 6-18 months than in the period admission-6months, as well as 
progression of the disease leading to a more unfavourable myocardial oxygen supply and 
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demand balance, could explain the lack of maximal adaptations to training after 18 
months. 
The · second important finding of the study was that maximal adaptations to training 
including an improvement in maximal exercise capacity, an improvement in cardiovacular 
efficiency demonstrated by beneficial changes during submaximal exercise and a resting 
bradycardia, required an attendance equal or greater than 80% for a period of 6 months. 
Third, it is also in the group with the highest compliance that favourable changes in LV 
function were observed. The 18 month cohort failed to elicit any further changes in L V 
function irrespective of the compliance with the programme. Patients who attended 80% or 
more sessions during the 6 month period showed a significantly greater increase in PFR 
and AV-RFR during exercise and a trend towards a lesser reduction in SC, a lesser fall in 
EF and a greater increase in PER during exercise than the other groups. On the other hand, 
patients with the lowest compliance (<40%) had the greatest decrease in SC and greater 
reduction in EF and AV-ER during exercise. Furthermore, even patients attending between 
60 and 80% of the possible exercise sessions did not show any deterioration in EF or AV-
ER, and ESC were more reduced after training, in spite of these patients having had an 
increase in ST segment depression and its duration post-effort. 
Since EDC failed to increase, an increase in heart rate from rest to exercise was the main 
mechanism by which patients in this study were able to maintain an adequate cardiac 
output during exercise, both before and after training. The increase in heart rate during 
exercise was significantly greater after training only in patients with the highest 
compliance. Such response could be due to a higher sympathetic activity or an increased 
sensitivity to catecholamines as a result of trainl!ig and could be indicative of some-
improvement in contractile function even in the absence of a larger increase in SC at 
similar changes in EDC and of a reduction in ESC. 
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The definite improvement in diastolic function and the trend towards better systolic L V 
function during exercise in patients who attended ~80% of the sessions is probably a 
consequence of a reduction in myocardial oxygen demands since heart rate, blood pressure 
and rate-pressure product at submaximal effort were significantly reduced in these patients 
after 6 months of exercise training. Since alterations in diastolic function occur early after 
occlusion of the coronary vasculature and improvements in diastolic function are also seen 
early after successful percutaneous transluminal coronary angioplasty (222), a faster and 
more meaningful improvement in diastolic rather systolic function could be expected in 
the presence of a more favourable balance between myocardial oxygen demand and supply 
after training. It is possible that meaningful changes in systolic function may require more 
intense training as has been suggested by some (115, 199,201). 
Patients in the highest compliance categories (>80% and between >60 and <80% of the - -
possible sessions) also trained at a significantly higher percentage of maximal heart rate 
than patients in the lower compliance categories. However only the group who attended 
80% or more of the possible sessions exhibited the greatest benefits. It is interesting to 
note that the energy expended per session expressed in kilocalories was the same for both 
groups indicating that these two groups only differed in the volume of exercise 
accumulated over time. Hence, volume appears to be more important than exercise 
intensity in these adaptations suggesting that there is a threshold in exercise volume above 
which exercise could induce maximal physiological changes and beneficial central 
adaptations in these patients. 
Our results in patients who complied with 80% or more of the possible sess10ns are 
somewhat different from most studies where the intensity of exercise training was set 
between 70 and 85% of the patient~ maximal heart rate that -showed little change in L V 
function after exercise training in patients with CAD (98,99, 103,134, 195-198). 
Ehsani and colleagues (115) showed that prolonged and intense exercise training 1s 
capable of improving the left ventricular systolic function of coronary artery disease 
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patients. In their study V02 max increased by 37% from 23 to 31.5 (p<0.001) as a result of 
training and submaximal HR, SBP and RPP at the same workload were significantly 
lower. Five of the 10 patients who had effort angina became entirely asymptomatic. The 
magnitude of ST segment depression was significantly less (0.16 ± 0.02 before and 0.09 ± 
0.03 after, p<0.005). EF at rest was unchanged, but was increased at the work rate 
equivalent to the peak work rate before training (51 ± 3 vs 57 ± 3 % after training, 
p<0.005) and during maximal supine exercise (58 ± 3 vs 52 ± 3 % before training, 
p<0.001). LV exercise reserve (change in EF from rest to exercise) was -1.0 ± 1% before 
and 4.0 ± 1 % after training (p<0.005). They also concluded that the primary mechanism 
for improvement in L V function in the majority of the patients was an improvement in 
contractility due to a reduction in myocardial ischaemia. Since patients adapted to this 
training regime have previously attained a higher concentration of plasma norepinephrine 
which per se raises myocardial oxygen demands, the improvement in L V contractile 
function in their patients was not likely due to a lower myocardial oxygen requirement, but 
rather to an improvement in oxygenation of some of the underperfused regions of the 
myocardium. 
The fall in EF during exercise in our patients was caused by a decrease in SV with a 
minimal change in EDY. In spite of EF falling in all patient groups both before and after 
training, a trend towards less reduction in SC an? EF was observed the higher the 
compliance. Our results are similar to those of Hindeman and Wallace (258), who 
compared the haemodynamic response to exercise conditioning of 14 subjects with 
coronary artery disease and normal subjects by performing first pass radionuclide studies 
in the erect position before and after 6 months of training. They reported that perhaps one 
of their most important findings was that ejection fraction which fell in all subjects during 
exercise before training, failed to decrease in most subjects after training. _ A more 
attenuated response in our patients could be explained by the fact that our patients 
exercised in the supine position and Hindeman's upright. 
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The Fick equation defines the relationship between cardiac output and the arteriovenous 
oxygen difference to V02 during exercise: V02 = Cardiac Output x arteriovenous 0 2 
difference. Since Cardiac Output = Stroke Volume x Heart Rate and Stroke Volume = EF 
x End-Diastolic Volume, the relationship can be expressed as: V02 = EF x End-Diastolic 
Volume x Heart Rate x arteriovenous 0 2 difference. At a submaximal level, the significant 
increase in V02 seen in our patients in the presence of an unchanged stroke volume 
suggests a compensatory increase in the arteriovenous oxygen difference to balance the 
decrease in heart rate. At a maximal level, in the absence of an increase in end-diastolic 
volume and EF, our results suggest that the increase seen in peak V02 after 6 and 18 
months of exercise training is principally the result of an improved heart rate response to 
exercise and widening of the arteriovenous oxygen difference. This is in keeping with 
most studies which have shown skeletal muscle changes -improved capillary supply and 
increased oxidative enzymes- after training in patients with coronary artery disease 
(98,134,259) and normal subjects (260-263). 
Furthermore, the L V response to training in our patients could also be explained by the 
age-related impairment of L VEF response to exercise which is characterized by a smaller 
rise in EF and a lack of decrease in ESV at peak exercise in the elderly compared with 
young subjects. This age-related deterioration in LV systolic function could be improved 
by relatively prolonged vigorous exercise training in older men (264,265), but not by 
programmes of moderate intensity. 
8.5 Conclusions 
Compliance m terms of attendance had-a significant influence on the changes in 
physiological and left ventricular function variables induced by exercise training of 6 
months duration. Patients who attended 80% or more of the possible sessions showed in 
addition to a significant increase in maximal exercise capacity, a resting bradycadia and a 
significant reduction in heart rate and blood pressure during submaximal exercise. These 
228 
favourable adaptations were matched by a significant improvement in diastolic function 
during exercise and a trend towards an improvement also in systolic function. Attendance 







9.1 Final Discussion 
We succeeded in addressing several methodological issues raised by previous studies and 
discovered novel findings about the relationship between left ventricular function and 
exercise tolerance in patients with coronary artery disease undergoing exercise training in 
a community-based cardiac rehabilitation programme in Johannesburg, South Africa. 
We studied a wide spectrum of patients with documented coronary artery disease 12 weeks 
post-myocardial infarction and post-coronary artery bypass surgery and 4 weeks post-
coronary angioplasty referred to a cardiac rehabilitation programme. Previous studies 
evaluated mainly patients post-myocardial infarction while admitted to the hospital or 
shortly after their cardiac event. These patients are not necessarily representative of 
patients attending outpatient cardiac rehabilitation programmes. Furthermore those studies 
do not take into account the spontaneous improvement in left ventricular function during 
the healing process. 
It is possible that the subjects enrolled into this study were not fully representative of the 
general population of patients with coronary artery disease because of prescreening by 
referring physicians in favour of motivated subjects or subjects thought to be poor 
candidates for surgical revascularization procedures. In addition there was self-selection of 
those subjects who continued in their exercise programmes for the duration of the study or 
who chose to comply more fully with the programme. Despite these potential selection 
factors, our study population included individuals with a broad range of clinical 
characteristics at baseline. Because of the heterogeneous nature of our study population, 
the possibility existed that physiologically significant effects of training occurring only 
within certain subgroups might be obscured by an analysis of data from the entire group. 
We used a control group representative of a population of normal healthy subjects for the 
measurements of left ventricular function while previous studies used institutionalized 
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patients without demonstrable coronary artery disease who were expected to have normal 
function, as their control group . 
We used a method of assessment of left ventricular function that allowed us to quantify 
with precision systolic as well as diastolic function, at rest and during exercise expanding 
the results obtained in previous studies that evaluated only systolic left ventricular function 
at rest. 
We evaluated a complete spectrum of left ventricular dysfunction by dividing patients into 
3 categories according to their level of impairment in L V systolic function. Most 
investigators have used an arbitrary cut-off point in ejection fraction as the criteria for 
classification of their population. 
Adherence to the training regime was taken into account when reporting results after 
exercise training. We used two different criteria: (a) For most studies, compliance with 
attendance was monitored to ensure that participants completed at least 60% of the 
exercise sessions during the period studied. (b) When we evaluated the effects of exercise 
training on left ventricular function, we divided patients into 4 categories according to 
their compliance with the exercise training program. This allowed us to use patients with 
poor attendance as a control group. 
Patients were enrolled into the study consecutively depending on their availability and 
consent for radionuclide ventriculography studies. We studied two major cohorts of 
patients: Cohort 1 included 171 patients who had the radionuclide ventriculography test 
done on admission and at rest only, and Cohort 2 included 118 patients who had the tests 
done on admission and after 6 months, at rest and during exercise. 
We confirmed our suspicions that patients enrolling into a contemporary community-based 
cardiac rehabilitation programme are of increasing medical complexity because of 
associated left ventricular dysfunction and/or myocardial ischaemia: 
232 
In Chapter 3 we compared the left ventricular function of patients in cohort 2 to that of 
a control group and found that patients had profound alterations in diastolic and/or 
systolic left ventricular function both at rest and during exercise. In Chapters 3 and 4 
we demonstrated that both cohorts were very consistent in the number of patients with 
moderate (EF>35 and <50%: cohort 1- 22 % vs cohort 2 - 23%) and severe (EF<35%: 
cohort 1- 16% vs cohort 2 - 15%) left ventricular dysfunction. 
We also found that several patients had residual myocardial ischaemia as assessed by 
electrocardiographic criteria: in Cohort 1 there were 38 patients with ST segment 
depression (22%) (Chapter 4) and in Cohort 2 there were only 9 (8%) (Chapter 3). In 
Chapter 6, we also identified 22 patients with myocardial ischaemia using a combined 
electrocardiographic and radionuclear myocardial perfusion imaging criteria (Cohort 
3). Risk stratification guidelines stratify patients according to the presence of left 
ventricular dysfunction and myocardial ischaemia, into low risk (no ischaemia, normal 
L V function), moderate risk (moderate ischaemia and L V dysfunction) and high risk 
(severe myocardial ischaemia and L V dysfunction). If our cardiac rehabilitation 
programme can be considered representative of other cardiac rehabilitation 
programmes around the world, we could conclude that a higher percentage of moderate 
to high risk patients are being accepted today into this type of programmes. Since we 
know that the incidence of exercise-related cardiovascular complications increases 
with the risk of the population studied, we have to assume that the risk of these 
complications could easily increase if cardiac rehabilitation practitioners do not adhere 
to risk stratification guidelines to guide the monitoring of their patients. 
Patients with severely depressed left ventricular function had a significantly lower exercise 
tolerance (Chapter 4) than patients with moderately impaired or normal LV function on 
-
admission to the programme, as evidenced by lower peak oxygen uptake, lower ventilatory 
threshold and lower treadmill time. However, the degree of adaptation to training was the 
same for all patients regardless of their degree of resting systolic or diastolic left 
ventricular dysfunction as demonstrated by equivalent increases in peak oxygen uptake, 
ventilatory threshold and treadmill time to exhaustion in all groups (Chapter 4). The 
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reporting of improvements in exercise tolerance in patients with chronic heart failure is not 
new. Earlier studies showed that improvements in maximal exercise capacity could be 
seen in patients with modest impairment in left ventricular function (Letac et al. (98): 
EF<45% and Lee et al. (132): EF<40%) and in patients with more severely depressed LV 
function (Cohn et al. (133): mean EF=27% and Sullivan et al. (134): mean EF=24%; Coats 
et al. (136): mean EF=l9%). 
However we are the first to report that the degree of improvement in exercise capacity is 
the same for patients with severely depressed (EF<35%), moderately depressed (EF<50 
and :::35%) and normal left ventricular function (EF:::50%). 
Our findings that the exercise tolerance of patients on admission or its improvement after 
training could not be predicted in any group by baseline measurements of resting systolic 
or diastolic left ventricular function (Chapter 4) is then not surprising. Our results are 
consistent with those of other studies that have also reported a lack of correlation between 
ejection fraction and exercise tolerance in patients with chronic left ventricular dysfunction 
(226-228). 
However, in most studies the correlation was restricted mainly to patients with severe 
heart failure and not made across a wide spectrum of patients with various degrees of left -
ventricular dysfunction. Perhaps of more novel interest is our finding about the lack of 
correlation between diastolic function and exercise capacity since little has been published 
about the relationship between these two variables. Since alterations in the diastolic 
properties of the myocardium may limit or prevent the increase in stroke volume during 
exercise (18_4), it would have been expected tha! patients with diastolic dysfunction had 
lower exercise capacity. But traditional non-cardiac factors such as age, gender, the Broca 
Index and forced vital capacity included in a multiple regression model explained nearly 
50% of the variance in exercise capacity. 
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It was previously thought that training patients with severe left ventricular dysfunction was 
unsafe because of possible training-induced deleterious effects on their already 
compromised left ventricle. In addition, it is well known that these patients are at higher 
risk of sudden death during exercise. These were some of the reasons for excluding 
patients with chronic heart failure from cardiac rehabilitation programmes. Cardiac 
rehabilitation is not well developed in South Africa and it was the responsibility of its 
largest cardiac rehabilitation programme to prove that patients with L V dysfunction could 
exercise safely in programmes of this type and derive physiological benefits. 
Accordingly, in Chapter 5 we were able to show significant increases in maximal exercise 
capacity and a reduction in the rate-pressure product at a submaximal workload as a result 
of training in 22 patients with EF<30%. These results are similar to those reported for 
patients in the EF<35% category in Chapter 4. The main difference between the two 
studies is that in this study, we measured the ejection fraction at rest and during exercise 
before and after exercise training and we were able to demonstrate that exercise training 
did not induce any deleterious effect in the left ventricular function of these patients. 
Although it remains unknown whether these favourable physiological adaptations could 
improve the prognosis of these patients, they were still alive after a mean follow-up of 26 
months (8 to 32 months). These results are quite hopeful if we consider that 10 of our 
patients have had congestive heart failure while in the hospital and a 26% 1 year mortality 
has been reported for patients with a history of signs and/or symptoms of heart failure 
(119). We could speculate that the reduction in resting heart rate seen in our patients after 
training, a manifestation of an increase in vagal tone, could have increased their resistance 
for fatal ventricular arrhythmias as it has been seen in animal models (122). 
It is interesting to note that only patients with severely depressed-BF (<35%) on admission 
to the programme, had an abnormally increased ventilatory response to exercise, that is, a 
higher VENC02 ratio at submaximal and maximal levels and a higher VENC02 slope 
(Chapter 7). Patients with moderate left ventricular impairment had a similar ventilatory 
response to those with normal LV function. However this is the first study to show these 
235 
changes in asymptomatic patients in NYHA functional classes I and II who did not have 
clinical signs and symptoms of congestive heart failure, since the other studies included 
patients mainly in classes II and III, with overt heart failure and who were on treatment 
with diuretics and digoxin (134,147,250,252,254-256). The higher the severity of heart 
failure, as assessed by the peak oxygen uptake, the higher the ventilatory response to 
exercise. Since patients whose peak V02 fell below 20 ml/kg/min seemed to have the 
higher ventilatory response, we could hypothesize that an inadequate cardiac output in 
these patients lead to lack of perfusion of certain ventilated areas of the lungs (253) 
producing a ventilation perfusion mismatch and an increase in dead space ventilation. 
Again these were the patients with the lowest ventilatory efficiency. Although exercise 
training increased maximum oxygen uptake and maximum ventilation in all patients 
irrespective of their left ventricular function, it was ineffective in reducing the higher 
ventilatory response to effort at any level of VC02 in the group of patients with more 
severe LV impairment (Chapter 7). There was good correlation between a low ejection 
fraction, peak oxygen uptake and the slope of the relation between minute ventilation and 
carbon dioxide production indicating as it has been suggested by others (252) that the 
latter could provide a more objective way of evaluating the degree of severity of heart 
failure since it is not dependent of the patient's motivation while doing the test. 
It was important to analyse the relationship between ischaemia and left ventricular 
function since it has previously been reported that patients with chronic heart failure and 
myocardial ischaemia may show a deterioration in their left ventricular function without 
any associated physiological benefits as a result of exercise training (190). This hypothesis 
was tested in different ways using different population groups. In Chapter 4 we 
demonstrated that all 7 patients with myocardial ischemia from the group with severely 
- -
depressed LV function (EF<35%) showed an improvement in maximal exercise tolerance 
as evidenced by a mean increase of 16% in peak V02• Only 1 of 6 patients with 
myocardial ischaemia in the group with moderate L V impairment did not improve his 
maximal oxygen uptake but the remaining 5 patients improved their mean peak oxygen 
uptake by 13.8% after training. In Chapter 5 we reported no deterioration in left ventricular 
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function even in patients with associated myocardial ischaemia and 3 of the 5 patients who 
showed ST segment depression on admission normalized their ST segment response after 
training. Making a diagnosis of myocardial ischaemia based only on electrocardiographic 
criteria has important limitations, so in order to increase the sensitivity of the method 
throughout the study we required the ST segment changes to be present both during and 
after exercise for the response to be considered ischaemic. 
Since we are accepting more patients with myocardial ischaemia for cardiac rehabilitation, 
we decided also to evaluate the adaptability to exercise training of these patients and the 
effect of ischaemia on left ventricular function. For years we observed that a high 
percentage of these patients did not experience chest pain during their exercise test in spite 
of clear electrocardiographic changes. In this regard some reports have indicated that the 
presence of pain could indicate the presence of myocardium that is more at jeopardy. 
To overcome the electrocardiographic diagnostic limitations we utilised a well accepted 
imaging technique using Tc-SestaMibi which had the advantage of not being washed out 
in the immediate post-effort period allowing for the patient to be evaluated at another 
facility, in this case the Department of Nuclear Medicine of the Johannesburg Hospital 
which was two kilometres away from our Center. 
It is well accepted that a drop in ejection fraction during exercise, measured by 
radionuclide ventriculography, represents an imbalance between myocardial oxygen 
supply and demand and can be considered a strong indicator of exercise-induced 
myocardial ischaemia. Little is known however, about how exercise training can affect the 
association between ischaemia and left ventricular dysfunction. 
We studied the mechanisms by which ischaemia affects ventricular function at rest and 
during exercise in patients with normal left ventricular function (Chapter 6) speculating 
that they could 5e extrapolated to patients with L V dysfunction. We already discussed that 
patients with coronary artery disease at entry to our programme had significant alterations 
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in the contractile and filling properties of the left ventricle when compared with normal 
controls (Chapter 3). We found that the heart with ischaemia differed from the heart with 
left ventricular dysfunction in its method of maintaining the cardiac output during 
exercise. The mechanism by which patients with left ventricular dysfunction-maintained 
their cardiac output differed from healthy controls mainly at rest while in patients with 
myocardial ischaemia the differences between patients and healthy controls became more 
marked during exercise. Patients with systolic L V impairment maintained their cardiac 
output at rest at the expense of a chronic increase in end-diastolic volume and a higher 
heart rate than healthy subjects (Chapter 3). As reported by others (211), patients with 
myocardial ischaemia developed an acute ventricular dilatation during exercise with higher 
increases in EDC than the control group (Chapter 6). The increase in EDC post-effort in 
both groups, patients with_ left ventricular dysfunction and control group, suggests that as 
heart rate decreases patients and controls are both able to dilate their ventricles to maintain 
cardiac output in the post-effort period (Chapter 3). 
As a result of training, patients with myocardial ischaemia increased their peak oxygen 
uptake and ventilatory threshold but failed to improve their cardiovascular efficiency by 
reducing their heart rate and blood pressure at submaximal workloads. Exercise training 
also, did not change the relationship between ischaemia and left ventricular function. The 
twelve patients with myocardial ischaemia, in whom we were able to assess left 
ventricular function before and after exercise training, showed no major changes in their 
left ventricular function when re-evaluated 6 months later, but showed some signs that 
could be interpreted as early indicators of progression of disease (Chapter 6). 
As expected, the physiological benefits induced by exercise training varied with the 
number of sessions attended and the duration of the stay on the programme. Patients 
attending 80% or more of the possible sessions for a period of 6 months, showed the most 
optimal adaptations to exercise training demonstrating the greatest improvement in 
exercise capacity not only at maximal but also at a suhmaximal level. In addition they 
showed a resting bradycardia (Chapter 8). Our results are quite unique in that the same 
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patients also showed an increase in the heart rate response to exercise and an improvement 
in diastolic function by increasing peak filling rate and average rapid filling rate during 
exercise significantly more than patients who attended fewer sessions (Chapter 8). The 
possibility of spontaneous left ventricular function recovery was excluded by enrolling 
patients post-myocardial infarction or coronary bypass surgery 12 weeks after their event, 
so we can conclude that the changes in left ventricular function seen in our patients must 
have been produced by exercise training. Central adaptations have only been reported 
previously in programmes of higher intensity, higher frequency (5 times per week) and 
longer duration (12 months) (200). We found a threshold for favourable changes in 
diastolic function with an attendance around 90% of a possible 72 sessions, at an intensity 
around 78-80% of the patient's maximal heart rate which is the middle of the conventional 
range of 70 to 85% of maximal heart rate. It is very possible that an improvement in 
systolic function may require a higher volume of exercise. We postulate that a reduction in 
myocardial oxygen demands as seen in our patients after 6 months of training is the most 
likely mechanism for the improved diastolic function. This may have also contributed to 
the trend towards an improvement in systolic function seen in the same patients: a lesser 
reduction in SC, a lesser fall in EF and a greater increase in PER during exercise than the 
other groups. 
The patients who exercised for 18 months did so at the expense of a lower quality of 
attendance: 93.5 % during the first 6 months vs 84.6 % between 6 and 18 months and 
failed to demonstrate a reduction in heart rate and blood pressure at the same submaximal 
workload. This coupled to some signs suggestive of progression of disease probably 
explain the lack of improvement in left ventricular function in these patients. 
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9.2 Final Conclusions 
The most important conclusions. of this study are: 
1) That patients with left ventricular dysfunction constitute a significant proportion of 
patients admitted to contemporary cardiac rehabilitation programmes. 
2) That there is no correlation between measures of both systolic or diastolic LV function 
at entry to a cardiac rehabilitation programme, and exercise capacity, before or after 
training and that the physiological effects induced by exercise training are of a similar 
magnitude irrespective of the degree of impairment in these patients ' L V function. 
3) That patients with asymptomatic left ventricular dysfunction and an ejection fraction of 
30% or less can derive physiological benefits from exercise training, at both 
submaximal and maximal levels, without deleterious effects on their left ventricular 
function. That in spite of the above beneficial effects, exercise training was ineffective 
in reducing the excessive ventilatory response seen in this group of patients. 
4) That exercise training is able to improve the maximal exercise capacity of patients with 
residual myocardial ischaemia enrolling into cardiac rehabilitation programmes but is 
unable to elicit physiological adaptations during submaximal exercise or to increase 
the threshold for ischaemia. These results suggest that aggressive coronary risk factor 
modification, particularly lipid lowering, should complement exercise training in the 
rehabilitation of this group of patients in order to slow the progression of the disease. 
5) That the mechanisms used to maintain cardiac output at rest or to increase it during 
exercise are different between patients with left ventricular dysfunction and patients 
with myocardial ischaemia. Patients with left ventricular dysfunction use the Frank 
Starling mechanism at rest, maintaining their cardiac output through an increase in 
end-diastolic volume, whereas an increase in heart rate plays the more important role 
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during exercise. Patients with myocardial ischaemia do not differ from healthy controls 
in the way they maintain cardiac output at rest but they increase their cardiac output 
during exercise also through an increase in heart rate but most importantly by utilising 
the Frank Starling mechanism leading to acute ventricular dilatation. 
6) That adherence has a significant effect on the type and on the magnitude of adaptations 
derived from exercise training: Patients who participated in 80% or more of the 
possible exercise sessions for 6 months derived most physiological benefits from 
exercise training programmes being able to increase their maximal exercise capacity, 
improve their cardiovascular efficiency, reduce their resting heart rate and even 
improve their L V diastolic function during exercise. 
7) That attendance for 18 months does not offer physiological advantages other than 
maintaining the maximal exercise capacity achieved by 6 months. However it may 
play an important role in promoting longer lasting lifestyle changes. 
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9.3 Recommendations as a result of the findings of this study 
Recommendations are made for patients to be accepted onto cardiac rehabilitation 
exercise programmes irrespective of their degree of L V dysfunction. These patients 
can derive physiological benefits from this type of program and maybe increase their 
threshold for ventricular fibrillation without adverse effects on their L V function. 
These recommendations can be extended to patients with myocardial ischaemia with 
the understanding that fewer physiological benefits are to be expected as a result of 
their participation in these programmes and that efforts should concentrate on 
education, improvements in psychological wellbeing and coronary risk factor 
modification aimed at slowing the progression of the underlying disease process. 
Aggressive lipid management with diet and cholesterol lowering drugs may be more 
important than exercise alone in reversing the disease process in patients with 
demonstrable exercise-induced myocardial ischaemia. 
Even patients with both left ventricular dysfunction and associated myocardial 
ischaemia could benefit from participation in cardiac rehabilitation programmes. 
There is little doubt that patients being accepted to modem programmes are of 
increasing cardiac complexity and because of the above at a higher risk of exercise-
related complications. Practitioners must therefore adhere to risk stratification 
recommendations to guide the degree of monitoring of their patients during exercise 
sess10ns. 
Cardiac rehabilitation practitioners should monitor and enhance the compliance of 
_their patient_s during participation in exercise training programmes in order to 
maximise the beneficial results obtainable from this treatment modality. It is possible 
that through better adherence patients could achieved improvements in L V function in 
programmes of conventional intensity without the ne~d to embark into high intensity 
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